.,

,.

UNITED STATES OF AMERICAFEDERAL TRADE COMMISSION

OFFICE OF ADMINISTRATIVE LAW JUDGESWASHINGTON, D.C.

In the Matter of

BASIC RESEARCH, LLCA.G. WATERHOUSE, LLCKLEIN-BECKER USA, LLCNUTRASPORT, LLCSOV AGE DERMALOGIC LABORATORIES, LLCBAN LLC d//a BASIC RESEARCH LLC

OLD BASIC RESEARCH, LLCBASIC RESEARCH, A.G. WATERHOUSE,KLEIN-BECKER USA, NUTRA SPORT, andSOV AGE DERMALOGIC LABORATORIES

DENNIS GAYDANIEL B. MOWRY d/b/a AMERICAN

PHYTOTHERAPY RESEARCHLABORATORY, and

MITCHELL K. FRIEDLANDER,Respondents

PUBLIC

Docket No. 9318

RESPONDENTS' MOTION TO EXCLUDE A WITNESS AND FOR SANCTIONSOR. IN THE ALTERNATIVE. FOR SANCTIONS AND FOR LEAVE TO

REOPEN DISCOVERY FOR A LIMITED PURPOSE

Pursuant to Rule 3.38(a) ofthe Commission's Rules of Practice, 16 C.F.R. §

3.38(a), Respondents Basic Research, LLC; A.G. Waterhouse LLC; Klein-Becker USA

LLC; Nutrasport, LLC; Sovage Dermalogic Laboratories, LLC; Ban, LLC; Dennis Gay;

Daniel B. Mowrey d//a American Phytotherapy Research Laboratory; and Mitchell K.

Friedlander (hereinafter the "Respondents") respectfully move for an order: (1) to

exclude Dr. Steven B. Heymsfield (hereinafter "Complaint Witness") for his testimonial

lack of candor and wilful non-disclosure of information responsive to discovery and (2)

to impose sanctions (in the form of a formal reprimand) against each of Complaint

1

Counsel individually for their complicity in and condonation of the wrongful withholding

of information responsive to discovery. If the Presiding Officer elects not to exclude the

Complaint Witness, Respondents seek, in the alternative, (1) the aforementioned

sanctions and (2) leave to reopen discovery for the limited purpose of investigating all

matters germane to: (a) the failure ofthe Complaint Witness to disclose to Respondents

the existence of six fraudulent studies co-authored by him; (b) the generally accepted

standards for listing of publications on a scientist's currculum vitae; ( c) the ethical

responsibility of a co-author of scientific works to disclose fraudulent data in those

works; (d) the supervisory responsibility of a senior scientist co-author (here,

Heymsfield) for a junior scientist co-author's (here, Darsee's) work; and (e) the extent to

which Heymsfields August 30, 2005 testimony raises questions of his scientific

integrty, reliability, and independence that may impugn the competence and reliability of

his scientific opinion.

In accordance with Commission Rule 3.22(f), 16 C.F.R. 3.22(f), Respondents'

Counsel has conferred with opposing counsel in good faith in an effort to resolve via

mutual agreement the issues raised by this motion and has been unable to reach such an

agreement. A signed statement documenting the conference is attached as Exhibit 1. The

grounds for this motion are set forth below.

I. PROCEDURAL HISTORY

The Presiding Offcer entered a scheduling order on August 11,2004. In

paragraph 1 1 of that order he required:

At the time an expert is first listed as a witness by a party, the listing partywil provide to the other pary: (a) materials fully describing or identifyngthe background qualifications of the expert witness, a list of all

2

publications, and all prior cases in which the expert has testified or hasbeen deposed. (Emphasis added.)

Immediately preceding the second deposition ofHeymsfield, he supplied a list

presenting cases omitted from his initial case listing. That late disclosure led his Honor

to issue an order requiring Heymsfield to appear for a third deposition. In his Honor's

March 15, 2005 Order on Respondents' Motion to Strike Expert Witnesses and for

Sanctions and Other Relief, the Presiding Officer found the Complaint Witness to have

failed timely to list a number of cases in which he testified over the last thirty years. That

March 15 Order reads in pertnent part:

After his first day of deposition testimony, Heymsfield reviewed hisrecords and determined that he failed to list a number of cases that he hadtestified in over the last thirt years. Opposition at Ex. 6. An updated listwas provided to Respondents immediately prior to this second deposition.Opposition at 24-25. Since his second deposition, Complaint Counsel hasproduced a copy of Heymsfields tral testimony in connection with FTCv. SlimAmerica, 77 F. Supp.2d 1263 (S.D. FI. 1997). Notice at 1. Thisinformation should have been provided to Respondents in a timelyfashion. Complaint Counsel acknowledges the error and has offered tomake Heymsfield available for an additional four hours of depositiontestimony. Notice at 3. Ths should be more than enough time to allow all

Respondents to complete their deposition of Heymsfield and to remedyany har from the delayed disclosures.

At his August 30 deposition, Heymsfield begrdgingly admitted withholding

additional information. Despite the August 11 Scheduling Order requirement that he

provide Respondents "materials fully describing or identifyng (his) background (...) and

a list of all publications(.. . )," Heymsfield revealed for the first time on August 30, 2005

that he did not list on his curriculum vitae (and he did not otherwise give to Respondents)

six publications he co-authored with John Darsee that were based on fraudulent data and

were rescinded by the publications in question for the fraud. See Aug. 30, 2005 Depo. at

462-463, lines 24-25; 2-9. He admitted that he did not supply Respondents with any of

3

the six studies, Aug. 302005 Depo. at 462, lines 5-22. He also admitted that he informed

Complaint Counsel of the existence of the six fraudulent studies and his involvement in

them when first retained by Complaint Counsel in this case, as well as in prior cases. See

Aug. 30,2005 Depo. at 658-660, lines 13-25; 2-25; 2-6; 655- 657, lines 10-25; 2-25; 2-

16.

II. ARGUMENT

FTC Rule of Practice 3.38 provides that "it shall be the duty of parties to seek,

and Administrative Law Judges to grant, sanctions or other appropriate relief as may be

sufficient to compensate for failure to disclose documents as ordered." The facts arising

in Heymsfield's August 30, 2005 deposition amply justify sanctions against Heymsfield

and Complaint Counsel along with additional relief. As explained in detail herein, Dr.

Heymsfield intentionally withheld from Respondents for over a year the fact of his co-

authorship of the six fraudulent studies in violation of the Presiding Offcer's August 11,

2004 Scheduling Order. Moreover, Complaint Counsel are complicit in and have

condoned that wrongful witholding.

Heymsfield is a professional witness for Complaint CounseL. He has been

retained by Complaint Counsel in numerous prior proceedings. Heymsfield testified that

he informed Complaint Counsel of the six studies and the fraud at the time of his

retention in this case. Indeed, according to Heymsfield, he apprised Complaint Counsel

in prior cases as welL. See Aug. 30, 2005 Depo. at 658-660, lines 13-25; 2-25; 2-6.

The wrongful withholding of the fraudulent studies is not an isolated event, but

indicative of a general lack of candor. Heymsfield's answers to many questions posed in

the August 30, 2005 deposition are halting, evasive, and incomplete. The overall

4

misconduct warrants exclusion of this witness. The facts presented in detail infra also

warrant the requested sanction of a reprimand by name of each of Complaint CounseL.

If exclusion is not ordered, Respondents seek the aforementioned sanctions along

with a determination by the Presiding Officer that adverse inferences are warranted

against Heymsfield for his wrongful withholding and lack of candor. In addition,

Respondents ask that his Honor order discovery reopened for the limited purpose of

affording Respondents: (I) the opportnity to depose Heymsfield for one day, not to

exceed seven hours;J (2) the opportnity to depose and obtain documents from all other

witnesses who have knowledge of Heymsfields involvement in the co-authorship of the

six fraudulent Darsee studies and of the truthfulness of his August 30, 2005 testimony;

(3) the issuance of an order to Heymsfield compellng him under penalty ofpeijury to

provide Respondents with a complete list of all materials in his files or under his control

relating to his co-authorship of the six fraudulent Darsee studies.

As is shown by the deposition transcrpt that follows, Heymsfield has engaged in

wilful non-disclosure of information required to be supplied by the August 1 1, 2004

Scheduling Order and in halting and evasive testimony concering his involvement in the

six fraudulent studies, his subsequent statements to the press about the fraud, and his

relationship with Emory Univerity after the fraud was discovered. Those acts of non-

disclosure and evasiveness reveal a lack of candor, if not outright mendacity, that renders

him incapable of being relied upon to testify trthfully at hearng.

i The scope of that deposition should include all facts and circumstances germane to (i) the failure of

Heymsfield to disclose to Respondents the existence of six fraudulent studies co-authored by him; (2) thegenerally accepted stadards for listing of publications on a scientist's currculum vitae; (3) the ethcalresonsibility of a co-author of scientific works to disclose fraudulent data in those works; (4) the

supervisory responsibilty of a senior scientist co-author (here, Heymsfield) for a junior scientist co-author's (here, Daree's) work; and (5) the extent to which Heymsfield's August 30,2005 testimony raisesquestions of his scientific integrty, reliability, and independence that may impugn the competence andreliability of his scientific opinion.

5

Heymsfields testimony reveals that he apprised Complaint Counsel of the

documents in question at the time of his retention in this case and in prior cases and that

he and Complaint Counsel neither disclosed the existence of the documents nor produced

them to Respondents. That complicity by Complaint Counsel in condoning and

facilitating the wrongful non-disclosure falls far beneath the minimum standards of

ethical conduct expected of governent attorneys. On December 9,2004 the AU

granted Complaint Counsel's motion for a protective order and quashed that portion of

the subpoena that required Heymsfield to produce copies of his published studies.

However, the fact that Heymsfield did not have to submit actual copies does not excuse

him, or Complaint Counsel, from failing to comply with his Honor's prior August 11,

2004 Scheduling Order that required all materials "fully descrbing his (Heymsfield's)

background" and "a list of all publications." Those materials and that list necessarily

require revelation of the six fraudulent Darsee studies.

Moreover, at his Januar 11, 2005 deposition, when asked his reasons for leaving

Emory University, Heymsfield said there was no reason other than "enormous

opportnity" prompting his depare from Emory (in direct contradiction to his

published statements in The Scientist that Emory University "asked me to leave,"

"considered me an eyesore," had "taken (me) off the ladder to the sky," and had made it

"obvious" that "there would be no promotions or opportnities." See infa at 17-18.

When the question as to the reasons for his deparre was repeated again, Heymsfield

reiterated that there was no other reason compelling his departre from Emory, in direct

contradiction to his published statements that Emory University considered him a pariah

6

after the discovery of the six fraudulent Darsee studies.2 This incident once more

underscores the profound questions relating to Heymsfields lack of candor during the

course ofthis proceeding.

The veracity of a witness is always in issue. Proof of wilful non-disclosure of

material and damaging facts and documents support witness exclusion, particularly in the

case of an expert. An untrustworthy expert can mislead and beguile the Presiding Officer

who, like counsel, looks to expert opinion with lay eyes. That misleading testimony can

lead to a miscarage of justice. Presiding Officers, paricularly in FTC deceptive

advertising cases, often place trst in the reliability and veracity of expert testimony in

forming ultimate conclusions on the extent to which health benefit representations are

backed by competent and reliable scientific evidence. Thus, when presented with direct

evidence oflack of candor and purposeful witholding of material (and damaging)

information that goes to the veracity and reliability of the expert, the Presiding Officer

must protect the integrty of the administrative trth-seeking process by excluding the

witness from testifyng. Given evidence ofHeymsfields wilful non-disclosure and

2 See Januar I 1,2005 Depo., at 204, lines 10-17:

Q. You left Emory University, what? '84?A. '86.Q. '86. And anything in paricular that prompted you to leave Emory University and join St.Luke's?A. Same thing. Enormous opportty.

Q. Any other reason?A. No.

Compare August 30, 2005 Depo., at 630, 631, lines 14-25,2-5:Q: Let me show you what's been marked as Exhibit 20, correct. Are you familiar with apublication "the scientist"?A. Yes.

Q. Ths is Volume One, Issue 13, May 18, '87.A. Yes.

Q. Down at the bottom, last full paragraph it says, and quotig you, "The response was thatEmory asked me to leave; my grats dred up. I was tenured, so they couldn't fire me. But theydefinitely considered me an eyesore. I was set aside-taken off the ladder to the sky. It wasobvious there would be no promotions or opportnities." See Exhibit 4.

7

halting and evasive testimony, the Presiding Officer cannot place trust in him to be

honest and unbiased.

Commission Rule 3.38 governs the discovery process in an administrative

proceedings, including sanctions imposed for failure to disclose requested evidence. At

the center of the Presiding Offcer's inquiry is the determination of whether the failure to

disclose responsive records is deliberate and willfuL3 Upon finding the misconduct cited

above, the Presiding Officer may order appropriate relief to remedy the injury caused.4

The sanctions available are enumerated in Rule 3.38(b), 16 C.F.R. § 3.38(b), although his

Honor is free to impose additional punitive measures tailored to address the gravity of the

offense committed. Specifically, Rule 3.38(b) provides:

If a party or an officer or agent of a pary fails to comply with an order, includingan order (. ..) for the production of documents, (...) the Administrative Law Judgeor the Commission, or both, for the purpose of permitting resolution of relevantissues and disposition of the proceeding without unnecessary delay despite suchfailure, may take such action in regard thereto as is just, including but not limitedto the following:

(1) Inference that the admission, testimony, documents or other evidencewould have been adverse to the pary;

2) Ruling that for the purposes of the proceeding the matter or mattersconcerning which the order or subpoena was issued be taken asestablished adversely to the party;

(3) Ruling that the pary may not introduce into evidence or otherwiserely, in support of any claim or defense, upon testimony by such pary,officer, or agent, the documents or other evidence;

(4) Ruling that the pary may not be heard to object to introduction and useof secondary evidence to show what the withheld admission, testimony,documents, or other evidence would have shown;

(5) Ruling that a pleading, or par of a pleading, or a motion or othersubmission by the pary, concerning which the order or subpoena was

3 In the Matter ofVerrazano Trading Corp., 1976 FTC Lexis 390, 400-401 (April 16, 1976).4 Id. at 40 I .

8

issued, be stricken, or that a decision of the proceeding be rendered againstthe party, or both.s

Moreover, Rule 3.38(c) provides:

It shall be the duty of parties to seek, and Administrative Law Judges to grant,such of the foregoing means of relief or other appropriate relief as may besufficient to compensate for the withheld testimony, documents, or otherevidence.

Complaint Witness has engaged in willful misconduct by failing to disclose

information required by the August 11 Scheduling Order (specifically by failing to

disclose truthfully and fully his participation in and knowledge of six fraudulent studies

that he co-authored). Those purposeful acts of non-disclosure by a professional FTC

witness are in direct violation of the Scheduling Order. They go to the hear of

Heymsfield's credibility and reliability as an expert. They are a repeat offense. In his

March 15, 2004 order, the Presiding Offcer held certain documents produced by FTC

immediately prior to Heymsfield's second deposition to be wrongfully withheld and

required that Heymsfield testify for four additional hours. That pattern of non-

compliance taints the administration of justice and intereres with the Respondents'

ability to present their defense.

The protective order granted on December 9, 2004 al~ost succeeded in insulating

Complaint Counsel from having to account before the Presiding Offcer and Respondents

for Complaint Witness' questionable academic and professional practices. The gravity of

the non-disclosure and the seriousness of the misconduct give rise to the question of

whether Complaint Counsel, then aware of the fraudulent studies, endeavored to evade

detection of the studies altogether. Such action severely undermines the trth-seeking

516 C.F. R. § 3.38(b)(I)-(5).

9

process and further suggests conduct beneath minimum standards of ethics for

governent counseL.

III. PERTINENT FACTS

The following facts were first revealed at the August 30, 2005 deposition:

1. Heymsfield co-authored six studies published in the peer-reviewed literatue

with co-author John Darsee. Those studies are:

a. Darsee JR, Heymsfield SB. Decreased myocardial taurine levels andhypertaurinuria in a kindred with mitral-valve prolapse andcongestive cardiomyopathy. (retracted by Heymsfield SB, Glenn JF.In: N Engl J Med 1983; 308:1400). N Engl J Med 1981; 304:129-35.

b. Darsee JR, HeymsfieId SB, Nutter DO. Hypertrophic cardiomyopathy

and human leukocyte antigen linkage: diferentiation of two forms ofhypertrophic cardiomyopathy. N Engl J Med 1979;300:877-82.

c. Darsee JR, DO Nutter, LC Hopkins Jr and SB Heymsfield.

Neurogenic skeletal myopathy in patients with primarycardiomyopathy. (retracted by Nutter DO, Hopkins LC Jr, HeymsfieldSB. In: Circulation 1984 Jan;69 (1):202)

d. Darsee JR, Heymsfield SB, Miklozek CL. Cirrhotic cardiomyopathy:

the hyperdynamic-unloaded-failing heart. Circulation 1979;60(suppl11):38 .

e. Darsee J, Mikolozek C, HeymsfieId S, et al. Mitral Valve Prolapseand Ophthalmoplegia. A Progressive Cardioneurologic Syndrome.Am Int Med 1980; 92: 735.

f. Darsee JR, Fulenwider JT, Rikkers LF, Ansley JD, Nordlinger BF,

Ivey G, Heymsfield SB. Hemodynamics ofLeVeen shunt pulmonaryedema. An Surg. 1981 Aug; 194(2):189-92.

2. Heymsfield did not list any ofthose studies as published aricles on his

curriculum vitae. Aug. 30,2005 Depo. at 451-452, lines 23-25; 2-12. See

Exhibit 2.

3. Neither Heymsfield nor Complaint Counsel supplied Respondents with a list

containing the six studies, or with the studies themselves.

10

4. The six Darsee studies were withdrawn from publication upon proof that the

data relied on in the studies were fictitious and fraudulent. Aug. 30, 2005

Depo. at 452-453, lines 20-25; 2-3.

5. Heymsfield at the time the fraud was revealed was a tenured professor at

Emory University. Aug. 30,2005 Depo. at 452, lines 7-12.

6. In The Scientist Heymsfield was quoted as saying: "The response was that

Emory asked me to leave; my grants dried up. I was tenured, so they couldn't

fire me. But they definitely considered me an eyesore. I was set aside - taken

off the ladder to the sky. It was obvious there would be no promotions or

opportities." See Exhibit 3.

7. Under examination, Heymsfield would not admit, but would also not deny,

having made the statement quoted in the enumerated paragraph immediately

above. Aug. 30, 2005 Depo. at 632-634, lines 3-25; 2-25; 2-10.

8. Heymsfield left his position as Associate Professor of Medicine at Emory

University School of Medicine in 1986, after revelation of his co-authorship

of the six fraudulent Darsee studies.

8. Under examination, Heymsfield admitted that when first contacted by

Complaint Counsel he revealed the studies and the fraud to them. Aug. 30,

2005 Depo. at 658-660, lines i 3-25; 2-25; 2-6.

9. Under examination, Heymsfield admitted he has previously informed

Complaint Counsel of the studies and the fraud when retained in other FTC

proceedings. Aug. 30, 2005 Depo. at 655- 657, lines 10-25; 2-25; 2-16.

11

10. Under examination, Heymsfield admitted that the fabricated facts that were

used in each of the six studies were produced by John Darsee, a medical

student at Emory University, where Heymsfield taught and with whom he

collaborated in writing all six articles. Aug. 30, 2005 Depo. at 462-463, lines

24-25; 2-9.

11. Neither Heymsfield nor Complaint Counsel informed Respondents of the six

fraudulent Darsee studies before Heymsfield begrdgingly admitted co-

authorship of them in his August 30, 2004 deposition. Aug. 30, 2005 Depo. at

453, lines 6- 15.

12. Under oath, Heymsfield refused to admit any specific responsibility for the six

fraudulent Darsee studies he co-authored and (1) would neither admit nor

deny any adverse actions or inferences against him from colleagues at Emory

and (2) would neither admit nor deny communicating the statement in The

Scientist (above). Instead, he testified haltingly and evasively to the questions

asked. Aug. 30, 2005 Depo. at 632-634, lines 3-25; 2-25; 2-10.

A. FAILURE TO DISCLOSE MATERIAL DOCUMENTS AND FAILURE TOTESTIF TRUTHFULLY

The following are relevant excerts from Heymsfields August 30,2005

deposition:

1. Heymsfield begrdgingly admitted that he did not list the six fraudulent

Darsee studies that he co-authored.

a. A: "(...) There might be something, something I've published that's

not there for, you know, for reasons of error, but not to omit anything.

12

If a paper, for example, there were several papers that were retracted a

number of years ago, those papers are not on my CV."

b. Q: "What papers are those?"

c. A: "There was a set of papers wrtten by a student at Emory

University, where I was a professor, and some of the information then

was later found to be falsified. That group of papers was retracted

from the journals and they are not on my CV." Aug. 30, 2005 Depo.

at 451-452, lines 23-25; 2-12.

2. Heymsfield acknowledged that an investigative committee found the data for

the studies to be fabricated by a co-author.

a. A: "(...) it was discovered he had fabricated some data at Harard, and

when an investigative committee was set up it was found that some of

the data he worked on while he was at Emory also was fabricated. All

ofthe papers at Harvard and at Emory that involved any fabrication

were retracted from the medical journals." Aug. 30, 2005 Depo. at

452-453, lines 20-25; 2-3.

3. Heymsfield confirmed that he co-authored the fraudulent studies containing

falsified data.

a. Q: "You were a co-author?"

b. A: "Yes, me and about 25 other people, 25 or 30."

c. Q: "'!bat were all on the same paper?"

d. A: "On all of his papers that were retracted, yes."

13

e. Q: "What about the ones that you were involved in, how many other

co-authors were there?"

f. A: "About ten." Aug. 30, 2005 Depo. at 453, lines 6-15.

4. Heymsfield haltingly and evasively avoided explaining his exact participation

and responsibility in the six fraudulent Darsee studies.

a. Q: "Does a co-author have any responsibility in regards to how a study

is published, a review of the data, things like that?"

b. A: "I'm not sure, you know, exactly what the question is you are

asking. Of course that, you know, people who are co-authors share

certain responsibilities for the data." Aug. 30, 2005 Depo. at 454-455,

lines 20-25; 2-4. (* * *)

c. Q: "I'm asking you what your involvement was in the study?"

d. A: "I was a colleague and I partcipated in the research with him. I

saw some of the patients that were in the study and I helped him

prepare the manuscript, manuscripts, severaL."

e. Q: "SO you were privy to all the data?"

f. A: "No. 'All of the data,' no. I rarely see all the data in any study,

except in studies which I'm the primary author ofthe paper." Aug. 30,

2005 Depo. at 455, lines 10-21. (* * *)

g. A: "You know, co-authorship, as I mentioned, can be based on any set

of crteria. There are ten different things you do when you are a co-

author. You have to meet usually two or thee of those different things

to be a co-author, so a part of it could be getting the funds to the study,

14

helping to prepare the manuscript, analyzing the data, designing the

studies. It's a rather long list. So co-authorship is very variable

depending on specific study." Aug. 30, 2005 Depo. at 456, lines 3-14.

5. Heymsfield acknowledged that the six fraudulent Darsee studies made

findings based on fictional patient data analyses.

a. Q: "What do you mean by the word 'fraud' in that context?"

b. A: "Darsee made up data that was eventually put into the papers. He

fabricated the data. He claims to have evaluated patients that actually

were not able to be found later (...)." Aug. 30, 2005 Depo. at 460,

lines 4-10.

6. Heymsfield alleged that he does not remember whether he sent retraction

letters to all of the peer-reviewed journals that published the study.

a. Q: "Did you write to the peer review journals that published the

studies and ask for retraction ofthe studies?"

b. A: "Well, I think that there were retraction letters and I believe that I

did sign some of them. I would have to go back. My memory on this

is not impeccable, but there were retraction letters and I believe that I

may have signed some of them. I don't recall specifically."

c. Q: "Do you have copies of any of those letters?"

d. A: "Actually I do."

e. Q: "And would you provide them?"

15

f. Ms. KAPIN: "Objection. If you have document requests you can take

that off-line and we will go through the formal process that has been

set forth in this case, and discovery is closed."

g. Mr. FRIEDLANDER: "Well, we are just learning about this. This

deposition hasn't been finished yet."

h. Ms. KAPIN: "I understand. All I'm saying is that there's a formal

process and the deposition is not that process."

1. Q: "But you'd be wiling to provide those letters?"

J. A: "Letters are published." Aug. 30, 2005 Depo. at 461-462, lines 19-

25; 2-22. (* * *)

k. Q: "If the letters are published, can you tell me where?"

1. A: "Yes."

m. Q: "And where are they published?"

n. A: "Whichever journals the retractions took place, the letters would be

in those journals and you could probably find them the way I

mentioned. If you just search PubMed you can dig up Darsee and you

will find those letters." Aug. 30, 2005 Depo. at 462-463, lines 24-25;

2-9.

7. Heymsfield admitted that he was interviewed by investigating committees but

disavows any specific memory of the facts and of whether records or

transcripts of the proceedings were made.

16

a. Q: "You mentioned that you were examined or questioned by the

committee that discovered these transgressions by Darsee; is that

correct?"

b. A: "Yes, I was interviewed by the committees."

c. Q: "Are there any transcrpts of those hearngs or those questionings?"

d. A: "There were reports of those meetings which were probably made

public to some extent and those could be obtained from the National

Institute of Health or maybe even from Emory University."

e. Q: "But do you know whether there were any transcripts made? Did

you ever read a transcript for correction?"

f. A: "Oh, you are asking me somethng that happened 25 years ago. I

don't remember. I don't specifically remember a transcrpt, as in this

type oftranscript, no. I don't remember anything like that. There

might have been some minutes, that would be logical, but I don't have

any specific recollection of it. It's very possible but it's not, you

know." Aug. 30, 2005 Depo. at 463-464, lines 10-25; 2-10.

8. Heymsfield testified haltingly and evasively about statements made to a

reporter about the circumstances prompting him to leave Emory University

after the exposure of the six fraudulent Darsee studies.

a. Q: "Well, the bottom line is that you were asked to leave Emory

University as a result, fair?" (* * *)

b. A: "If you can find that wrtten anyplace, anywhere in any reliable

document I'd be happy to affin its validity."

17

c. Q: "Down at the bottom, last full paragraph it says, and quoting you

(from The Scientist, dated at May 18, 1987; Exhibit 3 hereto), 'The

response was that Emory asked me to leave; my grants dried up. I was

tenured, so they couldn't fire me. But they definitely considered me

an eyesore. I was set aside - taken off the ladder to the sky. It was

obvious there would be no promotions or opportnities.' That's what

you told the reporter, right?"

d. A: "This is a newspaper article and I'm not sure what the quote

context I gave this quote, but if you can find anything objective, and I

don't mean a newspaper article, from Emory University, written to me

in any document, and you can go to the dean" you can get all ofthe

files, that asked me to leave I would be very shocked."

e. Q: "Get my question back. I didn't ask that question."

f. A: "This is a newspaper article."

g. Ms. KAPIN: "Doctor, you don't have to thow out challenges to

opposing question."

h. A: "Yes, yes." Aug. 30, 2005 Depo. at 630-631, lines 3-10, 21-25; 2-

22.

9. Heymsfield again testified haltingly and evasively about statements made to

The Scientist and states that implications stemming from his own quoted

words are "inaccurate."

a. Q: "That's the question. Did you tell that to the reporter?"

18

b. A: "I don't remember specifically what I told the reporter. This is

1987 that this was wrtten, but I'm tellng you that whatever context

this was in, I'm not sure what specifically was said to him at the time."

c. Q: "But you are not denying that you said this?" (* * *) "Right, you

are not denying it?"

d. A: "I don't know what I said to the reporter, but I don't, you know,

I'm telling you objectively that the statement you made earlier, that I

was - or you asked me was I ever asked, maybe we could go back to

that statement."

e. Q: "I'll do it in just a second."

f. A: "But whatever the implication of this are are not accurate."

g. Q: "But if you don't recall what you said I take it you can't deny

saying what's quoted here, right?" (* * *)

h. A: "This is a - this is a newspaper aricle - " (* * *) "No, I'm just ( sic)

tellng you that."

1. Q: "You are off my question. My question is very simple. I take it

that if you don't recall what you said you can't deny that you said this,

fair?" (* * *)

J. A: "I'm going to tell you what I see here. There's a quote from me

here, and we know what it says. I'll read it. 'The response was that

Emory asked me to leave,' and I told you I don't remember exactly

what I said. This is many years ago. I don't know how accurate this

quote is, but I do know that Emory never asked me to leave."

19

k. Q: "As you sit here today and you are under oath, can you deny that

you said what this reporter quotes?" (* * *)

1. A: "I don't know whether or not this is an accurate quote or not. I'm

just telling you the facts." Aug. 30, 2005 Depo. at 632-634, lines 3-25;

2-25; 2-10:

10. Heymsfield testified evasively about co-author responsibilities following

revelation in the deposition of his co-authorship of the six fraudulent Darsee

stu(lies.

a. Q: "Have you ever had an instance in which you have submitted an

article for publication or have been listed as a co-author upon the

aricle that you did not read in its entirety?" (* * *)

b. A: "Did not read in its entirety? You know, like I said, I have a couple

of hundred of papers that I've wrtten and worked on so I can't answer

it as specifically as you've asked it. Again, I would have to have a

specific example."

c. Q: "Well, can you conceive of an instance where you would have

allowed an article to be published with your name on it that you did

not read?"

d. A: "An aricle with my name, that I didn't read?"

e. Q: "Right." (* * *)

f. A: "Unlikely, but again a specific example would be helpfuL."

20

g. Q: "But it could have happened that you allowed an article to be

published with your name on it, that you didn't read in its entirety?" (*

* *) "If that's possible?"

h. A: "You said' entirety' this time, but you didn't say' entirety' last time

and so 'entirety' is very specific. So it's possible, yes, that an aricle

was wrtten with my name on it, that I didn't read entirely because I'm

fairly focused and I would have contrbuted and read the sections that

were assigned to me."

1. Q: "Now, is a co-author responsible for the entire article in your

judgment?" (* * *)

J. A: "Well, when you put your name on as an author you are generally

responsible for the content ofthe aricle."

k. Q: "Right."

1. A: "But not for necessarly reading it entirely." Aug. 30, 2005 Depo. at

641-643, lines 25; 2-25; 2-23.

11. Heymsfield admitted informing Complaint Counsel of his co-authorship of the

six fraudulent Darsee studies.

a. Q: "Did you inform the Federal Trade Commission in advance of your

expert report that you would not include the Darsee studies on your

CV?"

b. A: "I informed the Federal Trade Commission to the best of my

recollection, about the Darsee matter and other matters that are in the

past, that often come up in trals that, you know, where I - for people

21

tryng to discredit me for one reason or another. So I brought that up

with them a priority."

c. Q: "And you were told not to reveal that information to the opposing

counsel in this case?" (* * *)

d. A: "No, I was never told not to reveal any information as far as I'm

aware of."

e. Q: "SO let me just get this straight. You imparted the information to

FTC that you were on these Darsee stdies and that you did not

include them on your CV; is that correct?" (* * *)

f. A: "No."

g. Q: "What is the accurate story? Did you ever inform the FTC that you

were on studies, the Darsee studies and that they were not included in

your CV?"

h. A: "I've answered this several times. I'll answer it again."

I. Q: "Please."

J. A: "I informed the FTC of all of the matters that I considered issues

that come up in trials where attempts were made to discredit me one

way or the other, the Darsee was par of it, and the papers are such an

insignificant part of that. They are public record, you can go on to

PubMed and find them. And I have long since put that to bed in terms

of my career, so there was never - there are hundreds of small aspects

to the Darsee thing that I haven't revealed because I wasn't asked."

Aug. 30, 2005 Depo. at 655- 657, lines 10-25; 2-25; 2-16. £* * *)

22

k. Q: "Dr. Heymsfield, who among FTC counsel did you inform about

the Darsee studies?" (* * *)

1. A: "I informed the FTC about Darsee in general, but I can't remember

specifically who that was. I've interacted with several people at the

FTC so I don't remember exactly who that was."

m. Q: "Did you discuss it with the lawyers sitting in this room?"

n. A: "You know honestly I don't recall it's been oh, over a year."

o. Q: "But it was with lawyers for the Federal Trade Commission?" (* *

*)

p. A: "Yes."

q. Q: "You said yes, sir I'm sorr if missed it?"

r. A: "I always inform people who retain me as an exper about that,

yes."

s. Q: "And when did you inform them to the best of your recollection,

before or after you produced the expert report in this case?"

1. A: "Keep in mind that I've worked with the FTC for a number of

years, even prior to this case. I've been an expert on several

occasions, and I've always let people know it so does that answer your

question?"

u. Q: "No. When did you make the disclosure, to the best of your

recollection; was it before or after your expert report was prepared?"

v. A: "I'm going by recollection and it's always when people first call me

and ask me to be an expert for them."

23

w. Q: "All right. So it was when you were first retained in this case?"

x. A: "More than likely." Aug. 30, 2005 Depo. at 658-660, lines i 3-25;

2-25; 2-6.

As is evidenced by the transcript cited above, Heymsfield, who, by his own

admission has been an expert witness for FTC on numerous occasions, willfully violated

his Honor's August 1 1, 2004 Scheduling Order. He also repeatedly testified haltingly

and evasively to inquiries posed during his August 30 deposition. Those actions justify

the imposition of both Rule 3.38(b) sanctions and additional Rule 3.38(c) relief. The

relief should be tailored to reflect the gravity of the violations and the fact that Complaint

Counsel have condoned and been complicit in them. An expert who engages in

testimonial lack of candor and non-disclosure of material information canot be counted

upon to testify truthfully, fully and accurately at the hearng. Accordingly, the

appropriate sanction is exclusion.

The Supreme Cour prescribes use of strct enforcement powers in cases involving

this kind of discovery misconduct. In the seminal case of National Hockey League, the

Court issued sanctions in an antitrust proceeding by dismissing the plaintiffs case for

failure to timely comply with a discovery order. 6 Whle acknowledging that dismissing

an action is one of the most severe sanctions imposed, the Cour neverteless held that,

"(...) here, as in other areas of law, the most severe in the spectrum of sanctions provided

by statute or rule must be available to the (. ..) court in appropriate cases, not merely to

penalize those whose conduct may be deemed to warant such a sanction, but to deter

those who might be tempted to such conduct in the absence of such a deterrent.,,7 In this

6 National Hockey League v. Metropolitan Hockey Club, 427 U.S. 639 (1976).7 fd. at 643.

24

case, Heymsfield and Complaint Counsel were complicit in the wilful nondisclosure of

the six fraudulent Darsee studies, co-authored by Heymsfield. Heymsfield did not list the

six studies on his curriculum vitae. Neither he nor the Complaint Counsel listed them in

any other disclosure to Respondents. Heymsfield testified haltingly and evasively when

questioned about his involvement in and the consequences flowing from his involvement

in those studies. His Honor has full power in such a circumstance to impose the most

severe sanction, case dismissaL. The requested sanction, witness exclusion, is a measured

response calculated to redress the specific har, avoid miscarage of justice, and impose

an appropriate sanction.

B. EXISTING PRECEDENT FOR THE IMPOSITION OF SANCTIONSAGAINST COMPLAINT COUNSEL AND COMPLAINT WITNESS

Administrative Law Judges presiding in FTC adjudicative proceedings have broad

discretion to issue orders sanctioning misconduct. See 61 F.R. 50640 (1996). The

existing regulatory framework aims to reinforce effcient judicial administration and

integrty oflegal process. To achieve those objectives, the Commission revised the Rules

in 1996.8 Complaint Counsel's failure to ensure the accurate and full disclosure of

responsive information durng discover greatly impedes the Respondents' case

preparation, denying Respondents the full benefit of discovery. Heymsfield and

Complaint Counsel have hidden damagig information that goes to the credibility of the

Heymsfield and, to be sure, to Complaint Counsel's entire case (depending as it does so

greatly on the opinion ofHeymsfield). Because discover is now closed, Respondents

are foreclosed from furter discovery, including documents and testimony necessar to

8 Id.

25

probe fully the newly discovered matters, without the expense and delay of making a

motion to the Presiding Offcer.

Moreover, Complaint Counsel, through their purposeful non-disclosure of

damaging information, have violated the basic trust this governent places in them - that

they not only follow the law, the rules, and the orders but do so in an exemplary manner

above and beyond reproach. See Berger v. United States, 295 U.S. 78,88, 79 L. Ed.

13 14, 55 S. Ct. 629 (1935). Their condonation of and complicity in the non-disclosure of

the damaging information is unquestionably beneath the minimum standards expected of

governent counseL.

The Commission has upheld the imposition of Rule 3.38 sanctions in previous

cases that are factually similar to the present.9 Specifically, the Court has frequently

resorted to the sanction of adverse inferences, which are imposed on the party who has

relevant evidence within its control, as Complaint Witness does here, but fails to disclose

it. The failure to disclose gives rise to an inference that the evidence is unfavorable to the

non-disclosing pary, which inference is partcularly applicable in the present case where

Heymsfield's testimony reveals his co-authorship in six fraudulent scientific studies.

American Medical Association concluded that the application of the adverse

inference rule may be made "only when the pary's failure to produce documents is not

adequatelyexplained."JO The adequacy of the explanation is assessed on the basis of the

paries' conduct and accompanying circumstances. In the absence of "a strong

9 See, e.g., Olin Corporation, 113 F.T.C. 400 (1990) (Commssion upheld sactions for violation of

prehearg schedulig order); International Telephone and Telegraph Corp., 104 F.T.C. 280 (1984)(Commssion upheld use of sanctions where respondent wilfully witheld some of the documents requiredto be produced by an order, even after complaint counsel had reduced the scope of subpoena specificationson which compliance had been delayed).10 American Medical Association, 94 F.T.C. 701,706 (1979).

26

explanation for non-compliance," adverse inferences are appropriately drawn. i i

Heymsfield offers no substantive justification for his failure to disclose the six fraudulent

studies he co-authored. The apparent wilfulness of his actions should compel the

Presiding Officer to draw adverse inferences as to the motivation behind the sequestering

of the six fraudulent studies. Moreover, Heymsfields evasive and halting testimony

concerning his involvement with them casts serious doubt on his candor as an expert in

the proceeding.

In Arthur Andersen, the Presiding Officer held that the eventual disclosure of

required responsive material does not excuse a party from liability for sanctions where

the compliance exceeded the time limitations imposed by a court order. 12 The legal

obligations imposed by a cour order require Complaint Counsel and their witnesses to

respond to discovery in full, and to take ameliorative measures to ensure that the

requested disclosure is fully achieved. I3 Sanctions may attach even when the failure to

make timely disclosure stems from simple negligence. J4

Moreover, cours have adjudged sanctions to be appropriate when the responding

pary fails to disclose requested documents in a complete and accurate way to the

prejudice of opposing counseL. i 5 Complete compliance with discovery requests is crcial

in determining the scope of discovery, tral strategy, and tral preparation, perhaps even

more so for respondents facing an FTC enforcement action. If the requesting party relied

" International Telephone and Telegraph Corp., 104 F.T.C. 280,410-41 I (1984) (citing American MedicalAssociation, supra, at 195-196.12 Ohio v. Arthur Andersen & Co., 570 F.2d 1237, 1374 (loth Cir.), cert. denied, 439 U.S. 833 (1978).13 See Fautekv. Montgomery Ward & Co., 96 F.R.D. 141,145-146 (N.D. II 1982) (citing Haney v.

Woodward & Lothrop, Inc., 330 F.2d 940 (41h Cir. 1964); Allen Penn Co. v. Springfeld Photo Mount Co.,653 F.2d 17,23 (Ist Cir. 1981).14 Compagnie de Bauxites de Guinea v. Insurance Co. of

North America, 651 F.2d 877, 885 (3d Cir. 1981),affd sub nom. Insurance Corp. of Ireland, Ltd. v. Compagnie des Bauxtes de Guinee, 456 U.S. 694,102 S.Ct. 2099 (1982).15 Tee-Air, Inc. v. Nippondenso Manufacturing USA, Inc., 1994 U.S. Dist. Lexis 2026 (N.D. II. 1994).

27

on the incomplete record of initial disclosures made by Complaint Counsel and their

witness, they would inevitably be prejudiced by the omissions. J 6 Here, they would not

know of direct and material evidence impugning the credibility and integrty of

Heymsfield upon whose testimony Complaint Counsel heavily depend to support their

case.

Governent lawyers are held to a very high standard in the performance of their

duties before the public and the courts. Courts have frequently stated governent

attorneys' paramount obligation to comport themselves with the highest ethics. The

Supreme Court expressly invoked the elevated standard in the seminal Berger case,

arguing that "a governent lawyer is the representative not of an ordinar pary to a

controversy, but of a sovereignty (... )."J7

The Cour later re-emphasized the paramount ethical duties of goverent

lawyers by citing the Model Code of Professional Responsibility: "(...) governent

lawyers in a civil action or administrative proceeding (are held) to higher standards than

private lawyers (...)."J8 The governent's commitment to ensuring the highest level of

ethical conduct has similarly manifested itself in an Executive Order, which provides:

'The United States sets an example for private litigation by adhering to higher standards

J61d.17 Bergerv. United States, 295 U.S. 78, 88,79 L. Ed. 1314,55 S. Ct. 629 (1935); Freeport-McMoRan Oil

& Gas Co. v. FERC, 295 U.S. App. D.C. 236, 962 F.2d 45, 47, U.S. App_ LEX IS 7587 (1992); GrayPanthers v. Schweiker, 230 U.S. App. D.C. 219, 716 F.2d 23, 33 (D.C. Cir. 1983) ("There is, indeed, muchto suggest that goverent counsel have a higher duty to uphold because their client is not only the agencythey represent but also the public at large").18 Young v. United States ex. reI. Vuitton et Fils SA. et. al., 481 U.S. 787, 803, 95 L. Ed. 2d 740,107 S. Ct.

2124 (1987) (citing Model Code ofProtl Responsibility EC 7-14 (1981); (see also United States v. Witmer,835 F. Supp. 208,215 (1993); (United States of America v. Gaetano Vastola, et. al., 830 F. Supp. 250,254,(1993).

28

than those required by the rules of procedure in the conduct of Governent litigation in

federal court.,,19

C. RESPONDENTS ARE PREJUDICED BY COMPLAINTCOUNSEL'S AND COMPLAINT WITNESS' FAILURE TO DISCLOSE THEDARSEE STUDIES AND COMPLAINT WITNESS' HALTING ANDEVASIVE TESTIMONY

Complaint Counsel's non-disclosure of the six frudulent studies Heymsfield co-

authored prejudices the Respondents' preparation. Sanctions are necessary to remedy the

har, to penalize the misconduct and to prevent recurrence of the offense (this constitutes

a second instance of Heymsfield's failure to disclose in this proceeding).2o The non-

disclosure of the Darsee studies has effectively prevented before the close of discovery a

full and fair opportnity for Respondents to use all tools of discovery to expose the full

extent of the fraud and Heymsfield's responsibility for it.

In the course ofthe deposition, Heymsfield attempted to qualify his misconduct

by stating that the withheld information was not disclosed because it was no longer listed

on his curriculum vitae.2J That self-serving "justification" is completely unavailing.

Cours have held the self-serving arguent (that material sought would not have been of

value to the requesting party) entirely insuffcient to support non-disclosure.

Furtermore, Complaint Counsel canot raise the defense that the noncompliance

was inadverent. Complaint Counsel has the ultimate obligation of ensuring that

aComplaint Witness fully complies with the Presiding Officer's orders.22 Here, despite

awareness of the existence of the six fraudulent Darsee studies, Complaint Counsel

19 Executive Order on Civil Justice Reform, 27 Weekly Compo Pres. Doc. 1485 (Oct. 23,1991) (cited inCobellv. Babbitt, 1999 U.S. Dist LEXIS 20918 (1999).20 See March 15,2005, Order on Respondents' Motion to Strike Expert Witnesses andfor Sanctions and

Other Relief21 Contiued Deposition of Steven Heymsfield, MD., page 452, lines 4-5. Aug. 30, 2005.22 Fautek at 145.

29

condoned, and was complicit in, their non-disclosure. Heymsfield's noncompliance and

Complaint Counsel's complicity in that noncompliance reveal bad faith and warrant the

imposition of sanctions that wíl meaningflly deter such conduct in future.

There can be no doubt based on the Heymsfield testimony quoted above, that he

knew of, and informed Complaint Counsel of, his co-authorship of the six fraudulent

studies at the time of his retention in this case (indeed, in prior cases as well). Yet

Complaint Counsel - rather than disclose the existence ofthe fraudulent studies - became

complicit with Heymsfield in witholding the information from Respondents for over a

year until the August 30 deposition and after the close of discovery, at which point

Heymsfield, not Complaint Counsel, first revealed his co-authorship under cross-

examination (and he did so begrdgingly). The joint knowledge and non-disclosure is

deliberate. Heymsfield omitted the studies from his curriculum vitae. Complaint

Counsel assisted and organized disclosure, including the currculum vitae, and omitted

listing the studies aware throughout of the fact that they go to the credibility of their

chosen expert. In hindsight, it now appears, that Complaint Counsel's motion for

protective order preceding his Honor's August 11 Scheduling Order had the plain aim of

keeping the six fraudulent studies from disclosure. His Honor's Scheduling Order,

however, prevented that effect by ordering a complete listing of the articles - an order

Heymsfield and Complaint Counsel then chose to violate.

The purposeful non-disclosure of evidence revealing Heymsfield's co-authorship

of six fraudulent studies goes directly to his candor, credibility, and reliability as an

expert. The non-disclosure is thus profoundly materal. To ensure that this misconduct is

sanctioned appropriately, the sanction must be weighty - suffcient to deter recurence.

30

That is paricularly appropriate here in light of proof of a prior act of non-disclosure. The

appropriate sanction is to exclude Heymsfield, exclusion doubly warranted in light of his

testimonial lack of candor concerning the circumstances surrounding the studies, his role

in them, and the influence the fraud incidents had on his departre from Emory.

Ifhis Honor elects not to exclude Heymsfield, he should, at a minimum,

reprimand each Complaint Counsel by name, individually; proclaim that he wil make

adverse inferences against the credibility and reliability of Heymsfield's testimony at

hearing based on the misconduct, and grant the Respondents leave to probe in full all

facts and circumstances surrounding Heymsfields involvement in the six fraudulent

Darsee studies, Heymsfields statements to The Scientist, Heymsfield's departre from

Emory University, HeymsfieId's non-disclosure of the studies in these proceedings, and

Heymsfield's lack of candor in his August 30th deposition. Respondents are entitled to

examine and obtain germane documents from Heymsfield and each individual to whom

Heymsfield disclosed his involvement and paricipation in the Darsee studies.

Respondents are entitled to all correspondence between Heymsfield and any investigator

or investigative committees that evaluated the six fraudulent Darsee studies. They are

entitled to all correspondence between Heymsfield and the Emory University

administration or staff in relation to the Daree studies and his deparre from Emory

University. They are entitled to know precisely who among Complaint Counsel were

informed of the six fraudulent studies, and when they were informed. 16 C.F.R. §

3.38(c).

In short, Respondents should be allowed to pursue this matter until the whole

truth is revealed. They should be accorded all discover necessary to adduce the extent

31

to which Heymsfield was involved in the fraudulent studies and to test the credibility of

the statements he has already made in this proceeding. Truth is always in issue, and

Heymsfields credibility as a witness is seriously in doubt. Based on the facts presented,

the sanctions and alternate relief to reopen discovery are "reasonable in light of the

material withheld and the purposes of Rule 3.38(b)." The Presiding Officer may also

refer to precedent established under the Federal Rules of Civil Procedure to fashion

appropriate reliet.3

Respondents would be irreparably prejudiced if denied the opportnity to review,

rebut, and adduce information concerning the newly discovered facts. Respondents also

ask that Heymsfield be ordered to supply Respondents' Counsel a complete list of all

. materials in his files, or over which he exercises control, or in his possession, involving

and relating to the Darsee studies and his deparre from Emory University.

III. CONCLUSION AND PRAYER FOR RELIEF

For the reasons stated above, Respondents respectfully request that his Honor

exclude Heymsfield as a witness, exclude his exper reports, and exclude all documents

upon which he relied for that report, based on his purposeful non-disclosure of the six

fraudulent Darsee studies he co-authored and based on his testimonial lack of candor.

Respondents also request the imposition of sanctions against Complaint Counsel for their

condonation of and complicity in that non-disclosure. Respondents ask His Honor to

reprimand Complaint Counsel by name for the wrongfl non-disclosure of the six

fraudulent Darsee studies.

23 Grand Union Co., 102 F.T.C. 812, 1589 (1983).

32

Ifhis Honor elects not to exclude Heymsfield, the Respondents respectfully

request the aforementioned sanctions combined with an order re-opening discovery for a

period of sixty (60) days for the limited purpose of:

a. Authorizing a one day, not to exceed seven hours, deposition of the

C I. W. 24omp aint itness;

b. Authorizing Corporate Counsel to propound additional document

production requests to the Complaint Witness, for the purpose of

discoverng all documents related to the six fraudulent Darsee studies,

the Complaint Witness' involvement in those studies, the investigation

of those studies, those statements Complaint Witness made to The

Scientist, and the effect that revelation ofthe fraudulent studies had on

his association with Emory University;

c. Authorizing depositions and document production from any person

who has knowledge of the six fraudulent Darsee studies, the

Complaint Witness' involvement in those studies, the investigations of

those studies, the statements Complaint Witness made to The Scientist,

and the effect revelation of the fraudulent studies had on Heymsfield's

association with Emory University;

d. Compelling Complaint Witn~ss under penalty of peiury to give a

complete listing by name, subject matter, dates, addressees, and lengt

of all documents in his possession or under his control that relate to the

six fraudulent Darsee studies;

24 See footnote I concernng the scope of the deposition.

33

e. Compelling Complaint Counsel to identify by full name each counsel

aware ofthe six fraudulent Darsee studies before August 30, 2005, the

time each became aware, and how each became aware.

Dated: October 6, 2005

a an W. Emord

rd & Associ ates, P. C.1 00 Alexander Bell Drive

Suite 200Reston, VA 20191TeL. (202) 466-6937Fax (202) 466-6938

Counsel for Basic Research, LLCA.G. Waterhouse, LLCKlein-Becker USA, LLCNutrasport, LLCSovage Dermalogic Laboratories,

LLC, BAN, LLC

Stephen E. NaginNagin, Gallop & Figueredo, P.A.18001 Old Cutler RoadMiami, Florida 33157TeL. (305) 854-5353Fax (305) 854-5351

Counsel for Basic Research, LLC

Richard Burbidge, Esq.

Burbidge & Mitchell215 South State StreetSuite 920Salt Lake City, Utah 841 1 1

Counsel for Dennis Gay

Ronald F. PricePETERS SCOFIELD PRICE

A PROFESSIONAL CORPORATION

34

35

340 Broadway Centre11 1 East BroadwaySalt Lake City, Utah 84111Telephone: (801) 322-2002Facsimile: (801) 322-2003

Counsel for Respondent Daniel B.Mowrey

Mitchell K. Friedlander5742 West Harold Gatty DriveSalt Lake City, Utah 84111,

Pro se.

UNITED STATES OF AMERICAFEDERAL TRADE COMMISSION

OFFICE OF ADMINISTRATIVE LAW JUDGESWASHINGTON, D.C.

In the Matter of

BASIC RESEARCH, LLCA.G. WATERHOUSE, LLCKLEIN-BECKER USA, LLCNUTRASPORT, LLCSOY AGE DERMALOGIC LABORATORIES, LLCBAN LLC d/b/a BASIC RESEARCH LLC

OLD BASIC RESEARCH, LLCBASIC RESEARCH, A.G. WATERHOUSE,KLEIN-BECKER USA, NUTRA SPORT, andSOY AGE DERMALOGIC LABORATORIES

DENNIS GAYDANIEL B. MOWREY d/b/a AMERICAN

PHYTOTHERAPY RESEARCHLABORATORY, and'

MITCHELL K. FRIEDLANDER,Respondents

Docket No. 9318

ORDER GRANTING RESPONDENTS' MOTION FOR SANCTIONS AND FORLEAVE TO REOPEN DISCOVERY FOR A LIMITED PURPOSE

On October 6, 2005 Respondents fied a motion requesting the exclusion ofComplaint Counsel's expert witness Steven B. Heymsfield, M.D. (hereinafter ComplaintWitness) and for sanctions against Complaint Counsel or, in the alternative, for sanctionsagainst Complaint Counsel and to reopen discovery for Respondents to investigate the sixfraudulent Darsee studies and Complaint Witness' role in them.

Respondents have demonstrated good cause for their request to sanctionComplaint Witness and Complaint Counsel for wrongful nondisclosure of the sixfraudulent Darsee studies. Respondents have shown that the Complaint Witness hasengaged in willful non-disclosure of information required to be supplied by the August11, 2004 Scheduling Order and in halting and evasive testimony concerning hisinvolvement in the six fraudulent studies. Those acts of non-disclosure and evasivenessreveal a lack of candor that impugn Complaint Witness' credibility to testify at hearng.Respondents have also demonstrated Complaint Counsel were apprised of the sixfraudulent Darsee studies at the time FTC retained the Complaint Witness in this case andin prior cases, and Complaint Counsel neither disclosed the existence of the documentsnor produced them to Respondents. That complicity by Complaint Counsel in condoningthe wrongful non-disclosure fails to meet the minimum standards of ethical conduct

expected of governent attorneys. Respondents have also shown good cause to reopen

discovery for the limited purpose of investigating all matters germane to: (a) the failure ofthe Complaint Witness to disclose to Respondents the existence of six fraudulent studiesco-authored by him; (b) the generally accepted standards for listing of publications on ascientist's currculum vitae; (c) the ethical responsibility ofa co-author of scientificworks for fraudulent data in those works; (d) the supervisory responsibility of a seniorscientist co-author (here, Heymsfield) for a junior scientist co-author's (here, Darsee' s)work; and (e) the extent to which Heymsfield's August 30, 2005 deposition testimonyraises questions of his scientific integrty, reliability, and independence that may impugnthe competence and reliability of his scientific opinion. Accordingly, Respondents'motion is GRANTED.

It is hereby ORDERED that the presiding offcer will make adverse inferencesagainst the credibility and reliability of the Complaint Witness at hearing based on themisconduct present here.

It is furter ORDERED that Complaint Counsel Laureen Kapin, Joshua Milard,Laura Schneider, and Walter C. Gross II are sanctioned and reprimanded for thewrongful non-disclosure of the six fraudulent Darsee studies in violation of the August1 i, 2004 Scheduling Order.

It is hereby ORDERED that discovery is re-opened for a period of sixty (60) daysfor the limited purpose of:

a. Authorizing an additional day of deposition by the Respondents of the

Complaint Witness, not to exceed seven (7) hours, to explore: (a) thefailure of the Complaint Witness to disclose to Respondents theexistence of six fraudulent studies co-authored by him; (b) thegenerally accepted standards for listing of publications on a scientist'scurrculum vitae; (c) the ethical responsibility of a co-author ofscientific works for fraudulent data in those works; (d) the supervisoryresponsibility of a senior scientist co-author (here, HeymsfieId) for ajunior scientist co-author's (here, Darsee's) work; and (e) the extent towhich Heymsfield's August 30, 2005 deposition testimony raisesquestions of his scientific integrty, reliability, and independence thatmay impugn the competence and reliability of his scientific opinion;

b. Authorizing Respondents to propound additional document production

requests to the Complaint Witness, for the purpose of discoverng alldocuments related to the six fraudulent Darsee studies, the ComplaintWitness' involvement in those studies, the investigation ofthosestudies, those statements Complaint Witness made to The Scientist,and the effect that revelation of the fraudulent studies had on hisassociation with Emory University;

c. Authorizing depositions and document production from any person

who has knowledge of the six fraudulent Darsee studies, theComplaint Witness' involvement in those studies, the investigations of

2

ORDERED:

Date:

those studies, the statements Complaint Witness made to The Scientist,and the effect revelation of the fraudulent studies had on Heymsfieldsassociation with Emory University;

d. Compelling Complaint Witness under penalty of peijury to give acomplete listing by name and subject matter, dates, addressees, andlength all documents in his possession or under his control that relateto the six fraudulent Darsee studies;

e. Compelling Complaint Counsel to identify by full name each counselaware of the six fraudulent Darsee studies before August 30, 2005, thetime each became aware, and how each became aware.

Stephen J. McGuireChief Administrative Law Judge

3

UNITED STATES OF AMERICAFEDERAL TRADE COMMISSION

OFFICE OF ADMINISTRATIVE LAW JUDGESWASHINGTON, D.C.

In the Matter of

BASIC RESEARCH, LLCA.G. WATERHOUSE, LLCKLEIN-BECKER USA, LLCNUTRASPORT, LLCSOV AGE DERMALOGIC LABORATORIES, LLCBAN LLC d/b/a BASIC RESEARCH LLC

OLD BASIC RESEARCH, LLCBASIC RESEARCH, A.G. WATERHOUSE,KLEIN-BECKER USA, NUTRA SPORT, andSOV AGE DERMALOGIC LABORATORIES

DENNIS GAYDANIEL B. MOWREY d/b/a AMERICAN

PHYTOTHERAPY RESEARCHLABORATORY, and

MITCHELL K. FRIEDLANDER,Respondents

Docket No. 93 i 8

ORDER GRANTING RESPONDENTS' MOTION TO EXCLUDE A WITNESSAND FOR SANCTIONS

On October 6, 2005 Respondents filed a motion requesting the exclusion ofComplaint Counsel's expert witness Steven B. Heymsfield, M.D. (hereinafter ComplaintWitness) and for sanctions against Complaint Counselor, in the alternative, for sanctionsagainst Complaint Counsel and to reopen discovery for Respondents to investigate the sixfraudulent Darsee studies and Complaint Witness' role in them. Respondents havedemonstrated good cause for their request to exclude the Complaint Witness, to excludehis exper report and all documents he relied upon for its preparation, and to sanctionComplaint Counsel for purposeful nondisclosure of the six fraudulent Darsee studiesdespite the requirement that they be disclosed under the August 11, 2004 SchedulingOrder. Respondents have shown that the Complaint Witness has engaged in wilful non-disclosure of information required to be supplied by the August 11, 2004 SchedulingOrder and in halting and evasive testimony concerning his involvement in the sixfraudulent studies. Those acts of non-disclosure and evasiveness reveal a lack of candor.Respondents have also demonstrated Complaint Counsel were apprised of the sixfraudulent Darsee studies at the time FTC retained the Complaint Witness in this case andin prior cases, and Complaint Counsel neither disclosed the existence ofthe documentsnor produced them to Respondents. That complicity of Complaint Counsel in the

wrongful non-disclosure fails to meet the minimum standards of ethical conduct expectedof governent attorneys. Accordingly, Respondents' motion is GRATED.

It is hereby ORDERED that Steven Heymsfield, M.D., is hereby excluded as awitness in this proceeding. It is further ORDERED that his expert report and alldocuments upon which he relied for that report are excluded from this proceeding.

It is hereby ORDERED that the Complaint Counsel Laureen Kapin, JoshuaMilard, Laura Schneider, and Walter C. Gross II are sanctioned and reprimanded for

withholding from Respondents six fraudulent studies co-authored by Complaint WitnessHeymsfield.

ORDERED:

Stephen J. McGuireChief Administrative Law Judge

Date:

2

UNITED STATES OF AMERICAFEDERAL TRADE COMMISSION

OFFICE OF ADMINISTRATIVE LAW JUDGESWASHINGTON, D.C.

In the Matter of

BASIC RESEARCH, LLCA.G. WATERHOUSE, LLCKLEIN-BECKER USA, LLCNUTRASPORT, LLCSOY AGE DERMALOGIC LABORATORIES, LLCBAN LLC d/b/a BASIC RESEARCH LLC

OLD BASIC RESEARCH, LLCBASIC RESEARCH, A.G. WATERHOUSE,KLEIN-BECKER USA, NUTRA SPORT, andSOY AGE DERMALOGIC LABORATORIES

DENNIS GAYDANIEL B. MOWREY d/b/a AMERICAN

PHYTOTHERAPY RESEARCHLABORA TORY, and

MITCHELL K. FREDLANDER,Respondents

Docket No. 9318

CERTIFICATE OF SERVICE

I hereby certify that on ths ih day of October, 2005 I caused the Respondents'

Motion to Exclude a Witness and for Sanctions or, in the Alternative, for Sanctions and

for Leave to Reopen Discovery for a Limited Purpose, the exhibits thereto, and its draft

orders to be filed and served as follows:

i) an original and one paper copy filed by hand delivery and one electronic copy

in PDF format filed by electronic mail to

Donald S. ClarkSecretaryU.S. Federal Trade Commission600 Pennsylvania Avenue, N.W.Room H-159Washington, D.C. 20580

Email: secretaryêftc. gov

2) two paper copies delivered by hand delivery to:

The Hon. Stephen J. McGuireChief Administrative Law JudgeU.S. Federal Trade Commission600 Pennsylvania Avenue, N.W.Room H-l 12Washington, D.C. 20580

3) one paper copy by first class U.S. Mail to:

James KohmAssociate Director, EnforcementU.S. Federal Trade Commission601 New Jersey Avenue, N.W.Washington, D.C. 20001

4) one paper copy by first class U.S. mail and one electronic copy in PDF formatby electronic mail to:

Laureen KapinJoshua S. MillardLaura SchneiderWalter C. Gross II

U.S. Federal Trade Commission600 Pennsylvania Avenue, N.W.Suite NJ-2122Washington, D.C. 20580EmaiI: lkapinêftc.gov

jmilardêftc.govIschneiderêftc.govwgrossêftc.gov

Stephen E. NaginNagin, Gallop & Figueredo, P.A3225 Aviation AvenueThird FloorMiami, FL 33133-4741

Email: snaginêngf-law.com

Richard D. BurbidgeBurbidge & Mitchell215 South State StreetSuite 920

2

Salt Lake City, UT 841 i iEmail: rburbidge(iburbidgeandmitchelL.com

Ronald F. PricePeters Scofield Price

340 Broadway Center11 1 East BroadwaySalt Lake City UT 84 I 1 1Email: r:(ipsplawyers.com

Mitchell K. Friedlanderc/o Compliance Department5742 West Harold Gatty DriveSalt Lake City, UT 84116Email: mkf555(imsn.com

3

EXHIBIT 1

Rule 3.22 Statement

In accordance with FTC Rule of Practice 3.22(f) (16 C.F.R. § 3.22(f)) Corporate

Respondents' counsel Jonathan W. Emord and Andrea G. Ferrenz conferred with

opposing Complaint Counsel Laureen Kapin and Joshua Milard in a good faith effort to

resolve by agreement Respondents' attached motion to exclude a witness and for

sanctions or, in the alternative for sanctions and to reopen discovery for a limited

purpose. The matters in controversy in that motion remain unresolved. Copies of the

correspondence between counsel regarding this motion are attached. The date, time, and

place of each such conference and the names of all paries paricipating are as follows.

I) Jonathan Emord with Andrea G. Ferrenz called Laureen Kapin and

Joshua Milard on Thursday, September 29,2005 at 12:12 PM EST.

Emord set out the grounds for the motion and specified all of the relief

sought. Kapin and Milard asked for an email reiterating those

statements and for time to confer among counsel regarding the proposed

motion and relief. The requested em ail was sent on October 5,2005

and is included in Exhibit 5. The paries scheduled a second conference

calIon Wednesday October 5, 2005, at lOAM EST.

2) On October 5,2005 Emord sent Milard and Kapin an email requesting

a meeting at noon on October 6, 2005.

3) On October 5, 2005 Milard sent an email to Emord responding to

Emord's October 5, 2005 email (paragraph 3 above).

4) On October 6, 2005 in the morning Kapin called Emord and confirmed

the call would be later that day at 3 PM.

5) On October 6, 2005 Emord sent Kapin an email confirming the

conference call scheduled for 3 PM that same day to discuss the motion.

6) The follow-up teleconference occurred on October 6, 2005 at 3 PM

with Emord and Ferrenz participating for Respondents and Kapin,

Millard and two other FTC attorneys participating for Complaint

CounseL. Following discussion of arguent for and against the motion,

an agreement could not be reached.

~

t an W. Emordsel for Corporate Respondents

2

Page 1 of 1

Jonathan Emard

From: Jonathan Emord

Sent: Wednesday, October 05, 2005 11 :18 AM

To: 'jmillard~ftc.gov'; 'Ikapin~ftc.gov'Cc: 'MarkQuinn~basicresearch.org'

Subject: Time Certain for Thursday Call

Dear Mr. Milard and Ms. Kapin:

Pursuant to 16 C.F.R. 3.22(f) of the Commission's Rules, we conferred on September 29, 2005, commencing at12:12PM. Present in the conference were for all ofthe Respondents, Jonathan Emord and Andrea Ferrenz, andfor Complaint Counsel, Laureen Kapin and Joshua Millard. During the conference, we informed you of ourintention to file a motion to exclude a witness and for sanctions or, in the alternative, for sanctions and for leave toreopen discovery for a limited purpose. In particular, we explained-based on testimony from the August 30, 2005deposition of Complaint Witness Heymsfield--that the Complaint Witness and Complaint Counsel had wrongfullywithheld from Respondents information identifing six fraudulent studies in which the Complaint Witness was aco-author. We explained that the six fraudulent studies were not listed as required by the August 11, 2004 Orderof the Presiding Officer; that they had been omitted from the Complaint Witness's curriculum vitae; and thatComplaint Witness had testified to disclosing the existence of the studies to Complaint Counsel at the time of hisretention in this case and in earlier cases. Based on those revelations, we asked you to withdraw the ComplaintWitness voluntarily and to accept sanctions voluntarily for the wrongful withholding. We said that we would seekthat remedy from the Presiding Offcer and would, in the alternative, seek to reopen discovery to fully explore allfacts and circumstances germane to the Complaint Witness's wrongful withholding of the fraudulent studies, to hisinvolvement in them, and to his lack of candor in testimony at the August 30 deposition.

Ms. Kapin explained that she could not respond to our request at that time and stated that she would confer withher colleagues and would respond this week, eventually identifying Thursday, October 6, as that date. YesterdayI sent an email to Ms. Kapin explaining that I would be available for the Thursday call at noon or later at herconvenience but have not received confirmation of the time when she (or you) can be available. Please confirm atime on Thursday. Please also confirm that you wil supply me with a definitive answer to our requests.

Sincerely,

Jonathan W. Emord

10/5/2005

Jonathan Emord

From:Sent:To:Subject:

Milard, Joshua S. pMILLARD~ftc.govJWednesday, October 05, 2005 11 :51 AMJonathan Emord; Kapin, LaureenRE: Time Certain for Thursday Call

Dear Mr. Emord:

Although I do not have time to respond to all of the many allegations in your letter,please permit me to remind you (as it was my understanding that you had previously beenadvised) that my colleague Ms. Kapin was out of the office yesterday, and is out of theoffice today, observing a religious holiday. Ms. Kapin is scheduled to return to theoffice tomorrow, but I am not aware of her schedule then. I am confident that Ms. Kapinwill contact you in response after she returns to the office.

Joshua S. Millard, AttorneyFTC Enforcement Division202.326.2454

-----Original Message-----From: Jonathan Emord (mailto:JEmord~Emord.comJSent: Wednesday, October OS, 2005 11:18 AMTo: Millard, Joshua S.; Kapin, LaureenCc: MarkQuinn~basicresearch. orgSubj ect: Time Certain for Thursday Call

Dear Mr. Millard and Ms. Kapin:

Pursuant to 16 C.F.R. 3.22(f) of the Commission's Rules, we conferred onSeptember 29, 2005, commencing at 12: 12PM. Present in the conferencewere for all of the Respondents, Jonathan Emord and Andrea Ferrenz, andfor Complaint Counsel, Laureen Kapin and Joshua Millard. During theconference, we informed you of our intention to file a motion to excludea witness and for sanctions or, in the alternative, for sanctions andfor leave to reopen discovery for a limited purpose. In particular, weexplained--based on testimony from the August 30, 2005 deposition ofComplaint Witness Heymsfield--that the Complaint Witness and ComplaintCounsel had wrongfully withheld from Respondents information identifyingsix fraudulent studies in which the Complaint Witness was a co-author.We explained that the six fraudulent studies were not listed as requiredby the August 11, 2004 Order of the Presiding Officer; that they hadbeen omitted from the Complaint Witness's curriculum vitae; and thatComplaint Witness had testified to disclosing the existence of thestudies to Complaint Counsel at the time of his retention in this caseand in earlier cases. Based on those revelations, we asked you towi thdraw the Complaint Witness voluntarily and to accept sanctionsvoluntarily for the wrongful withholding. We said that we would seekthat remedy from the Presiding Officer and would, in the alternative,seek to reopen discovery to fully explore all facts and circumstancesgermane to the Complaint Witness's wrongful withholding of thefraudulent studies, to his involvement in them, and to his lack ofcandor in testimony at the August 30 deposition.

Ms. Kapin explained that she could not respond to our request at thattime and stated that she would confer with her colleagues and wouldrespond this week, eventually identifying Thursday, October 6, as thatdate. Yesterday I sent an email to Ms. Kapin explaining that I would beavailable for the Thursday call at noon or later at her convenience buthave not received confirmation of the time when she (or you) can be

1

available. Please confirm a time on Thursday. Please also confirm thatyou will supply me with a defini ti ve answer to our requests.

Sincerely,

Jonathan W. Emord

2

Page 1 ofl

Andrea Ferrenz

From: Jonathan Emord

Sent: Thursday, October 06,200510:03 AM

To: 'Ikapjn~ftc.gov'Cc: 'MarkQuinn~basicresearch.org'; Andrea Ferrenz

Subject: 3PM Conference Call

Dear Laureen--

As per your request, we wil contact you at 3PM today to conclude our discussion on our pending request for youto agree, voluntarily, to withdraw Heymsfield as a witness and to accept sanctions for the wrongful nondisclosureof the six fraudulent studies Heymsfield co-authored. I wil call you at that time.

Sincerely,

Jonathan W. Emord

10/6/2005

EXHIBIT 2

Appendix :I:Steven B. Beym!ilit1d, 'M.D.

Obsi Resh CenterStLue's-R-Øbseelt Hospital109 Amerda Avene#14C

New¥orkN.Y.lOO25Phøne:212~523.;356"1

Fu:212.;SZ-3.,3S71E..ma: SJI:~COluibia.ed

Beepe 877.-61..2687

Birtb date: JULy 15,1944Bii1p~:'Broklyn New YorkCitibKp:U.S.A.

Acaeøic Traig

Hunter _College,CityUnîersit of New Votk 'B.A. Chemist 1962-196Mt SD-SchoolofMedcIie.,New York, NY. .MD. 1969-1971'LicenS jilGA, 1913

Liqmin NY. 1987

Tra~eebip~att

Emory UDivenit, AtJanta,Gergia;Medicallnter: '''1-1972

Emory University , Adanta, Georg; Medical Reident - .o)c - ,int~alMediciD~ 191z.i973

Emory Univerìty, Adanta -6eTgi;FellovrinMedicine,

~pt ofPhacolQgy: 1973-1975

Profasonal'Organntions

,America Federûon of Clica ResechAmt:ca Intu ot:NutnonAieñ~Socêtofclicai NutonSoutëmSøc ,ofClièa Investgaon (inve)Amerca Socety ,or:Parenter'and B~a1 NutrtionNort America Association ,for th Study ,of Obesity

Academic Appointmellts, '1975-1978 AsiStt Profess ofMedcie,

Emoi' Universit, School ofMedcIne1975-t 983 Assist Dior,

ElioryUiiverity., Clicà Reseach"Faciity19.78-1986 Asocte PrfesSt of Medcie, ,

27~

j

.1

1980-1984

'l9~6-1994

1986-

1986-

1~87-

199- i 991

199..

'1994-

1998-

Emor University,School ,ofMediciineDirector.I)sioIiofNution.Deparnt ofMedicie.Emory University, :SchoolofMedicineASsoiatProfessorofMedcìne~Columbia University,Coii~eofPbysiciansand SurgeoQS, N.Y.

Vjsii~gPhysìcianRockdel1er Univerity, N.Y.

Direcør. HtianBndy Composion Laborarry and Weight

Contrl Unit .of-the Obesity Resech Center, ,St. Luke~s.;ROoseeit Hospita Center.Resch Scieitist l)arent of£.ergy,BroØkbven Na'onaLaboraloty.AssoCiateProf~$$or()f Applied PhySiology,l'ea¿hetsCoilege,Coiuibia :Unìersìty

'Deputy ,Director, Obesty Reh Center,St.Lúe's-Rooselt Hospitl:ProfessorofMed¡cùi~. Cølumbia University,College 'ofphySicîansan Surgeons, N.Y.Afliate Faculty Memer,Columbia Uriversity: DeparmèntofBiomedical Engineering .

'Hospita AppOmtments

Associat Attendi :Physicial St. Luke's..Roosevelt Hospìtal Center

BORon

::ea's List 1965, 1966 - Hunter Coege, City University ,of New York.

.Phi Sigma, 1966 - Honoraibiology .society Hunte College.Deals Ust 1968, .t969 -Medcal Units, University J)fTennessee.Mosby Awad in .Clinjcal Medicine, 1971 - Mt. SináSchool'ofMedicine.First Plac Award -..A Em.ory Univ. ltousesReseh llay, 1972.,Cruhe Awar - Annual BmorY Univ. H()u~Reseach,nay., 1914.

.,Cliai an Reseach S.eola, ,Amercan CollegeofPhxsicians, 1979-198Z.

. Uononi Menlber. Lan Amercan .& . Argentine Medical As~Ciatotis, 1985.

HoroWiAl~nì Awar4, MouIi Siiai School ofMedic;ine- 'ÔUtstâDdii

:Medicalfuvestiglltoi:.1987 - ..ButiigiWelcomé S.cholar :inßuic Science, 1988.lIo:nonuMembet,American Dietetc Associaton, 1996.HonoraMemb.er,Cbilean Clinic8 Nutrtion AsiioeÌáoi.1997.'Uønor Member, New York Dietetic Association, 1991;.

:.F:nur BeadefleThòmps'OnLereship,Rutgers Uriiversity, 1998.lldlerit'Medical S.ocietLecturesp, J 999.

Fif.ÄiuatClwcai Nuton Founwltion Lect~P. .l 999.

lUoades ,Awad, Ameñca SoCÎètyofP.aenterand .Enteral.Nutntion, 2002.lOPS AwaCl.North Amercan Asciation for

the :StudyofObeSty.2003.

28

d~parmentàl.Committee

ExecveCoIDee, Obeit ,ResearchCemer:lntuteofItuman Nutrtion,E:Kective CommtteeNuttin Commtt, Head, St. Lue's-Roc)seveltHospita

'Other Profe$ioòal Activities

,EditoBoards~

:ÇurrniJoum.lofParentetal and Enteral NutritionAmercaJouin of

Clincal NutionIntetiona JoUofBody Composition Researh

.

Age :&: Nuttin.

NUtñ.tiOD ;RevìewsClcal NutrtiOD

Adipo~es

Pii:..NulrtioninClínica1 PractceAmerca Jourl ofllmaii BiologyThe JoumaofNutrtion, Heath & Agng

Colisultatie:

Ouent:

Boad of Advisors, America SocietyófParentera1 'and Entèral NitntionScience Commttee, InemtioDtCtr. for Assessmen.ofNutntiona Stat, Miai.IL

Nort Amerca Association for the Study of Obesity, IAO n~prestatve

Naûon3 AçaémyorSdences, instjtueofM~clie;Cortitteeon 'MilitaNutrion

Natonal ÀC8deInyofSCieDcesIntitute of:Medìciae, CQIDtiUee on TtSsterneReplacment in Elderly Men .

Budgel,Flie, .and AiditCoinmittee~andLoi) Rage Plang 'C()1iunitt~American Society ,of Cfuicaf Nutrtion

PaS

BoardofDireetors, American So.cietyofP.artnteral ,a:dEnterat NutritionPubIicatioa:ManagementCommitte~.American Society ..of ClicalNutriiionUnìtedStaes'PbarCQpoeiaConvelition, AdvìsoryPanel 'on

Nutñtion and

Eleclýts

29

'Nort Amcs Ascia.tion forthStudyofO~ìty(NAASO). NQlIllUODSComm

Seceta. AmencanSociety of Clinical Nutritiôn

(jVeCentâR.la,tions 'Comnittee. America SèlCi~yof:Parenteraland Enterl

Nl1trtionChai. NutraonSupprtOuid.eHneCommittee. Amerca Society Parent and EnterNutrtion . .'Chll.PUlielolicy'CQinttee. Nort

Amerca A.50ci~tj()n for .the :Study of

ObeChair. PublicationCoinnittee, Amen~Society 'ofParntetaian En NutrtionCbai,;postadate Educaion 'Commtti;. Anca Socetyof ClinicalNunNominatQ8 .Commee,America SocietofCticâ NutritionPrident. ,Food and NironCouncil :ofGreatèr New Yø~k

Prident AnericaSociet of Parteal an .EnteralNutnûon

Vice Preiidem. Amercan Socet of CliicáNl1trtion

Presiden.t, AmercaSøciety .ofClica.NutrtionCounci~AmeriGllJl Society

of Clinicai Nutrition

PUBLICATIONS

Orl2iàl.Peu-lùviewelAnÏc'es

i. Me~erAL. Hey:mñeld SB; .Grndy SMThe litogenic index -a nuieriaexressioofor the :rdative :Iitbogericity ofbile.'Oaöeterolpgy 62:499-501, 1972.

2. Metzger AL. AdlerR, Heymsfield sa. Grndy SM. Diurii varation in bilar

lipid cOmpsitio,n. NEng J Med288:333-336. 1973.

3. HeytieldSR Cystc dilaion oftheIntrabepatcbifartf (CaòiisDise)-3SQggesedtreatmeni: ,Garoeterolgy64:'663. 1913. .

4. We.~ger J.lIeyifieldSB. Adsorpon of bile 'by aluminum 'hydroxide. .J Pbanaool

Exp Ther l4:l63-165, 1914.

5. ,RidmaD,ChwlaRKlte.ynsfteldSB.,BcíEilRí 'ShojiM. V1)g1er~ NixonÐW.l1rina excreton,ófdie ea~-related glycoproteiBDCI:etlecof .,chemotherapy: Ann IiterMed .s6.:174-179~ 1977.

'~. Chawla ~RK HeynsfieldSB,. Wadswort AA, Shoji M. Rudøcø D. lslation an

diaaciritlQn øÎaglycoprötein (JBB5) in theii ora,patient witlu:atCioinof

íletolon.Cai~ResJ7:g13""'873, 191': , .

.7. HeYmfield SB, :Be.thel RA,IludmanI). Hyperesonsívenesof,patents'WêliDica .anprenyopathê:myotoricI.yStophy to .him ,growt:honnone. 1 Cli

. Endoci1ol Met 45:147-158, 1971.

30

8.Sçhant Re. FeIner 1M Heyfield Sll.GìlbertCA. SbulmanNB, Tute EP,

. Blumenstein BAEchocadìograPhcstdies ofteft veiicularanyand

function'in eSsential hypertenon"Cardiovasc Med 2:477-491,1971.

:9. GiberCA, Nutt DO. Felner JMPefJV, Heyisfield$B,Schl RC-Echodioghic .stnf Cldiac dimensions andfuncioninthe emaDce.tredatblete. Am J Caiol 40:528-533,1977.

10. Cuttr G. HeymsfeldSB,Kraus i. Le ES, MCDl1l M. Stamlei T.;Watson RRace,

~tion andprevalenceof.hypereiiiofi Am J Epid~miol106:351~3.61,1911.

11. HeymfieldSB. BethelRA lJaI Be, Mils IB,Moseley .MH Kosto JL. RudmÐ.Anbolic acioiisofredced .aiid S..eabanidomethylated human growt

hor:o.iand Ìt$ plasmi diKesin .man J ClinInvest60:563-570, 1977.

.12. Heymfield SB.'Bethel RAAnsley ro, 'GibbsD.M, 'FeIner JM,NutternO. .Cardiacabnormites in cacheçtic~tients before and duriaútrtional repletion. Am Hea195:'584-594. 1978.

11. Heymsfield SB. McNish T.P~ikìnsJV,FeInerJM. Sequence Citcadiac chages'inlAhenncnrscrlardystrophy.Am Hea J 95:283":294, 1978.

14. Rudtn n, Davi$GT.Piest il, Pattern JH,KutnerMlI, lIeysfi.ed SB. BetelRA Prevalence of growt honione4efiCiencyinchidren with cteftJip or pale. J

Pedlai93:378';382, 1918.

15. BetelRA Jansen.(t, Heymsfieli: Sll, Ansley ro, HerSh T, RudmanD.Nasgasc hyperalmentation thaugha polyetylene catheter: an :~emative toteafvenous byperaentaon. Am J ClinNu.tr 32: IU2.:n 20, 1979.

16. Heymsféld Sll,Ölafson RP; Kutner MH Nixon OW. A iadiogtaphicmetod ofqua.tifingptotein-caoric'underntntion. Am J ClinNutr '32:69i':702. 1979.

17.N~ÐÖ. Muray:G, Heymeld SB,Fu.UerEO.theeffeciøfchronicprot-caorie unerntrition in theraton myocardial functonand cardiac funeon.Circ .

Re.45:l441S2,1979.

18. HeymSfield SB., Fulenwider T, Nordliger 'B, :BailowR, SonesP , KutnerM.

Accurat~ meaement .oflivef,ki~n~y and spleen v91umeandmass by_. .compueried axìaltoi:o~phy. Mn lniem Med90~l85-181,i919. .

19. Heymfield sa, NoelR, Lynn M. Kuter M. .Actu:rcy .o.fsofttissue densty'.Pedcted by CT. J 'CömputAsìst Tomagr 3::859-36Ó, .1979.

. 20. . Heysfield SB~;Betbel RA Anley in, Nixon DW, RudmanD:Enteral.byentaon:an -alternative to ce venous hyperalimentation.Anlntem

31

Med '90:63-71, 1979.

21. Nixon'DW. HeymsfeldSB, CohenAE, Kutner MH. Ansley J, LawsonDH,Rudma ,D. Proteicaorieundemii:irition în bospítaizcace .patl;nt. Am JMOO68:683-:90, 1980.

22. ßorowitz ~ Smith J. Heymfield sa. Nutñonasupport of the ttaupatient. J

Med Assoc '69:81~819. 1980.

23. aeymsfield Sa, :Snûthl,Kael S.llarlow J,LynMJ,Nixon D,Lawsn D.:Energyùiabso.r6on:measemert .and nlJñtioná consèquences. Am JCIi Nut34: 1954-l96Q.i 98L

24. Horo~ JH 'RyPin Ea, Hendêfson 1M, Heym.sfiØld SB~ Motltt SD,BainRP,

Chawia 'RKPleier ie.. Rudman D. .Evidence for Ünpairmentoftranssrlfuôonpatway in cirhosis. Gaeiierology8 i :'668-6.75, J981,

'2"5. LawsonDH, N'ixon:DW, Kuter MH Heymstield sa. Rud~ D., Mofftt $,.Ansley J. 'CbawlaIt.EDteral VefSlJS parente ,nutrtioDl,1 supportincancetpatients.

Cacer'Treat Rep 65 (supplemeii 5): 101..i06, 1981.

26. .NixonÐW,"LawSonI1H,K.utnet M,.Anley J, Schwar.M: Heymsfiéld sa. Chawla

lt Ca.gb 'm i~;udmiw'D. HyperaIimentationofthe cancer patient wit protein-

c8oneunderutrion. Cacer Res 41:2038-2045., 19'8.1- .

27. Hend~son.JM Heymeld SB, HorowitzJ,lC1;tierMH..MearemeJi of liver and

spl~Ji volume .~y .computed tomogrphy. Anassessnient 'øf reproducìbilty,àidchages foud folloWing a 'sèlective,distalsplenpreDal shunt. RadiølQgy l 41:525-52?,l9Bi.

28. 'Nixon DW,Mofftt S,LawsonDH. Anlèy J, LyimMJ,.:KutnerMHlleyifi~ld.sa, Wesley';M, Çbawla,R Rudml). Tot~pateôtera mitritionasan'a(juncÜochemotherapyof:inetasa:tic .colotect cacer. CanèerTreat Rep65;; Supplement$;121-128,1'981. .

29. Smith J, Horowitz J. H~ndèrsonJM, .HeYInfield 58. Enteral1iyperalention-In

unernoushedpatieJrs with cirrhosis :!ld.asces, Am Jelin Nutr.'35:56";12, 1982.

30.lIeYuiñeld ;sa, McManus 'C~ Smith I., Stevens V, Nixon OW. Anthropometricmeaementoroiu~Cle mass: revised 'equations for :(culating ,hODe-iïCßar"musclearea. Am J elin NUt 36:68()69:t~.1982,

.3 i .SiDtb JL, Areaga ,C, Htymfield 'SB.lncreasdureaeliesis .and inpaired mtrogenuse dug ,ÌosÌon .ofa synetic ainoacid formula. N Eng.J Mea '306,:1013-1 Ola.

1'9.82. . -

32

\

32~ Heymsfield SB, McManus C, Stevens V. Smith J. Muscle mass: Reliable indicaorofprotei..energymalutrtion severity

and outcome. Am J Clin Nutr 3 5:1 192~1199,

1982.

33. Heymsfield SB, Steven V. Noel&, McMaus C.Sinith J, Nixon D. Biachemicalcomposiion ofmusçle in normal and semi stared human sUbjec: relevance to

antbOpQmetric measurements. Am J Clio Nutr 36: 131-142, 1982.

34. ßrubl;er LlL PrisaitML, HeymsfieJd SB. Computer-assistednutntiona

asesSent. PhysComp 1:39-4'1, 1983.

35. HeymsfieJd SB, Areaga C, McMas C. Smith J, Mofftt S. Meaurement of

muscle .masii 'huma: ~idìtyof the 24 hour urinar creaine method. Am J

elin Nutr:37:418-494. 1983.

36. SnithJL,Heymsfield SR Entera nutrtional support: form~aprepacationfrommodular inedients. WEN 1:280-288. 1983.

-31. Bagatell CJ. Heymsfield SB. Effect Df meal size on myocardial oxygen

.reuirements: .implications for-postyocardial infarction diet. Am JClinNutr,39:42.1-426,1984.

33. HeymsfieldSB,Bleíer 1. WhitmireL. McManus C, SiIith-Andtews J,Hallenk J.

liersh T. Nutrent bioavaìlabilty from nasojejunally' administered enteral formulas:

co~arson to solid foOtlAm J elin "Nutr 39:243-250, 1984.

39. McManus C,Newhouse R Seitz S, NixOQ n, Poppendiek n, Heymsfield S. Human,grient-layer caorimet developmel) ofanaccuraw and pracca instent forclinica stdies. JPEN8(3):317.,320, 1984.

40. HeaCA, MeManusCB, Seitz S,Gro$smanGD. Staton GW. Heymsfield S8. Asimple an acte :indireccáorimetr syem foras~essment of resting

energy

expenditue. ¡PEN 8(1):45-48.1984.

.41. Hil JO, Heymsfi~id "SB, McManusUI C. 'DîGiolamo M. Meal size and thermic

reSponse to :food in'mae:$úbjecasa function .of maximum :aerobic capacity.Metolism 33:743-149., 19.84.

42. Heymsfield sa, Head CA, McManus lllCB,Seitz S. .StatonGW. GrossmanGD.Respirator. cadiovasula.r, -and -metaboliceffettonenterahyperaJimemtlon: .Inuenceoffopntiadoseandcompositon. Am J CliD Nutr 40:U6-130, 19.84,

43. Daly J'. HeymSfeld SB. lleadCA, Harey LP, NiXon-ÐW, Ka~tfllGrossman .OD, Jfenèrgy.reqirement: Overestation

by widely used. prediction

t9ation. Am J 'Coo N\l 42:ll70-1174. 1985.

33

44. Isner.~ Rober we, Heymseld SB. Yager J. Anorexia nervosa and sudden

dea..A ItterMed 102:49-52, 1985.

45.. Hil JO,DiGirollio ,M, Heymseld sa. Thennic effect of food afer.in~edver~s tube.deliveredineas.Am JPhysio1248:310-374, 1985. '

,46. JlædCA,Grossil GD, Jorda JC.Hepler 'EL, H~ymsfield SB. A vale system for

the :~eineaementof èn 'expendituredurigmehançally veøtilatedpatents.R.pCae 30:969-,973, 1985.

. 47. :Ut JO. DiGiolaoM, HeymfieldSa. Anew approach for studyigdi thermk

respons io diear fuels. Am J CHDNute 42: 1290-129&, 1985.

'48. J.;awsonDH, StöktonLH, Bleier JC. Acosta PB, lleymsfieId sa, Nixon DW. TheeltÇ 'øfaphenylalanie andtyro.sIne rescted

diet on elementa:lbalance _dies

and 'plasmaanÏtogr of patents with dissemìtedmålignantmelanoma.Am J,Coo Nw 41:73-84, 19&5.

49. Heyisfield Sa. ,McManus ,ca. Tisecomponertts of weightlossincance patents.

Cancer 55::i~l8-249. 1985.

50. Heymfièld SB, McManus C,Hlll J,piGirolamo M, Nixon D, Hea A,;GròssmaG.. :Bíoeergetic studi~ in ,adult 'patients recvenng from semi-staraton. Int J ofObesity 9(sipp. 2): i 47 -153, 1985. '

5 i. Atar''lIB, ,Ha WD, Heysfield sa, Kutner M, Wells JO, TutteEP. Hlgh-

cabohydrate diet: Antitretic,and'bloopressue response in normal men Am'J

CfulNutr 44:341-348,. 1986.

52. Heyinfie1d SB,Casper K. Aithtopometrcasessment of theadlthospit8:patient. WEN 1l:36S-1S. 1987.

53. Heymeld SIJ. Ca'K,Funar J. Physiologìcresponse and clinicål iiplicationsofniitioD$Qpport AmJCardiol 60,:756-810, 1987.

54. lIeysfieldSB..Hil.JO,Evert M,Casr K, DiGiolamo M.EnergyExpendítue

dugeoiious i.asc infusion offuet infuence offormJa InmsioD:fate.

Am J CliD Nutr45:52~533. 1931. .

55 . Roi.isupong C, Heymsfield SB,CasperK" Hill JO. :ContiuousnaoeDh';ral

tee: inverse relation betee infsion tateàndserum levelsofbilitl)ìn. WENl l:544546. 1981.

56. Heyçld sa. RoladeIlIl Casper K, Sete ltG, KomndaM. Application pf

'elecOlIetÌcandsound waves in mitrtionaassesment. LPEN i 1 :648-69$.19S.

:34

\

57. Leff).,JIÜI JO.¥atesAA Costonis GA Heymsfeld Sa. Restligmetellicrae:

mearemeii.relabily. WEN 1l(4):354-358.19S7.

58. Heymsfield SB, Caser K. GrossIIaQ GD.Bioenei;getic and metbolic resns to

contious verSlsint~ttentnaentenc feeing. Metablism 36(6):570':575,

1987.

S9.Eval WK Nixon DW,Daly 3M ,Elenberg SS, Gadner L. Wolfe E,ShepberdFAFeld oR, Gn1J R, ~Fine S. Keicny N, JeejeebhoyKN. Heymstie1d S,Hoffan l' A.Arandouùrdstudy ofDralnutritional support

'versus .adlib nutrtioo8intaeidugèhemôthenpy for advaced oolorecalandnon-smaU-:ellungcacer.lClín,000015:(1):113":124,1987.

60. HellerPA, Shrir E. AkawiS, Heymeld SB. .Free amooacidfomna:nitrogen utiiztion andmetabolic effecinnorm subjects. lPEN 11(6):533..539.

1981.

61. Nixon .l)W.KunefM, Heymsfield sn,Fo1tz AT ,Car C.. :Seitz S. .CaerK, Evan'wK, Jee~bhoy iKN, Daly JM,HeberD,PoppendièkH, Hoffan FA. Resgeneigyêxpnd~in luiig and colon cancer. Metbølisi: 31(11):1059-1064. 1988.

62. Heymsfleld SB. RooogiSlthoag C, Evert M, 'CasperK, H~nerP, AkawÌ SS.:Fibersu;pp1ementation ofentèr formula$:effects on

th bioavaHabilitofmajor

nunentsand;gasroìiltestil tolerance. WEN 12:26.5-73, 1988. . '.

63. He.fitld Sa,. CaspeK. Continuous nasoentenc feediig:bioenergçticand

metabolic response.dur recoveryfroinsemisttion.Am J elin Nut 47:900

'910,J988.

64.. Baugarer RN, Heymsfleld SB, RocheAF. Bernardino M. Abdomina

'cøinösitionquaniìted by.computed tomography. Am JCli Nutr48:936-94$~19jl8.

65.n~yinñèhi .s13~CBSperK. Hea J,Guy .D. Rate of weight loss dunngunde.neejng::rettion tolevèJofphysical :activity.Metabolisri38(3):2J 5~2Z.1989.

'66. HeymsteldSB. CasperK. CongesÜYe~heart faìlure; di.icalmanagement by use ofcontiousnBSoenencJeeng. Am JClin Nutr 50:539-544, 1989.

67. :H~ymsIêld ,SB,'Wang J, Hesbka 'S, Kehayias n.Pieispn RN Jr.Pua~ho1on:abSoipiomeiicoinpason .ofbonemiøraJand softtisuemassmeasuement in

'Ýivo witheslished 'inethods.. Am JClW Nutt 49: 1283-1289,1.989.

3S

, .

68. Heymsfield sa, Wan J. Ke1iyias J, Heshka S.LiChtmanS,PiennRN Jr.Chemi~ detnnmation of human body density in vivo: relevanøetohydrenitomet. Am J CliNutr 50:1282-1289, 1989.

69. Wan J. Reymsfiø1dsn. AuletM, Thornton Je,Pierson RN Jr Boy faifromboy;deJit:undeet weighg vs.dual. photon absorplÌOiJet. Am JPhysiolE329-

.ES34, 1989.

10. Heyfield S8,Wang J, Lic:htnw S, Kamen Y, Kehayias J,PìersonRN J.Bod

composion melderly subjects: a crticaappraisa øf clmicalme:odólag.Am Jeli Nutr50:1l67-:t175. 1-989.

1 i. .ReinusIF. HeymslÏeld Sa, WiskindR.CasperK,GaambosIT. 'Ethaol: relativefuel value andmêtliceffec~ vio. Metolism 38:125-135.1989.

.12. lleymsfiCid SB,'SirthR, Alilet M, . Benn B, Lichtran S. Wang I,Pieron RN Jr.

Appendiailar .skeletalinusele mass: measurement by rlual ;photon :aboipomet.

Am JClinNutr52;21+218, 199.0. .

73.. Heymsfidd SB.Lichtman S).,BautnarerRN Jr, Wang J.Kamen Y. Alipra,tis A,.:PiersoRN Jr. Body composìtìoß:òfhumas: wmparsonoftwoímproved four-compaientmode1s that differ in eKplle, leèhncalcoòiplexity. and .radiationexosu~. Am 1 Clin Nutr 52:52..88, i 99(.

74. Devli MJ,WalshBT.Krl JG~Heymsfeld SB.Pi-Sunyer'FX, ÐantzcS.

Metaolic abootmiesin bulimia neisa. Arch (in,Psych 47:144-148, 1990.

75. CaserK, Mattews DE,Heymsfieid SB.Ov~deeding: cariovascuar and

:metbolic .resp"01i durngcontiuoiis fonnula insion in adult hum~. A,n J .eli:Nutr 52:602-609, 1990.

16. Vanta1eTB. Y8Jg MD. Heymsfield S8, Fun Re. :BoüeauRA Height-

.nørmaedindícesoftbborly's fat-freem8ss and Jatmass:poentialy iisefulindicars or nutrtinna sttus. Am J CljNutr .52:953-959. 1990:

"7. Heymsfield SB,Wal M. . Body rorrp.osition ¡n'huinans: ;advan'Cs in :the

-developmentofnilticomparel)t ,cheniçal models. Nutr :Rev 49:97-108, 1991.

78. Kotler OP.Tierney AR FeraroR, CuffP~ Wang J,PiersnRN 1r;. HeymstieldSitEnter alimentation and repleton oCbody ~iiiias.in málourished pati~nt with

a.cqiredinunodeficieney sydrome. Am JClinNutr.53:J-6, 1991.

79. Kebayias n. Heymsfield SB.'LQMonte AF. Wang J,Pierson RNil. 10 Vivodetl:miion ;ofbody fat bymeasurin.g tota

body .cafon. ~ J Clin Nutr 53.:1339-

l344,1991.

36

. ...

80. Heymsfeld SB, Wak M,KebayiasJ, Lichtan S, Dilmarian F A.Kam~Y" WangJ, Wak M, PiersonRN Jr. Chemicál,an elen(:nt 'anysis ofhw ,in

Vio U$llg

im,provedbody composition c,nodels. Am JPltysiol261 : 19()-198, 1991. '

81 .,:Pierson RN Jr, Wan J, HeymsfieId sa. AuletM,Mazriegos M,~TleteyM,SnùtbA, Thomon J. MeaSung boy fat:calibrÌIgthe rulers. inermethodooinsonsin 389nomiCaucaansubiec. Am JPhy.sio1261 :103-108, 199,1. '

82. :Baugaer RN, HeymsfieldSB, Lióhtman S, 'Wan J,Pierson RNfr~ Body

,composionÙleldedy,peple: :effecoftrion esates 'Oil :predictive,equatìoii

in theetdetly.,~ J elin Ntitr 53:l34'5-H53?199L

c83. ,(ìeliebt A,Melton~PM, McCrayRS, GaeD. Heymsfield sa, ADìr "M, :Øabi

, ,SA. ,C1îcatnl of silicone-robber gastc hJlloontPtrea obesit.liifJ J Obes15:259..266, 1991.

84.Wak M. KtallG,MallegosM, Wang J~PierSQnRN Jr:,Heýmste'J 'Sa. Rellltive'exanonofextracèlltilarfluidinobese ver nonobes~ women.AIJPhysiol '261 :19.9-203, 1991.

85. Orz 0, RussellM, Daley U, BaumgarRN,Waki .M"Lichma$, W:a J,Piersøn RN Jr, Heyfield SB. DifferenCe 'ìnskélet8 IÎuscle andlione .mier '

lIass'betweenblackand 'wnte 'fetn¡llesand their relevance to esmates of boy

compsition. Am ielin Nutr'S5:8-13..1992.

86. Berm WH Raynes-Berman E,tleymsfield SB, Fauci M, Ackerman S.'Themcidenceand _comorbidityofpsychiatric disorders in

obesity. J ,Pers Dis6:t68-175..B~ '87.W'angJ,RusseU M.Mazariegos M~:BuraterS, Thornton J"Licbtma S.

Heymseld SB,'PiernRN Jf.Body fiby dual :pboton ,absorpt.omet:',coinparns with tritional methods' Ii Asians,blackS, aod 'Caucasian. Am J Hum

Bioi '4:501-510"1992.

88. Wan ZM"Pjerii:RN Jr, Heymstield SB. 'the 'five level mo~el:.;iiewapproacht()

orgini7.ingbody comJiositionreseach. Am J C)i Nutr 56:19":2'8, 1992.

19. Lichtman SW, 'Písarska K,Betn E~PeSt()neM, :nowlüg H, Offenbacher'E..

Weisel -It H~lia S. Mattews HE;, Heyfield sa. 'Discrepancy beteen $élf-

reped and actual caloric :itaeandexerciseìn øbese 'subje~. 'N Hng) Moo327: l893-:1~98, 1992.

90. :MazegosM,Kràll0, Wang J, Waki M. Heymsfi:ed$B. ';PiersonRN Jr.,Thomtnie, Yasumura S.llody ,cnIDosition ~dsurgica treatmeIitoføbesit:effecof

weight losson fluid distbutiQn. Ann ',Sutg 216:69-73,1992. '

37

91. Allison DB, Heshka S,Pierson.RN Jr, Wang J, H~ymsfield SB. The anysis and

identifcationof'bomcilogiei-lmoderatot variables when the.moderatr is

contious: an ilustion witanthropoinetnc data. Am J'luma BioI 4: 7n-782,1992.

92.A1hu I, SmoloWItz J,Lichtman S, Heymsfield SB, Wang J, PiersonRN Jr., Pi-Suiyer Px.Composítionotweight loss ii severely obtsewomen: .a 'ne look ,at old

metods. Metaoli 41(10):1068-1014, J992.

93. HeymsfieldSB.. Wan ZM, Baimg~i1er'RN,Dihnanan.FA MaR, YasmuraS.BodyComûon and a8: ,a study by in vivo :neutroiiactivationanalysis. JNut123:432-437,1993. .

94. HaLC,CoatesRJ, BløckG,Greenberg ltEisbGwA. Forma M, Aust DF,Chen V, HeymsfieldSB. ~enreGeptorstatus and dietai intaes .i:brea

cancepatents.Epideio1ogy 4 :25-31, 1993. .. .'95. 'Bern wa Bero ER, Heyisfield 'SR, ;Fauci M, Ackerman KThe .effec 'Of

psyCluatrcdisorderson wetght loss inçibesity clinicapatients. Behav:Med 18:167.-172,1993.

96. Wak M, HeShkaS, Heymsfield :8B.. Long-ter lípidlowenng,behavior.modificatio~ an weight loss inòbeewomen. Nutrtion 9:23-28, 1993.

97. Bauinarer 'R, RhyneRL, Gary PL, HeysfieldSB.lma tecbnquesand'aitoincal body-composition in agin. J Nu123 (Suppl 2):444--8,.1993.

'98. HeshkaS,Fèld 1( Yan M, Allisön DB, Heymsfield SR Restig energy

expendit~e in l~ 'obe: .across-valîdationand comparson or prediction equations.J Am Diet Assoc 93: lOll -6, 1993.

99. Allison DB. HoyK, Fourner A, Heymsfield SB.CanetcdIerènces in men'spreeren~forwomaIils'bQyshape contbute to ethnic difernces in femaleadsity'? ObesRes 1:425-4:34,1993.

. tOO. MIison DB. Jles.bk '$, Heyield SB.:Evide.neofa .major gene With pleiOt()pic'acon for :acadìøvaCllar diseaensk syndrome jnch¡ldren yoJingertha 14 y~.AmJDis.Chld 147:1298-1302, 1993. .

-38

103. RoubenoffR, Kehayias JJ,Dawson-HughesB, HeyinfieldSB. Use ofdu enerx..r~y absorpomry in'bodycomposìtiöostdies:nötyet agoldsttlard. Am JClin Nut 58:589-91. 1993.

104. Heysfièld SB. WangZM.BioÎmpedanceanlysis: modeling~pproach atthe.ñve-levels of body copositon and influ,e~ce of etbnicity. Age Nutr 5:106110, 1994.

105. Heymfield S8,lIeSbka S, Matews DE. Doubly labeled water measures ènergy

use. Scientifc Amercan~ Sa 'Mea. 74-83. 1994.

lU6.Zumoff ll. Stni. GW, JIeymsfield SB. .Lichtmn S. A radomizedOlble-hlindcrosovelst(lyof tbeilti~beSitY effecofetiocbolanediöne. Obes Res 2(1): 13-18.

1994.

107~ PeimI, Wang ZM, Bub'~ Alison DB, Burastero S, Heysfield So. Body

composition 'and two-mpartment model assumptions in male longdistce

runers. Med Sci Sport Exerc 26:392-1.1994.

108. HeymsfieldSB, Allison DB, .Pi..Sunyer FX, Sun Y. Columbia respiratory chamber

indirect calorieter: a new approach ioair flow:modelig. Med .Biol En çøni32:40610;1994.

109. Alisn DB, NeBe Me, Heshka. S, l.eymeld "SB. Race effectiò the genecs ofadolesc(:nt's body mass indeK. Int.! Obes 18:363-368. 1994.

110. GeraceL, Al~pranis A, RussellM, Baugaer RN,WaoZM Wang .I, Pierson

RN Ji;, HeymSfe1d SB.Skeletal difference :beeen black and wbitemalesai

their relevance 'body ,compositiou estimates. :Am J -Hum Bioi 6:255--62, .1994.

lll. MazegosM. WangZM,GaUagherD,BaumgaDerRN. Wang J,lieron.RN Jr,Heymsfeld SB. .Aginin femaèS: changes in the 'fve "levelsøfbody composition¡md their relevace to the two.comparentchemcá modeL. J GefontOl Med Sei

. 49:201-208, 1994.

ll2. PagneHaA, 'Calo M,CaenaroG. Sahmdin V, JusP, Simni G, H~yisneld Sa.

:Oardiac .cachexia:Pre-opei'veandpost-opeenutrtiona managment. WEN

18:409-416,1994.

113. Alison DB. 'HesdS. Neae MC,Lykken nT, Heymsteld sa. A ogenetíc:analysisofrelativ(: weight among 4020 twn pairs \vithan emphasisoÎsex efects. Heal

. Psych 13(4):362-365. 1994.

114.WaigJ.Thmtoß ie. Russll ~ Burastero S,HeymsfieidSB~ PiersonRN 1r. . Asíanshave lower body mas indexbuthigberfat %tba whites: comparsons

of

annpoinetrc'mearements. Am J 'Cli Notr 60:23-8. 1994.

39

l1S.KadersBS, PIlmann-JoyP, Forey JP,Heymsfield sa, Hebe D, ElaSholIRMAshley 1M :ReevesRS, BJackbun nL.The black AmericanlifestyleintetntIon

(BALI): the deSign of awetgh loss program for working class Afca American

women. J Am DiêtAssoe34(3):31O..i, 1994.

116_BurszleinDeMytenaere S,GiK, HeyislÎe1d SB, Furst P, Askaaz J, D'Atlls

N. Elwy'DR. Gac emptygin humIU: . inuence of different regens of.parentetalnutñion.Am n:lm Nutr60:24L8, 1994.

117. Hoy K, HeSaS, AlisønD, Grai;l E,BJankR, AbiriM,Heytnsfield Sa. Obeand ~hepatobilar annorinillÌties: tedu.ce risk ofliverfucton testchaei an newgallstone formionviith weight lOSSQß IØw cáorie díets. Am JCIiNutr60:249-54, 1994.

n 8. Heymfield SR,Gnnager D, PoehlanET, Wolper C, NonasK, NelsonD. Wang

ZM. Menopau chages in .bodycomposition and energy expnditue. £'i

6erpntoI29:377";389,1994.

119. .StcnbacbG. Heyinfield SB, Olanen NE, Tighe A, Holt PR. Effec ofcaoncrestrction :pn.:Cloriicprøliferatiônin .ôbes pctsons: implications forrolon cace .prcvenìn.Caer Res .54: 1194':7, 1994.

120. BlarDM, Clai'kRV, Heymfield SB,Rudma DR, Blank MS. Endogenousopioids8Ddhypo-gonadsminhumaóbesìty. Brain Res BiilJetn 34:571-574,1994.

121. .Economos CD, Nelsn:ME, Fiatarone.MA DallalG, Kebayias J, Heymsfield.:SB,Wang J,ZboNl., Yasumuf.a S. Ma:RM Vasani A, Pierson R Detennationofbone. mmeralcontetby Lun, lIologic.~d Norland duåJ energy x-ray

ilsorpbQmeters'(DXA), de1ayed:gaima,neutroactivation (DNA). and 'chemical. 'analysis. Am JClin Nutr56:93-98, iø94.

122. Heyifield SB, Dary PC.MuhleimLS. GallagberD, WoïperC, Alison DB.Thecaoñe: my:measement,andreaty.. AmI ClinNutr62:1034S-1041S, .1995.. .'

123. 'Spit.A, Hey.isfieldSÐ, Blank .Re. Drug therapy for.obesity: clinicalconside.t;tions.End Pract 1(4):27+279, -i 995,.

.124. Wan J.Thoniton ie, Burero S, HeYinsfieldSB.PiersonRN Jr. Bio-ímpedce.anysisJor eStIation ohota boy:potasiull -tota body wate... .and -fat-free.main.whiie, 'black and Asian adults. Am JI-mB'ioI7: 33-40,1995.

125.. Allison 'PD, KandetsBS, Os;ge GD, Heymsfield SB~ Heber D~F()rey JP. ~Elasott

RM 'Blackbum,GL. Weight-fela4: atttudes and beliefs aiong obe Afca.American.Women. J NutEd 17(1):18,.23. 1995.

40

126. Sepulveda D..Allson Dn,Gomez il, Brown RA PiersonRNlr. Heymfield SB.l.ow~ÙUandpelvc bo~miner denit aMong

individuals with downsyndrome. Am TMent R,etardlOO: 109- l 14, 1995.

127. AlIisonDB.G9mezJE. Hesbla S, Bábbitt RL, Gelieb.ter .AKreibiçhK, ßey¡eJdSB.Deeadre metaolic rae among persons

wi downsyndtome. Int J

Obes 19:85'8';86't 1995.

" 128, AUisonDB, .Paultre F, HeymsfieId SB,PiSunyer.FX. Is the intra:.utereperod

~ya critica;peRød for the development of adiposity? lot JObes 19:397-4,1995.

129.Aln DB.aeSS, NealeMC, TisblerPV,.Heymsfield'SB.Geetic..enwonmeiandphenotyic links beteen body mass :index and blood presamoag women. Am J Med Gen 55:335-341. 199.5. .

110. ..Buhl KM 'Ga.lbigher n. Hoy 1( .Matthews DE~ Heymsfield SB. UnexplaÙleddisance in :body.weight regaton~ diagnostic outcome in .patientsreferr tor

dbeityevaluationreportg low.energy intåes. ¡ Am "DietAsSb 12:1393-140~

1995.

n LAlison DB.PaQlire F,Goran MI,PoehnianET, IleymsfieJd SB. Staca "

coosidermons'regardin the use 'of ratios to adjust .data. Int J ,Obes 19:638-643,1995.

132. El.,Gaal A, Galager D, Nawr.A, Gadli.iP, Gomez J, AllsooD, Steiberg JS.Shumac 0, BlanR, aeymeld SB.Efkctsofobesjy onQT,1l ,an QTc.intervals. AiJCarwo115:956-959.1995. "

133.~rI.ioJA, Wai.J. PiersooJrn Jr, ßeymsfield SB.Age-related chaes ìn

. musciiloskéleta mas beeen black an white women. Metabolim 44: 30-34.

i~95.

134.PiersonRN Jr, WangJ.Thoniton ie. KotlerÐP:Heymsfield SI. WeberDA,MaRM.Bone ;minen.andbody'fat ,measurements by,two .absòrptiomet systems:"comparsoIl wítbneion.acvaton analysis. 'Cåc tissue lnt .'56:93-9$.1995.

13 s. Allison DB, Kreibich K, HeshkaS. lIeymsfield SB. A (aIdomied placebo-controlledclcaltràl nfan~cupressure device for.weight Joss. in JObes 19:653-

.65.8, 1995.

:16. Wan ZM. Heshk:S. Pierson:R, H~yins:field SB. Systema;ticQrgaiztion.ofbøy-.çomposion meddolog: :anoverview witl emphasis

on :component-based "".metods. At.J ClinNuir 61: .457-65, 199.

41

137. Heymsfield S8, Gaagher D, Viser M, NU.ñez C, Wang ZM. Meaureli~t ofSkelet musCle: labratory and~pidemiolqgica metotlsJourofGerontlngy50: A23-A29, 1995. .

:18. Heynsfield SB, Wang ZM, Visser M, Gàagerp,PieIson:RN Jr.teehnquesus in the,nearernentófbody composition: an.overVew'with tmphasis on

bioelecca impedance anl~sis. Am JCliD Nutr 64:487S-494S, 1996:

.139. Heshka:S.lleym$fleldSB, Nuñez'C,FittanteAM Spit A, 'P1sunyerFX.:Obesty-id risk of gallStonedevdopmenton 1200kca règlat food :diet. lIl OJ 00020:450-454, 1996.

,-,".."

141. :Wan~ ZM, Visser M, MaR, BauigarterRN, :KoUer D. QaUagher'D, Heyeld_ "SB. Skelçt muscle mass: evaluation by neutriia:vatioD ,arid du ,ei1erX-ry:absorpiometmethods. J ApprpllY$io180(3)~824431" 1996.

142. GaagherP, Visser M. Septvm D.PleionRN Jr, .Hà' I. Heysfield Sil. Howuseful is' body mass index fOTcomp8Òsonof body fate$sacross 'age, ;gende,andetcgroups?Am JEpidem 143:228~239.1996. -

143. Ailison Dlt Neae Me. Kezs MI, Alfons VC, Hesbka S. Heym$tièldSB.Assorttive matig for relative weight genetic implications. Behav Gen'26: 1 03-

111,1996.

~

- ij~,~,I~,J

t~

~~

140. Wang 1, Thornton lC,Huraser5, tanelibaumS,HeymfieldSB.,:P;iennn Jr. 'RN.

Compañonofboayrnass index an body fatp.eri:entaiilgPuertØRJta, 'lllacks,Whes,:an Asians living in the New York 'City area. ObesRes 4:377':~l84, 1996.

144.R.osebam t4Ravuss E, MaUhews DE. Gier:C. Ferraro R. H~sfieid sn,Hirsch J, Leibel.RL. A :cømparativesi4yof .dfferentniea 'of asssing long.:ter

énerg,CJqendit,inbuans- AmJPhysio1210:496..S:0, 199.

145. Ecnomos CD. NèlsonME.Fiataône MA Dawson-Hughes B, HughesG, DaalGE,Heynifield SB,Waag J.Russell-AUlet.M, YasuDluta,s, Ma:R, Vaswan AN.Pierson RN Jr. A'multi--niercompansonof DXA instnient: -in

vivo .and ,in

Vio tneaurèments ofboneminetcontentan(I deiiJt. AmJiCliNut 11:2705-285,1996.

146. W~ZM.GclagherD,Nèls()n MG.Mattews.DE,HeymsfieldSB. Tot.body. lIkelet muscle mass': evauatonøf24hour,ürnacreafe,tx~tIon metoØby.. ,computeraxaltomøgrap~y. Am lClin N,Pt63::S63.;869" 1996..

147. Galagher'p", VisserM, WapgdZM Haris T, Pieron RN 1i:, HeystIeld sa:Metabolicay acve compnen 'of fat-rree.body',mass:ìnuence :Qfag~,:adsit,.and gender_ Me~òlk 45.:992-997, i 9.96.

42

148. Wan ZM,Sun YG, Heymsfield SIl. UriDarcreaÎne skeleta muscle ma Qletod:

a,predcton eqio~ ba.seoDcöroputenzedaxìal tomography, Bioiied EDW Sci 9:

185-190.1996.

149. llosoobaum M, Nicolson M..Hirsch J, Heymsfield Sa.. Galagher D, ChuF.LelblR. :Effec of Gener, Body Composition, and Menopause on Plasma.

Co~çetratonsofLein JCli .Endöcnologyand Mêtabolism81(9): 342~3427,1996. .150. Nuñez C,Gáaglir D, 'Visser M, PiSunyer FX,. Wang ZM. Heymsfie1d .SB.

Bioimpeceanysis: evaluatiônofleg~t.ltïsystembasedon presse conta,foot"'padelecodes. MedSci SpQrtExerc 29(4):524-531, 1997.

lSl.Galag.o, ViSSer M, "De Meersma RE,S~púveda D., Baugarer RN, ;Pîein

JlN Jr, Has r. HeymsfieldSB. AppendicUa. skeletal muscle mass:.efecof age.

gendtf. andethcity. J Appl ~PhysioI82(l):2i9":235), 1991.

i 52. Pietobell A, Rothcker O. Galagher D. Heymfi.eldSll ElectrocadiogaphicQTc.ÍIteral: short-tem weight losseffects.Int lObes 21 :110-114, 1997.

153. .RoubenoffR, H~ymstiêldSB. Kehayias JJ, CainoD JG, Roseberg ni. StadardiztioD -of nomenClature of body composition in weight loss. Am J .Coo

Nutr.66:192-196. 1997.

154. 'Zaboni M,Amellini .f, TurcatoE, Todisco p. Gallagher D,.Grave RD,Heymsfield

SB, Bosêo O.Body fat distibution before and ..aer weigh gai iDanrea

nervosa.Int J Obes2J :33.;36. i 997.

lSS.Vissl-GaaghecD, DeureDberg:P, Wang J, .PiersonRNJr. Heymsfield SÐ.

Dtnsìtyoffat-free .body .m.ss::riationship with .ta~.:.age, and level of body fats..

.Am JPhysiol 272:78 t -787. 1997.

156. Allin DB. Galagber D, BeoM, Pí-SunyerFX, Heymsfleld SB.Body'mæis 'indexiid :a:n"'cause mortalty among people age 70.and over: the longitudîaJ ~dyof

aging.lnt J Ohes 21:4244~1, 1997.

157.Gelièb~ A MaherM.Geacel.. Guti B,. HeymsfieldSB, HashS. Eff~ ofstengt or aerobic trainn.gQn body .composition.restng metabolic rate,an ~peaoxygen consum.:ioni n obese dietng subjects. Am JCli .Nutr 66:551-593, 1997.

158~ Albu J, .Shur M.Curî M,Muiphy L. Heymsfield 'SB,Pi-Sunyer FX. Res .metabolic .~inobese.premeIlopausai black women. .Am J elin Nut'6":;53 i~538,1997_

43

159. WangZM Deuenberg P, Wang J, Heymsfield SB. Proporton of adipose tie-

free body m3SS as skeletal muscle: magnitude and consancyininen. Am JHuBio9:487-492, 1997.

160. Leer SA, P~on A, HeymsfieldSB,Wang J, Thornton J, Pierson 'RN Jr. Bocfat and water chanes 'duriapregncyin wornen witb aifferent body wetght and

weight gan. Obst-(iynèCl9O4):483-438, 1997.

161. EconomOS CD, Nelson ME, Fiaiaone MA, Oallal GE, H~ymsfièid SB,Wan J,Yasmar Ma:R, "Vaswan AN, Russell-AuletM,PiersonRN. A multi-cente'comparson Qfdual ,energy x-ràjninsorpometers: in vivo

and in Vitro. softtissue

meaement. Euro) ClinNutr 51:312-317, 1991.

162. Nag D, DeMeersman R,GallagherD,Pietrobelli A, Zion AS.D"lyD; Heymfield.SÐ- Qrcinter(cadiac repolatiori): lengt~ingafer meas.ObeRell"5(6):531-531.1997.

163. TanYX NuñezC,Snn Y, Zhang K,"Wang::ZM Heynñeld SB. New ~ecodsystem for ra.pid "WhoJe-bodyandsegmt;tabioirpedance asessmeiit. Med SciSport Exerc 29:1269':1273, 1997. .

164. BauarerRN, RO$sR, HeysfieldSB. DoeS adi,posetissuejnfluencebioelecca impedance in obe men and women? J Appl PhysiolS4(-):257 -26Z.1998.

165.Pietrobell A, Faith MS, AllisonDB, GallagherD,Chiumeiio G, H~yisfield SB.Body masindexasameaureof.adiposity among children and adolesceÌîts:avalidatìonstdy. J Ped. 13'2(2):20421'0, 1-998." .

166. WangZM, Deurenbeig P, nuo SS, Pietrobell A, Wan 1, Pierson Jr. R, Heyfield

SB. 'SÏ!-oomparmem" :boy:coinpositionmo(el: Inter-:methd comparns "()ftolalbodyfàtmeaeinem. '1DtJObes. 22:J29.:~n1, 1998,

167. GaUagher Q, Heymsfield SB. Muscle distrbution:variUioQs with body weight,

gender, and age. Appl ltdiatIsot. 49(~/6):733-734, :1998.

168..Pietrobell .AGalagbcr D. .Baumgarer lt, RossR" Heyilêld SR 'Le RVidue for DXA two-ompoilènt soft..tisse model: JnØuence oOfage,and tissue

or

organ type.1\pl Rad,;it lsot 49(516):743-144, 1998. '" .

169: Heymsfield SB, 'Gallag her 0, .GrammesJ, Nooez C, Wa; ZM, .Pietrobèl A._Uppe "

exremity sk~letJIiisqle .lls: potentál..of mea:sem~nt With ..sìngle frequencY "

bioimpedance .aiysi:t. Appl Radial loot 49'(5/6):473-474, 1998.

44

no. Wang ZM, Deurenbei:gP, RuimeiMA Kotler D. Heymsfield SB. Tota bodyoxygen: Assessment from body weightancj tota body water. Appl Radiat Isol49(516):603~605, 1998.

17"1. WtUg 2M, DeurenbergP, Mattews DE, Heymsfield S8. Urina 3-

metbylhistidine excretion: association with total body skeletal musCle mass bycomputerized axial tomography. JPEN_ 22(2):82~86,l 99&.

f72. P.1etr'obelli A. .Allison D, Faith M, BeccariaL,BosioL,Cbiumello G, CampfieldLA, Heym.sfield SB. Prader-Wili Syndrome: Relation$hip of adiposity to plasmaleptinleveJs. Obes Res 6(3): 196-i01, 1998.

173. .Comizio R, ;Pietrobell A, Tan YX, Waig ZM, Withers &,T, Heymsfield SB, BoozerCl' Total body lipid and triglyceride response loenergydeficit: relevance to bodycomposition modeL. Am J 'Physiol. 274: E860-E866,1998.

174. Pietrobelli ;.1 Wang ZI'vl,FormicaC, Heymsueld SB. DuaJ..energy x-ray'absotptiometry: fat estimation errörsdue to variation 10 soft tissue hydration. Am J.Physiol 214: E808-E816, 1998.

.175. Gan4gherO, Belmonte.o, Deurenberg.P, 'Wang 2M, Krsnow N, Pi.;Suayer FX,Heymsfièld SB. Or:gan~tissuel)ass nieasuremeritaHowsmodelìngofREEandmetabolically active tissue masS. Am JPhysiol 275(2): E249-E258, 1998.

176. Ricci TA Chowdhury HA, Heymsfield S8, Stahl T. Pierson RN Jr,Shapses SA.Calcium supplementation Süppressesbooe turnover during weight reduction. J Boneand ~1ìner~ Res 13(6): 1045-1050,1998.

in. WangZM, -Deurenberg P,Wang W,Pierson RN, Heymsfield SB. Fraction ofcaibon~freebody mass as oxygen isaconstant hodycornposition ratio in llien. J.NutT J28:J008-loiO, 1998.

178. Pietrobe1li,A, Morini .p, Battstini N,ChíumelJo G, "NuñezC, HeymsfieldSB.Appendicular skeletal muscle mass:prediclion from multiple frequency segmentalbioimpedanceana:lysis.Eur JClin Nutr 52: 507-5.11,1998:

179. MitsiopoulosN,.SauingarerRN, HeyinsfieIdSB, Lynfi W,Galhtgh~D,RossRCadaver validation ormagnetic resonançeimaging and computerized -:omograp~ymearement .o.fhumanskeletal muscle. J ApplPhysiol85(1): 115- i 22,1998.

180. Miihtheim LS, Allison on, He.shka S, Heymsfi¿ld SB..-P9 unsuccessful-dieters. .. .intentionally underiepori foodintakt? lot J Eat :DisordZ4: 259-26(),-1998.

18.t Altsoil DB, NathanJS, Albu JB, Ueymsfreld SR, Duprat U,Pi-Sunyer XMeasurement challenges and other practicalconcerns when studying .massìveIy:obeseindividuals. lnt lEal Disotd 24: 275-284, 1.9'98.

45

182. ShapsesSA. Heymsfield SB, .Ricci T A. V oJuntary weight reductonincreaes bonetumoverand loss. SerQno Symposium 19: 180-~184, :'998.

183. Heymsfidd sa, AlHsøn DB~ VasseHi JR :Greenfidd D, Nunez C. Garciniacamhogia(HydroxycitricAcid) as a potmitiàl anti-obesity~ent: A randomized-doublebJind contron~dtriat JAMA 280 (18): J596-l6oo.1998.

184.laxion ALedermanSAH~ymsfield SB. Wang J, Thornton JC. Pierson RN JrAnthropometncequations for studying body fat in pregnant women. Amer JOinNutr67:l04-10, 1998.

:185. ;DavidsQn M. DiGirolamo .M.For~yt J, Halstea C, Hauptman J, Heber D,PleimburgerD, HeYlUsfleld SB, LucaC.RöbbinsD, Chung J. Long-term weight.controland .reduction!n risk tàctorsiil obesesubjecls receiving orlistat: a lipaseinhíbitor. JAM A 281 or 235":242, 1999.

." . 0.

186, .Ledennan SA. .Paxtori A. 'HeymsfieJd sa. Wang J, Thornton J. Pierson RN JrMaternal fat and wat~rgahiduring ,pregnancy: do they ..faise infant birth weight? AmJOb:stetGyecol l80: 235..240, 1999.

187. Nuñez C, GallagerD, Grammes J, Baumgarter R.. Ross R. Wang ZM, ThorntonJ, HeymsfieldSB. Bioimpedanceanalysis.:potential for measuring lower limb'skeletal musCle mass. JParEnt Ntitr 23: 96-l03, '1999.

188. PietrobelJi :\-,Lee RC, Capristo E, Deckelbaum RJ, Heymsfield 56. An:independent, inverse.associationofbigh-density lipoprotein dloJesterolconcentration with nonadiposebodymass. Am J Clin Nutr 69(4):614-20, 1999.

189.Gu W, Tu Z, Kleyn PW, Kissebah A. Duprai L. LeeJ, Chin W, Marui.s, Deng N,. Fisher SL, ;Franco LS. HumP. YagaloffKA, Nathan J, Heymstield SB, Albu j,~i-

Suoyer X, Allison OB. Identification and functional analysis of novel humanJnelanocortì:n-4 receptor varant. Diabetes 48(3): :635,,639, 1999.

190. Kim J, Wang ZM, uallagher D.~ Koder ;oP, Ma K, Heymsfeld SB.E.ktracclular-wateJ":.sodium bromidedillition eslimatesC:llpared to other mafkers inpatients

withacquitedininlunndeficiency ;syndrome. WEN 23(2):61-66~ '199...

191. Mott 1W, Wang J, Thornton JC, Allson DB, Heymstìeld sa, Pierson RN. Therelatronshipbetween body fat and age in 4 ethnic groups. Am JClin Nutr69: 1007-1013,1999.

192. Clasey It, ,Kaaley J A, Wi'~ernanL, HeymsfieJd SB, T~tes Ç.b. GutgesellME,'Thorner MO. Hart.an Ml, Weltman A. 'Validity ofbody'rompo.sitioñ assessment. in younger and older males 'and femaJes.J Appl Physio186(5): j 728-173'8, i:999.

46

193. NuñezC, Kovera AJ,Pietrobelli A, Heshka $, Horlick M, Kehayias JJ, Wang ZM,Heymsfield Sa. Body composition in chiJdrenandRdultsbyair .diiõpl!lcementplethysmography.Eur J Clin NutT 53: 382-387,1999.

194. Allison DB, ZannoJl R, 'Faith MS, Heo M, Pietrobell¡ A, Vanlta:Jie TB, -Pi-SunyerFX. Heymsfield SB.Weight -Joss intreases and fat Joss deceases aU-case

. monaljtyrate: Resi;ltsfromtwo ind~endeot cohort studies.lnt J Obesity 23 :603-611, 1999.

19.5. WangZM, DeurenbergP, Wang W, Pietrobelli A. Baumgartner R.N, HeytnsfieldS8. Hydration offa:-:ee body mass: new physiological modeling approach. Am JPhysiol276: E99S-EI003,J 999.

.t 96. Faith MS,Pietrobell A, NuñezC. H~o M, HeymsfieJdSB, AllisOn DB. EVidencefor ¡-ndependent genetic influences on fat mass and body massindex .inapediatTÌctwin sample. Pediatrics 104:61-67.1999. .

197. Engelson ES,KøtlerDP, Tan YX, AgiDD, Wang J,Pierson RN,HeymsfieJd SB.Fat distribution in HIV .,jnfectedpatients -l-eporti",g 'truncalerilargementquantifiedbywbole-bodymagnetictesonanceimaging. Am.J Clin Nutr69:-l l62-1l69,19~9.

198. Heymstield sa. Greenberg AS, Fujioka D, Dixon RM. Ki.shnerR, Hunt T, ,LubinalA Pat.me J, Se1fB.HuntP, McCamish .M. Effectof.escalatingdose Jecombinanrleptin on .weight t05sin oheseand .iiön..obes.e adults: a randomized controlled triaL.J AMAi82: .1 493-J 596. 1999.

199. Wang W; W~g ZM,faith Ms,Kotier D. Shih R, Heymsfield SB. RegiQnaJskeletalmuscl.e measurementevaluat¡onof new dual..energyx~l-ay absorptiometry modeL. J

Appl Physiol 87(3): 1568~J5Î5. 1999.

20Q.Wang J, HotlickM, Thornton JC Levine L, Heymsfield SB, :PiersonRNJrCorr~la(ionsbetween Skeletal MusCle Mass and Bone Massin Children 6-18 Years:Influen'cesofSèx.Ethnic.ity,and Pubertal Status. Growth, Development & Aging63:99-lO9, 199.

201. 'Wang ZM, Deurenbefg.P, Wang 'W,PiettobeUi A Hauß'garnet RN. HeymsfieldSB.'HydTationoffat~free :body ma;S$:new :phys'iolagicaJ 'mGdtJingappmach. Am.J. tPliys.iol. 276:E995-E100J, 1999. . .

202. Lederman SA, paxon A. Heymsfield SB, WangJ, ThorntonC, PiersonRN JrMaternal fat-and 'watet gainduringpr.~nancy: Do they raise infant birth weight?Arer. i-Übst..& GYR. 180:235-240, :1999.

'203. ZingarettiG, Nuñez C, -Gallagher D, Heymsfield sa. A New l'heoreticafMo~el forPredicting :ßioelectncal ,Impedance Amilysis. Annals :of The New York Academyof Sciences. .904:227-Z28, 2000.

47

'204. ,Punyanita M, Nuñez C, Robiano F, H~ymsfieLd SB. The Assessment -of StatureUsing an lnfrared Technique. Annals of The NY Acaemy of Sciences 904:276-279,200.

205, Ueymsfield SB,Gallagher D,Wang ZM.Body Composition Modeling: Applicationto Exploratiun ,of the Resting -EntrgyExpenditureFat-:freeMass Relationship.Ailnalsof-th NY AcademyofSciences904:290~298, 2000.

206. Wang ZM, DeureJibergP, Heymsfield Sa. CellUlar-'Level Body CompositionModèJ: A New Approach to StudyjngFat-Free Mass Hydration. A"nals of the NYAcademy-ofScieoces 904:306-Tl1, 2000. -

''201. NooezC, Tan Y. ZingarettiG,PtiyaoitaM, RubianoF,-WangZ. Heymsfield SB.The llesPFedìctive Model for 'Estmating 'Fat-'FreeMass. Annals of the NYAcademy øfScíences 904:333-534,2000.

208. RubianoF, Nuñez C, Heymsfiéld 5B. A Comparison ,of Body Compo. sit ionT eduñques_Annalsof the NY Academy of Sciences 904 :335-33 8,2000.

-209.GaUagherD,Allen A WangZM, HeymsfieJd SB, Krasnow N. Smaller OrganT4ssueMassi1l the Eld~rly Fails:to Explain Lower R~'tjng Metabolic "Ráte. Annalsof:he NY Academy or-Sciences .904:449-455,2000.

2lO. BedogniG, Pietrobelli A:Heymsfield ~B,Rountauroli.C,Borghi A., Ferrari F,- Banistini N, SalvipJi G. Influence .ofBody Composition on Böne MineralConient¡nElderly Women: A J)eljminary Report. .Annalsofthe NY AcademyofSciences'904:489-490, .200.

2-1 1.L-eöne P, Galllagher D. Wang 1, Heymšfield .Sa. Relative Overhydration ofFai-freeMass in .Po.stobese versuS Never ..Obese Subjects. Ann NY Academy nfScÎences.904: 514-519, ~2000.

212. Heymsrield SB, Nuñez C, Testolin t. 'Gallagher :D. Anthropometandmeihodsoflwdy co~positjon measuremnt for research and .field :applic~ioni!l the elderly.

. _ .Eur J.Clin Nutri :54(supp 3)~S26.;S32, 2000.

.2 l 3 . DaUagher It Heymsfleld Sa,Heo M, Jehb SA, Mui:gatroyd 'Pit Sakamoto Y.Heall-hypercent boqy fat ¡ranges: ,.an approach for developjngguideLlnes based upon:hoity .mass index. Am J Clio -Nutr 72:694-:701.200'0. .

214.-HeymsIield sa, 'Segal KR, -Hauptman J,Lucas;CP,Boldrln MN,Rissanen A;Wildïng JPH, Sjosti.om L Wéjght,ioss vt'tb orlìstat 'improves 'glucose tolerance andreduc:es,pr()gr~ssiøn to:impairedglucost-iolerancc.and type2diaõetes in obese:aduJts. Arch Int Med160: '13"21-'1326.2000.

48.

215. Lee RC. Wang ZM, Heo M., Ross R, Janss~n I, Heyinsfield 5B. Total..bodyske\etalmuscle mass: development .andcr()ss~validatjon of anthropometric predictionmodels. Am) Ctin Nutr 72: 796-'803, 20'.

2.16. Testolin CG, Gore R. Rivkin T, Hodick M, ArboJ, Wang ZM,ChiumelloG,HeymsfieldSB. Dual-Energy X-Ray Absorptiomeuy in Pediatrics: Analysis ofPercet Fat Estimated Errors Due to Variation in Soft Tissue Hydration. J ApplPhysiol.2000 D~:89(6):2J65-72_

217. :EconomosCD, Neisol1.1\1E,Fiata~ne MA, Dalla:U GE.Heymsfield SI3,Wang J,RusstH-AuletM, YasumuraS, MaR, Vaswani AN,Pierson RN,. Amulti-cnter

.comparison 'ofdual-energyX-ray absorptiometers: in vivo and in vitromeasurements of bone inineralcoòtentaid density. Am JOin Nutr 200 Juti: 7.1

(6):1 392-4()2.

21$. Economos CD. NelsonME, Fjatarone MASinghMA, Kehayias JJ, DaHaJl GE.Heymsfield 58, Wang J, YasumurnS, Ma R,Pierson R.N.BQnemineralmeasurements:acoinpadsonofdelay:egamma neuU'o.naCtvation, dual energy x-

ray absorptjometryanddir~ct chemicälanlysis. ûsteoporos lilt 1999: '10(3):200.;6.

21 9. Economos CD, Nelson ME, Fiatarone MA, DallaJI.:GE, Heymsfield sa, Wang J,YasumuraS.Ma R, Vaswani AN, RusseU-Aulet M. :Pierson RN. A mu:lti-centér

. comparison of dual-energy X-rayàbsorptiometers: .jtiviv.o and in vitro 'soft;iissue

measrenents. Eur Jehu Nutrl997 May: "5 L(5):3 12-7.

220. Baumgarner fLN, KoehlerK, Ross RR, Romeo L,GalIagher D, Heymsfidd SB,Gar PL, Lindeman RÐ-Epidemiology ofsarcopenia 'i"elderly people in New:Mexico. Am) Epidemiol.1998Apr 15; 141(8):755":63.

221. Ricci T A. HeymsfieldSB, Schreiber TB, Ch()wdhuryHA,Rosato MT,Sbapses SA. ~10dera1e caloric restrictioniricreaesbone rtSorptioninobese ,postmenopausalwomen. Am lCljn Nutr. 2001 Feh: 73(2):347-52.

.222. Jans.seD 1. Heymsfield SB, WangZM, Ross R. Skeletal mass anddistribuiioii in 463-men and women .aged18':88 years. J Appl Physiö189: :81":88, 2000._

223. Janssen 1, HeYffsfield 5B, Baumgarner R, 'Ross R. :EstImatiòn'nfskeletál musclemass by bioelectncal impedance ~anal)'sis. J ApplPhysio189: 465-471 T 2000.

224. Plane.boom L, Chôban :PS, Heymsfield SB. NutritioJ1SupportofCriticaJ:y 111 Obese

. Patients. From NutriiìonSlJport to PhaTmacøl.ogi~ Nutitipn in ihelCU. Updalein.lniensive:Care and Emergency Medicme 34: 327~3J1.2000. : .

Z25.GaUagher D. .Ruts E, Visser M, Heshka S, Baunigartner RN,Wàng J,PiersonRN,Pi-Sunyer,FX, Heymsfield SB . Weight stabjJtymasks :sarcopenia -'¡nelderly menand'w.omen. Am JPhysol 279,:~E366..E375,.200.

49

226. ,Gallagher 0, Kovern AJ. Clay-WiUìam G, Agio D,leoneP, AlfJu J, Matthews DE,Heymsfield SB. Weight loss in obesepost-menopausid women: .no evidence ofadverse alterations in bodycomposìtionand ,protein metabolism. AmJ PhysiolEndocnnol Metab 219: E 124-E 13 l, 2000.

227. Shih R. Waa:g ZM, Beo 'M,Wang W, Heymsfield SB. Lower limb sk:el.etal musclemass: devèlopment ofduid-energy X-ray absorptio~tryprediction model. .J AppJ

'PhysiuI89: l 380-l 386, 2000.

2.28. WangZM, Heshka S,GatlagherD, -boozer C, 'Kotlern, Heýmsfidd sa. Restingenergy expenditure fat..free'mass relationsmp:new .insights pi-vided by 'bodycOinposition modeling. Am JPhysioJ. 279: E.SJ9~E545, 2000..

229. -LawaI A, EngelsonE,Waig J, Heymsfield SB, Kotler D.Etlui valento:st~peniainHIV"'irifected individuals 'studied 'before and during the era o"fhjghlyac:tiveantiretroviral therapy. Al5 2001 Jan 26: 15(2):278..80.

230. Lee R. Wang ZM, Heymsfield SB. Ske.ltal Muscle Mass 'andAging: Regional andWhole-Body Measurement Methods. Can. J. AppL 'Physipl.26: 102-122,2001.

23.1 .M'îngroneG, Bertuzi A"Capristo .f: GteGo AV, Manco M, 'PietrobeHi A, .Salinari :5,Heymsfield SB. Unreliable "Use of-standard .musdehydration value in obesity . AmJPhysioJ Endocriool Metab. 2001 Fèb;280(2):EJ65-1L

232. Boozer eN, Nasser lA, Waag V, Chen G. Soloman JL, Heymsfield SB. Nl herbal

supplement containing Ma Huang~Guarana for weight loss: a randomized, double-blind trial. IntI J Obesity 25:316~J24. 2001.

.233. Wang ZM. Pi.Sunyer, Kotler :uP, Wang J, :Pierson RN Jr. Heym$.fie1d SB.Magnitude and variation oftotal body potassium .to fat -free mass ratio: A .cellulaT;levelmodelingstudy. Am J 'Physiol18J : EI ..£7. .2001. .

234 .WaQg ZM, Hesbka S, . Zhang K, ßoozer C, Heymsfield sa. Restingenergy.expenditure: Systematìcorganization 'and critique of prediction :metboGs. ObesityResear¿h9(5lJ3 1-33"6, '2001'

23S.PietrobeHi A, Heymsfield sa, WangZl\tGaJlagherD.. Multi-component ibody.coinpositionmodels: receßtadvancesand future direcions. .European Joutmd ofClinical Nutrition '55:69-75,2001.

216. BedogiG, PierrobeUi A, Heymsfiéld S B.. Atho.s B,Manziefi AM,MQrini p.,.6attistini N, Sàlvi01¡Ù. Is body fI~index. a measure dfadiposiiy in celderlywomen? Obesity Reserçh 9( 1), January 200 1.

511

237. Rosenbaum M, Pietrobell A. VasellJ'R Heymsfield sa, Leibel RL. S.exualdimorphism in circUlating leptinconcentrations is not accounted fOT by diff~encesin adtpose tisse distribution. International Joumalof Obesity .25:1365-1 J 7.1. 2001.

238, ShapsesS, Yon Thun N. Ricci T. Ospina M.Pierson R. StahlT, Heymsfi¿ld SB.Bone turnover and density in obese premenopau.\õl women during moderate weightloss and calcium supplementation. JoumalofBone and Mineral Reseach. 16(1 ):1329-1336,2001.

239. WangZM, O'Conit9rT.P. HeshkaS.Heymsfieid SR. The reconstruction ofKJeiber's law at the organ-tissue leveL. J Nutr 131-:2967-2970, 200 I.

240. Park YW, Allison D, -Gallagher D, Heynisfield Sa. Larger ~Ountsofvisceralådíposetissue in As"ian-Americs.Obes Res9:3S1-387. 2001.

241. Heymsfield SB,GaUagher D, Kotler DP1 .Wang ZM. Allison DB, Heshka S. Body-size dt;pendenceofresting enegyexpenditure can .be ,attributed to rloilenergetic

homogeneity oftàt-freemass. Amer J'Phy.siol ~ EnøociÍilOlMetab 282(1 ):E 132-E 138,2002.

242.Ctuurilea WC,Guo SS, Zeller CM, Reo NV, BaumgaiterRN, Garry pJ, Wang J,Pierson RN Jr. HeymsfieJd SB,Siervogel RM. Total body waterretèrence values;and ptedictionequations for adults. Kidney lnt 59:2250..2258, 2001.

243. Rosenbaum M,.Mui:hy EM, Heymsfield SB,:MatthèwsDE, Leibel RL.Low doseleptin administration reverses effeèts of sustained weight-reduction on energy.expenditùre.and circulating concentrâtiönsofthyroid hormones. J ClinEtidocrinolMeta. 87:2391-2394,2002.

244. Janssen" Heymsfield sa, Ross R. .Low relative skeletal muscle mass (sarcopenta)inolder:p.ersonsis a.ssociated with functional impairmentao :physical disability. JAm Geriatr Soc 50:889~896, 2002.

.245. Janssen :1, Heymsfield SB. Ross R. .A;pplicationofsimpJe_aRthropometry in .theasses~ment of health risk: Implications for the Canadian Physical Açtivity, Fitnessand 'lifestyle Ap.praisal.Can J AppJ PhysioI27(4):396-4 14, 2002.

246. Heymsfield SB. Wang ZM, Shen W. Body .compösjtionin-pediatrics to geriatrics: alesson ror nutritional monitoring. In: Labadatios D. .Pichard C,.ed.Clinical .

Nutrition: Early Intervention. NestlëNutritrQn Workshop Series Clinical &Perormante Progllm 7:239-255~ 200l., .

247. Park YW, Heymsfield S8.Gallagher.D. Are:dual-energy X-ray åbsorpiiomeiryre8ional estimates associated with visceral adipose tissueinasS?lnt J -obes 26:g78-983,2002.

51

248. Kaufman BA, WarenMP,Dominguez 1£, WangJ. Heymsfield 5B, PieasonR-N.Bone density .andamenorrhea in ballet . dancers -are rélated loa decreased restingmetabolic rateandlower~ptínlevels. JClinEndocr:nOI Metàb87(6):2777-2783,2002.

.249. Engelson 'ES,GlesbyM, Mendez:O, Albu J, Wang J, Heymsfield SB, Kotler DP.Effect of Recombinant Human Gtowth Hòrionein the Treatinent of Visceral Fat

Acçumulation:inHIV Infection. JAIDS .10:379-3'9'1,2002.

25"0:. Kim J, Wang ZM, Heymsfield SB. BaumglJrtnerRN, Gallagher D. T otal':bodyskeletal muscle mass: 'Estimation by newdual..energy X~i'ay absorptiometry .method.Ani JClin Nutr 76=)7.8-383, 1002. .

251. Zhu SK, Wa'18 Z"M. Heshka S, Heo M,faithMS, Heymsfield SB. Waistcircumferenc~ and .obesity..assciated risk factors ,among whites in the third Natiòn;;lHealth and Nutntion Examination Survey~ dinicalactioo thresholds. Am JClinNutr 76:743-749, 2002.

252.Pietrobelli A. Nunez C.. Zingaretti G,.Battistìiii N, MoriniP, Wang Z, Yasumura S.. Heymsfield SB. AssessfIerit by~bioimpedance_offOfea O1uscle-cellmass: Anewapproach to calibraiioil. EurJ-Clln NutT 56(8):723-728,2002.

.253. HayesM, Chustek M, Wang ZM,GaHagherÒ,Heshka S, Spungen A, .BaumanW,Heymsfie1d S8. DXA:Potentiai forcteating a metabolic map .of orgaiMissue restjngenergre~pendJture components. Obes Res W(lO):969-977, 2002.

254. EontaineKRGadbury .q, Kral J. Albu lB. Heymsfield SB, Allison D. Quantitative.,prediction .of:bodydiameter in severely .obeseindividüaJs. Ergonomics 2002; 45:49-60.

255. Wang ZM, BeaM. Lee.~ Kotler D, Withers R, Heymsfield SB. Muscularity inadultbutnns: proportion of adipose tisslJe~free body mass as skeletal muscle. Am JHUinailBiol :\3(5):611-619.. 200;1.

256. Agin D~ GàJ1agher D. Wang J, dHeym'sfie1d SB. 'Pierson RN, KOtler:D. .Effects of'wheyprotéin .'and resistanceexer:ciseon body 'cell mas~, 'Olusclestren!,1h,andquaIity

oHifeinwotnenwith .HIV. AIDS J5( l8):243 J-244Q, 200 L .

257.P:ietrobelli A, Allison DB, Heshka 'S, HeaM, WangZM, .Bertkau A.LaferrèreB,Rosenbaum 'M, Aloia JF, ,Pi-Sunyer FX, Heymsfield SB. Sexual dimorphism ¡ntheeIlergycontent'ofweightchange. IntJ Obes 'R-elat Metáb nisord 26(1 O)~ 1339-.1348,

2002.

. 258. 'Pietrobéll A. fa'ithMS,Wang J, .Brambi.f1aP.ChiililUmÖ G. HeyÌnsfiéld S'B. Association orLean Tissue :and Fat -Mass with Bone.niineral,c-ontentaild :density in

:ltaiian ~hildrei\ and adolesc~mts. Obes Res IOfI): 56-;60., 2002.

5i

"259. SalinarS.Bertruzz A, Mingrone 'G.Gapristo~,Pietrobelli A,Camioni.P,GretoAY, Hey!lsfièld S8. Newbiciimpedanceanalysis model accuratelypredìctslowerlimb fflJde volUJn: validationby 'magneticresonance imaging. Am llhysiolEndnçnnol Metab 282(4):E9.60.£966,i002.

260. 'WangZM, Pi-Sunyer Ex'KQtler DP, Wielopolskí L, WithersRT, Pierson RN Jr,Heyms:fieldSB, MulticQrnp,onent ,methods: Evaluatio.n of new and traditKma:lsoft-

. iissue mineral models by in vivo neutron activation analysis. Am J Clin ,Nutr76:968.414.2002.

26I.Fernandez JR. Heo M, Heymsf¡eld SR, .Pierson RN JrPi-SunYer :fX, Wang ZM,WangJ, JIayesM. Allison 'D.B,Gidlagher O. .15 pecentage body fatdiffefentìallyr~lated to body massindex in Hispanic Americans, African Amer"icans,andEuropean Americans? Am J ClinNutr 77(1 ):71-15. "2003.

.262. Wllg Z, ZhuS, 'Wang J,' Piersoil RN iT, Heymsfield SB. Whole..body,skeletalmuscle mass: Devdöpmeritand validation .0ftolal-bodypotassium prediction

. models. Am J Clio Nutr 77(.1 ):16-81,2003.

263. .chumlea We. -ouo 55, :,uczmRrski RJ, Flegal KM, JohnsonCL. Heymsfield SB,. LukaSkî HC,Friedl K, Hubbard VS. Body composition estimates from NHANES ilhioeleci"ial'impedance data. Int JObes 26: 1596-'1609. 2002. .

264. Sun SS, Chumlea we, Heymsfeld S8. Lukaski He, Schoeller D.FriedI K

Kuczmarski lU, Flegal KM, Johnson CL, Hubbard VS. Development of.BiOelectr;¡callmpedance AnaJysis Prediction Equations for Body Co.mpO"sitionwiththe Use ofa Multicomponeiit Model for Use.in Epidemiological Surveys. Am JClinNu:t 71:331":)40,2003.

265. TaylorJE. PostonlI WSC, Haddock CK, B1ackbumGL, Heber D, Heymsfield sa,. 'ForeytJP. 'Psychometric 'characteristics of the General Well-Bèing Schedule (GWß)

with Afrîcan-Americanwomen. Qual Life Res ,i2.:3~1-39, 2003: . ,

:266. Wang J, Thornton JC. :Bar .S, Williamson B. GalJagherD. Heymsfield 58, HorlickM, Kotler D, Lafetrêre, :LaureI Mayer, Pi-SunyerFX, Pierson Jr. RN. :ComparisoDsøfwa:ist circumferences measured at 4 sites. Am J .cin Nutr 77:319-384, '2003,.

267, WangZM,HtshkaS,Waog J, Wielopplski L, Heymsfield 58. Magnitude and

varìaiipn-of fat-free maSs density: acellular ..Ievelbody composition modeling Study .Am JPhysiol Eildocnool Metab 284£267 -E213. 2003.

268. Park YW, ZhuSk, pa:laniappan L, Heshka $, Camethon MR, Heymsfield Sa. Th~metaboli'C :'syndrome: 'preválence and associated nsk Factor Findings -in the US..

':Population From the third National Health and Nutrition Examination Survey.'19.8.8-'1994. Arcti Intern Med 163:427-4.3'6,1003. .

53

269. Andrade S, Lan SJJ. Engelson ES. Agio O,WangJ. Heymsfield sa, Koder D. (Useøf a Durnin-'WQmersJey formula tòestii:ateçhange Îtisubcutaneous fat content inlHV~infected sùbjecis. AmJ Clin Nutr75:S81-59~,2002.

270. Faith MS. Keller KL, Matz P, Johnson SL. Lewis R, Jorge MA.RidJeyC, Ban H,'Must S. Boo M,Pietrobelli A. Heymsfield sa. AHison DB. Project Gtow.,2-Gehet:.a studyofthecgeneticand environmental 'influences on childeatingam;lobesity,

Twin Res ,2002 Oct;5(5):472-S.

271, Salinari S, Benuz A, Mingrone Ù,ÇapTisto E, Scarf one A, Greco A V,HeymsiieldSB.Bioinipedance, analysis: a usefu iechnìque fOTassessing 'appendicular Jean softtis'Suemassand distribution. J ApplPhysiol 2003 Apr-;94(4):1552-1556.

272. Roseribaum M, Vandenborne K. ,Goldsmith R, SiinoneauJA. f-eymsfield S.JoanisePit Hirsch )~Murphy.Ë, Matthews 0, 'S~gal KR,Leíbel RL. 'Effects OfExperimental Weight :Perlurbatioil On Skeletal Muscle 'Work 'Effciency 1n HUllanSubjecs, Am .JPhysiol Regu'J Integr Comp 'Physicil 2003~ 285:Rl8J-Rl92. '

273. Shen W. Wang Z, Tang H, Heshka 'S,Punyaruly:a M, Zhu S,Lei J, HeymsfieJd SH.Volume estimates by imaging ,methods: modelc()mparisons with visihle woman asthe reference.Obes Res 2003 Feb; l 1(2):217~25.

:274, Shen W, Wang Z,PunyaoitaM, Lei J, Sinav A. Kral JG, ilmielinska C. 'Ross R,Heynisfield SB. Adipose tissue ,quantification by imaging methods: a proposedclassification, ObesRes 2003 Jan; 11(1):5-16.

275.tttiogerl\1P, Littlejohn TW, Schwarz SL. WeissSR, Mcllwa,in HH.fleym:sfield58" 'Bray GA, Roberts WG, Heyman ER, Stambh~r-N, Vica 'C Guter HP.Recmbinant variant of ciliary neurotrophic factorfot weigli:loss'in,òbeseadults: J\randt1roized.:dose.;ranging study_ lAMA 2003;2'S9Ç14): l826-J8J2.

276., Allison .oB~ Gadbury G, Scbwart.LG, Mur4gesanR, Kraker )L, Heshka :S.:FontaineKR, Heyrnsfíèld:SB. A novøl'soy-based meal.teplilcementfonnula fOrweight Jos's 'among obese individuaJs: A randomized controlled ;¿lil'ica'i triat ,Eur 'J'Clin Nutr2003~57(4):514-j22.

277. Janssen 1, Heymsfield SB, Allison DB. Kotler DP,Ross R. Body inass.index andwaist circumference independently .contribute to the :predictron 'of nonabdominal,,abdominal-subcutaneous, and vìs.c~ral fat. AJ!J'Clìn.Nutr. 2002; 75(4):'68J-8.

278. He'Q.,EngelsonES, Album, Hj;ym.sfield SB, Kotlernp. :Preferential:Jossof:omeritaJ-mesenteric fat durg growthh()nno,ne th~y :ofHlV-assoiatciJ.:lipodystrophy. J Appl :Physiol 2003~ 94(5):2051-2057.

54

J

!

l~

-j

:279. Heymsfield SB, van Mierlo -eM, vander Knaap HeM., Heo M,Frier H. Weight:management using a mealreplàc-ementstàtegy: meta andp061ing analysis from sixstudies. Int J Ob~ RelatMet Oisord 2001; 27(5):537-549. .

280. Barbosa-Silva Me, -.Barros AJ, Post CL, WaitzbergDL.HeymSfield S8. Canbioelectric-aímpedance analysis identify malnutrition in preopei:ative nutritionassëssment? Nutr 2003; 19(5):422-426.

28 LPhîUips Ga, JiQg T, Heymsfield SB. Relationships .in men 'ot.sex .liormones, insulin,adiposity, and risk factors for myocadial infarctioil,Metabolism 2003; 52(6):784~790.

.282. He -Q, BooM., Heshka $, Wang 1, .PiersonRN Jr,Albu J, Wang ZM, -HeymsfieldSB..Gàllagher n. Totàlbødy -pøiassiumdifferspy sexand.raceacrnssthe.adult age

span. Am j Clin Nûtr2003~ 78:7.-77.

283 .~ZambÐni M, Tur-calo 1: Santana H, Maggi 5, Hars TB.,PietrobeUi A, Heymsfield

S8, Micciolo- R,;BoSllo,o. Therclatioosbípbetween ',bødycomposition and. physical perform~nce in older wo.men. J ArtGeriatr Sac 1999; 47:-1 403-1408.

284. Lee 'Re, Ramirez LM., WÜ~lopolski :L, Heymsfield SB, Wang Z. 'Ratioof Sôft-Tissue Mineral to Total-:BodyW ater: A Stab:leBody Composition Ratio.International Journal of Body Composition Res~arch 200J~1 :77-8.Q.

285. Zhu Sit, Wang ZM, ShenW, Heyriisfield S8. HeshkaS.Perceiltagebody fat raogesassocí~ted with metabOlic syndrome risk: .Resltsbasedl.p.on the third NationalFlea:ithand Nutrition Examination Survey (l98:8-94). American JoumalofClinicalNutntIon200.3~ 78:228-235..

286. Ci.fuentes :M, JohnsonMA. 'LewisRO, Heymsfield ;$.B, :Chöwdhut:y HA, Mød~esky:eM, Shapses.S. Bone turnover and body weight -re1atiònShips differ :in :notmal-weight comparedwithheavier postmenopauSal wonien. Osteoporos Int2003:14(2): 116-J22. -

2-g~ .St-'O'le MP, Heymsfí~ld .SB. Usefulness Of Artificiál Sweete.ners For- Body WeightControl. Nu1TRëV 20Ó3 :61 :2 1"9-2il.

2lšS. 'MingroneG, Marino S, .DeGaetano A, Caprìstø 'E, Heytnsfield SB, 'Gasbariniq,

Grec-o AV. ,Different limiUothedbody's abriity ofincreasin.g fat-free mass.:MetaboJism 2001; 50(9): 1004.;7.

289.öaJlagl-er D, Heshka.5; Heymsfleld SR l)ubiousassumptio.ns 11l1derlying :theadjustment of metabolic rates for changes 'in 'fat-,freemass. J Clin.EndoerinQl- Metab.2003)454-5.

55

290. NuñezC, Gallagher D.Spungen A, Bàuman W.. Heymsfield 56. ATe Age-RelatedBioirnpedace Analysis Effecs Also ,'Pres~nt inPatients with Spinal Cord Injury?Relevance toClinicalPredictoitofSkeietalMustleMass. -International Journal ofHodyComposition'Reserch 2003;10): 11-16.

291. Shen W. Mao X, Wang Z. Punyanitya M, Heymsfield 5B, Shungu"DCMeasurement oflntramyocelIular Lipid 'Levels with 2..,0 MagnetîcResonanceSp:ectroscopic Imaging át L5 T.Acta njåbetol'2003~ 40(Slippll ):S5.14

292. loanJ1idou E,Paditla J, W~ng J, Heymsfield .$B, Thrnton JC, Horlick 'M,GaUagherD,Pierson RN Jr.Pencil..beari~versus Fan-Beam -Dual..'£nergy :X";R~y .AbsorptiometryCompansonsacross 4~yStems: Appendicular 'Lean .Soft Tissue.Acta niabetol 2003; 40(Supplt ,1):S83~5.'

293. Sun At HeshkaS, Heymsfield SB, Wang j,Pi.ersonRN Jr,'Oaîhigher D.1sthere anassociationbetweenskdetid ,inusclemass.and bone mìner~density among Arrican-Am~ncan, Asian-American, 'and European-American wQoien?ActaDi.abetø! .1003;40(Suppl-1 ):S309-13.

294. Jones Jr -A. Shen W, GaUagher D, H:eshka 'S. :St-OngeMP, Wa~g ZM, HeymsfieldSB. ,Bödycomposition differentesbetween African-Ameiicanand Caucas~an

Women: Relationship to restillg energy requìrements. Am J. Clin Nulr 2004 ~79: 780-6.

295. Shapses SA. HesltkaS, HeymsfiddSB. Effect of Calcium Supplementation -onWeight 'and Fat Loss .in Women. J CHn Endocrinol Meta:b89:632..63 7, 2004.

296. St. Onge MP, RubianoF, :DeNino WF, Jones Jr A..Greefield D,Fergusun .PW,Akrabawi S, Heymsfield Sa. Added Thermoge'nic and SatietyEffects of-a MixedNutrÎènt vS.'a Sugar-Only ;Beverage. . International JouiTai ofO:besity 2004;28:248-253.

291. St. Onee l\1P, Keller Kt. HeyJnstìeld SB. Changes in Childhood Food Cölluiiiption.'- . ."Patt~rrs: a.Cause for Concern hi Lightöflm:reasing Bodyweïghts. AmJ Olin Nutr2003;78: 1068-73"

298..Spphtr AB, Thornton JC, WangJ,PierSQn R:'l .1r" Heymsfield :SB, ttprlick ~tMeasurement 'ofP.erceitt Body Fat in 4'1 JChildreiland Adolescents: A Comparisonof Dual-Energy X-ray AbsorptiometiytoaFour~COOlpartmerit Model. 'Pediatrics .2004;1.13: 1285':90.

.299. Heymsfield sa. MeRsurementsof ener-gybalance. Acta D.iab~tologica.2003~4n:SI17..Si11.

300.S011gMY, Ruts E. Kim J, Janum:alal.Heymsfield S,.GaUagher D.Sarcopenia and.ìncreased adip.ose tissueinfifration øfmusCIe jnelderly Africa American women.

56

Am J Clio NUir. 2004 May;79(S):874-80.

301. Zhu S, -Heshkao5, Wang Z, Shen W, AlIsqn DB, ,Ross R, Heymsfield SB.Combination of ßMI and Waist Circumference for Identifying Cardiovascular Risk

Factors in Whites. Obes Res. 2004 Apr;12(4):633-45.

302. Fai(h J\.15, Keller KL, Johnsòn SL,Pietrob~iií A,Matz PEt Must :S. Jorge MA.Coopeiberg J, Heymsfield SB, AHispn DB. FanlÌJlal aggr~ationof energy intake in

'children. Am fClin NutL 2004 May;79(5)::844':SO.

303. Silva AM, ShenW. Wang Z, AloiaJF.Nelson 'ME.H.eymsfield sa, Sardinha .LB,Heshk;i S. Three..ComparmentModel: Critical Evaluation HasedUpon NeutronActivation Analysis. Am JPhysiol Endocrinol Metab.2004 lun8

304. Wielopolski L, Ramirez LM,Coyle PK, Waag ZM, Heymsfield SB.Proof-of-Principle to Meaurt Potassium in the Human Br.çin: a Feasibility Study.InternationallournaJ of Body Composition Research 2004;2-37-43.

305. Schneider B, Wang J~ Thornton JC, Arbo.J, HorlickM, HeymsfieJd 'SB,Pierson RN.ACCuracy, Reproducibility, and Normal TotidBody:Potassium(TBK) .RangesMeasured Using the Renovated Whol.e Body40K Counter ofSt. "Luke's-RoöseveltHospital :lotemational Journal of ßody Composition Research 2004~2:51-60.

30.6. Chu¡i SC Jr.LiuSM,U Q,Sun A, DeNino W:F, Heymsfield Sa,GuòXE.T rans..enic compleinentationofleptin r~ceptordeficienc)'. ll lnci-easedleptinreceptor transgene dose effects on obesityldiabetesand fenility/lactationinlepr-

db/db mice. Am JPhysiol Endocrinol Metáb. 2004 Mar,286(J):EJ84-9L

307. LeeRC, Wang Z, Reö M, Ross R, Janen i, Heymsfield SB. Total-bodyskeletalmuscle mass: development and cross-'validatioil of anthropornetticpredìciiOJmodels. Am JClil1 Nutr.2000 Sep;72(3):796..803.Erratumin: Am j,Clin Nutr 2001May~'7(S:):99S.

308. St':OngeMP, RúbianoF, Jones A Jr, Heymsfield Sa. Anewhand..held indirect.calodmeter io measure postprandial energy expenditure. Obes Res. 20.04

Apr;)2(4):704";tJ. .

309. WielopolSki L, Ramirez LM, CoyleP, Heymsfield S, Zimman .1_ Sotneas;pects ofmeasuring levels of potasium in. the :brain. Acta.l-iabeio.l .-20.03 00t;40. StlpplJ:573-5. -

310.. Wie1op.olski L. Varsky n. 'Pierson R, -Goldberg M, Heymsfield 5, Y';uniura S,cMelnychuk ST, Sredniawski J. Gamma resonance,absorpiipn. Newapproa(;h:¡n

huma,nbody compési.tion studies. Ann N Y Acad '5ci. 2000.May.:.904:229~3.5.

57

31J. Heymsfield SB. The weight .debate: balancing foodcompositi:on and physical'activity.Preface.Am J 'Clin Nuti:. 2004 May:79(5):897S~898S.

312. Sun AJ. Jing T, HeymsfieldSB,P;híllips GB.Relationsh,p ofleptin 'and sexhormones .töbo,ne mineral density in men. Acta Diabetol. 2003 Oct;4(J SupplI :5"101-5.

Sun AJ, Hesbka :S, Ht~ymsfield S8,Wang J,Pierson RN Jr., Gallagher D.ls there an'asso.crationbetweenskelet~.1 musclemass and "bone nÙneri;l density among African-American, Asian-American, and "Eur.j)e~n.AmeJican\-:omen? Acta Diabetol. 2003OctAOSu.ppl J :S3()-13.

'WangZ, Shea W, Kotler OP, HeShkaS, WidQPolskiL,Aloia.JF, Nelson f\1E,Pierson.RN Jr, HeymsfieldSB. TotaLbodyprotein: R new ceUular Jevelmass and:distribution.-predictionmodeL. Am J èl.in Nutr.2Ò03 Nov~78(5):979~84.

WangZ, St.:Onge MP~ ~uiiberri B,J;i-Sunyer'FX, Heshka~, Waqg J, KotlerÐP,

GaIJagb.er D,Wie1opolski:L,:Pierson RN Jr,Heymstield SB. ,BodyceU mass: modeldevelopmeni and y,alidatlon at the cellular :Ievel ofhodycomposítion.Am JPhysiol

- EndocrinoJMetab. :i004:286:El23-128.

Wang Z, HeshkaS, Wang J,Wieløpolski L, Hey'sfidd sa. Magnitude and variation offai..free'massdensity::aceJ11l1ar.:level hodycoinposìtion modeling stndy. Am J PhysiolEildocrinolMetab. .2003 Feb;284(2): E267 ";73.

WangZ, 'Pi-SuoyerFX. Kotler UP, Wielopolski L, WithersRT,Pierson RN Jr.Heyrtstièld. Sa. Multicornponent 'methods: evaluation .ofnew and traditional soft tissue'mineralmodèlsby ,in vivo neutron :activation analysis. Am J Clin Nutr. 2002Nov;76(S):968-74.

SUn 5S, Chumlea we, Jl~ymsfi.eldSB, Lukaski He, Schoeller D.Friedl K,Kuczmarski RJ, Flegal 'KM, Joh.nsonCL, Hubbard VS.nevelopnieht,ofbioeJectrical

"impedance .analysis :prediction equations for body co.mposition with .the use of aniulfic-omponent model.fo.r .use .in epideiIio'logicsurvey,s. Am.J Clio Null. 2003F:ib.~77(2);331-40.

-Janssen 1, Heymsfield SB, Ross R. Applicationofsimpleanthropômetry in theasStssment of health risk: . implications for the Canadian Physical Activity, Fitness andLifestyle ApptàÍsiil Can J AppIPhy:siol. 2002 Aug;t7(4P%'-4l4. Review.

Janssen I, Heymsñelc: S8. Røss oR .Low rélatjve skeletal :muscle :ttass fsàiopenia) il.ø1derpersons lS.assoèiated with functional -impairmentaid p~ysicaldís'abiliiy. JAmGeiatr :Soc. 2Q02Ma,y;5D(SY889.:96.

58

Janssen 1, lleyinsfield SB, Allison DB, Kotler DP, Ross'R Body mass index and waistdrcumferenceindqlendendy contributelo the predctionof nonabdominaJ,abdominal$ubcutaieous,andvisceralfat. Am JOin Nutr.2002 Apr;75( 4 ):683-8.

Janssen l. Heymsfield SB.BaumgarterRN, Ross R. Estimation of skeletal muscle massby bioelectricalimpedanceanalysis. J ApplPhysiol. .20öAug;89(2):465..71.

Janssen 1. Heymsfield 5B, WangZM, Ross R Skeletal muscle mass and dislributionin468 men and women .agenl 8~88 sr. j~ppl Physil)1.2000Jui~89( 1):81-K

NunezC, Gallagher U, Gtamines J, R.atimgartnerRN, Ross R, Wang Z, ThømtonJ,Heymsfield SB.Bjoimpedançe .analysis: potential for measuring lower limb skeletalmuscle mass. JPBN J Parenter Ent.end Nutr.l 999 'Mar-Apr~23(2):96-1 03.

.Gu W, TuZ, KleynPW, Kissebah A, Duprat L, Lee J,Chin W, Marti S, Deng N. Fisher'SL. Franco LS, ßurnP, Yagaloff KA Nathan J,HeymsfieldS. Albu J,Pi-Sunyer F-XAllison nB.ldentiticationand functional :analysìsof'novelhumanmelanocørtn-4Teceptor varants. .Dia:betes.I999 Mar~48(3):635-9.

He Q. :Engelson-E$, Wang J, Kenya.S, lpnescu G, Heymsfield S8, KotlerDP. Validation

ofaneii~pticalanthropometñc model to estimate visceral compartment area. Obes Res.2004 .feb~ '12(2)250":7.

He Q, EngelsonES, Albu IB, Heymsfield SB, Kotler DP. Preferential loss of oinental-mesenteric fat -during .growth hormone therapy of HI V-associated lipodystrophy. J ApplPhysiol. 2003 May;94(5):2051-7.

Engelson ES,GleSby~U, Mendez D, Albu JB, Wang J, HeymsfieJd sa. Kotler DP.Effector reconibinal1t .hunlangtomh hormone in the treatment of visceral fa:r'.accumulation in mv infecion. J Acql,ir hhmune.Defic Syndr. 2002 Aug 1;30(4):379-9'1.

Kotler'OP,LopesJ, Engelson ES, Wang J, AginD, Heymsfield 5B. lnteradions 'arnotigsex, HIV infection, and fat:tedisrribution. AIDS Read. 2000 Oct; 1 0(lO):5:89-'94.

:Shen W. Wang Z. tang fi, H~shka'S, :Punyanitya M,Zhu:5, Lei J, Heyinsfi'eld :sa.VOlUßle ~stimates 'by imaging methods: model comparisons with visi.bl~ woman asthe reference, ObesRes. 2003 Feb;lI(2):217-2!.

Shen W,PunyanityaM.. WangZ, GalJagher D, St-Onge'MP: A1bu J, HeyinstleldSI3,Heshka S. Vis(era 'adipose tissue: reJations bttweesingle~slice areas aJdtotalvolume. Am ) Clin NUlI. .2004Aug;80(2):2TI-8..

$t-OngeJvfp, Wang Z, Horlick M, Wang.J, H~ymsfield .Sa. Dual-Energy X-RayAbsQrpiometry. Lean -Soft Tissue Hy(jraiioJ\: lndependentContñbutlon~oflntra- 'and'ExtrâceUular Wattf. Am J Physiol.EndocrinoJ Metab. ~004 )úl 6 (Epúb ahead ,ofprintl

59

"

''''- \

PietrobeUi A.Rubiano.F, St.;:Onge MP, Heymsfeid sa. Newbioimpedanceanalysissystem: improved phenötping with whole-4xxly .analysis. Eur J Oì" Nutr. 2004 May 12

Ar1idesi,n Press

Ramirez L~ Wieto¡iolskiL, Heymsfield Sß, Wa.g Z,CoyJe PK.Evaluationofthelibraryleast-squaresmeihod versus'trapezØjdal method for anamllysis of potassium spectra withJowcoiinti:ngSUristiçs.

"Sun SS, ~Chuirilea we, Heymsfield ;SB, .LlikaskiHC,ScboeUer D,Friedl K, ,Kl,ëZmar.skiRJ.Flegal KM, Johnson'CL, Hubbard VS. Reply to ,L TE: ;Bloeleçtrical j~p.edanceanaly~is forpredictiag body,cornposltion: What áboUi the eXtemal validlly:of new,Te~ressionequations? Am J 'Clin NPtr.

H~yesM., Cl;ustek M, Hestlka S, 'Wang ZM, Pietr.obelli A, Heymsfield SB. Low PhysicalActivity LevelsofModem Homo Sapiens Among Ffee..Ranging Mammals.

.tee SJ, Janssen 1, Heyi;sfiel.d SH,ltoss R. 'Relatíonbet\..een whôl~ 'body and .regional

meaS\res bfhurtan skeletal musd.e. Aiier l Oin Nutr.

:Artcl~ Submitted

Adeyemi'L, Engelson E, Wang J, Heymsfield sa, Kotler U. Case cQntrol studies of bonemineral content InHIV-infected men .studied "before .and during .iheera oflL-\ART.

LaoSJ, EilgelsonES,.~gin D, HomélP, Wang J. Heymsfield sa, Kotler Ð:P. Validation. of dual-.nergy x.rayabsotptiöme,tr ê! a 'ineasu"re 'of change '.infat .cm.panments as~imatedby magoeticresonaceimagitig .in ;HJV -infeçedaduJ~s.

Tatg H, WuEd X Gallagher 1), Heym~field SB.Monochroine Image Representation andSegmentâtionBased on tb~ Pseudo-CølorandPCT transfonnatioiis.

'ßa(bo~..'SitvaMÇG,Barrös Al, lleymsfieJd 'Sa. -Bioelectrica'limp:edan.eanalysis: .Popula,tionreference values forphaeailgle 'by age 'and ,sex_

Hoffm-a DJ. 'Philìps Ga, Wang ZM, Galiagher:D, Heymsfitld SB. Less VisceralAdipose Tissu'e in Adult Afiican~AmericansCompared to 'Caucaians.

Bes SE, 'dda 'c.ruz :MN., Shapiro ,AE, Wang J, Pierson RN. Heym~fieid S.B Bopzer.CN,Ferin M, 'Warrenf\4P. Woinen",átb 'Exerise Associated Amenorrh~ HaveaP~adoxica:1Change ,in MetáHç 'Parameters_.

. Case :Report

1,0

1. Vincenti FG, Heyinsfield sa. Reversible malignant hypertension and azotemia dueto ureihralstncture.Arch Intern Med 137:170-372,1977.

:2. Heymsfield 58, Smitb-Andrews JL, Hersh T- Hoinenasoenteric feeding for

malabsorption and weight 'loss refractory to C(nvent1önal therapy. Ann (ntern Med98: 168-170, 1983.

3. .AtTarah HB, MarsRL, Someren A, Smith ll HWB, Heymslield SB.Myoglubinuria

and acute renal failure: association with intravenous infusioß. Southern Med J77:9 i 8..92), 1984.

.:ßook.:ChapterlReviews

:). HeymsfieJdS8.. Ginical data: tbebasis ofnorma:Jandabnormal. In: Walder HI(

Hall SO, Hurst JW, eds. Clinical Methods: thehistory,phys-caland laboratory.examinations. Boston: ButtenvorthPublishers, 1033-1040,1976.

"2. H~ymsfield 58, Nutter 00. The heart in protein-calorie llAdernutlÌtion. In: HurstJW,ed. Update I: The Heart. New YoikMcGraw-Hiii, 191-:2()9., 1979.

3. fleymsfield 58, HorowitZ J,Lawson D. Enteralhyperalimentation.ln: Ber;k E, ed.Developments ¡ndigestiv.e diSese. Philadelphia: Lea& febjger, 59-:83, 1980.

4 Heymsfield SB,Noel R. Radiographic amilysisofbody comp,osition ,bycomputerizedaxialiomograph)'. In: Ellison N and Newell G,cds. Nutr Cancer17: 161-172,1981.

5. Nixon OW, Mofftt S. Olkowski Z, Ansley J, Kutner M, Lawson DH,Heymsfie1d

SB; Lynn M, :Rudman D. P.arenteral nutritíon supplementation in cancer. In:Howard, Alan., Ba'ird.MêLean, eds. Recent Advances in Clinical Nutrition. Loridon:John Libby & Co. 198'L

-6. Heymsfield. S8, Smitb JL, Redd $, WhitW0l1h 00. . Nutritional.suppon ,in ,cardiacfailure. In: Mullen JL,CrosbyLO, Rombeau JL, cds. Symposium .onsurgicalnutrition. Surg C1in North Am60l :635-652,1981.

1. Horowitz J, Sm.ith J. Lawson D, Heymsfield SB. Nutritionalmanagementofthe

surgical patient. In: 'Walker Hand LubinM,eds.ManagementDfthe Surgicall.atient. Bosion: Butten..orthPi.blishers. 1982.

'8. 'PiJbeam SP, H~d A, GrossmanGD, StatonGW, H~ymsfieid Sa. Undernutrition

and the respÎraiory system (par 1). Metabolic and physiologic consequences: RespTher 13:65-69, 1i;83.

-9.Pilbeam SP, Head A Grossman GD, Staton GW, HeymsfieJdSB. Undrnutrition

and the respiratoiysy.stem. (paI 2). Nutñtionalsl!Ppoi1_ Resp Ther 13:72-78.) 983.

\.61

..

10. Heymsfield sa, Tochìlin N,McManus ca, GeITon G.Nitrogen Balance. -:linConslt 4(1). 1984.

'i I. HeymsfieJd S8, McManus Hie, Seitz S, Nixon :0, Smith J. Anthropometric,assessment ofadultprøtein~energymalßutrition.ln: Wi-g,ht RAandHeymsfieJd SB.eds. Nutr.jtional Assesment oftbe Hospitalized Patient. Boston: JllackweHScieniificPublications,lnc-, 27 -82,J 984.

.,12. Heyms1ield -SB, Andrews 15. Enteral nLiirition¡dsuppört.ln:Rerk JE,ed. Boçkus:Gastroenterology. Vol?, 4th edition.Philadelpnia: W;B. Saunders Co, 4361..4378.1985.

13. Heymsfield sa. Human Body Composilion: Ana:lysisbycomputerzed_-axialtomography andnudea.magneticreso~nce.ln: Vargan NG, ed. Humana.odyComposition and Fat Distribution. EL1Ro-NUT report 8: CIP..Gegevel1s KonìnklijkeBibliothèck,D.en Haa 1985.

J 4. Heymsfield SB. C-Iìni~1 Assessment of Lean Tissues: Future Oiredions. In: Roche.AF ,eØ- _BOty'-Compositiön Assessments-in Y outhand Adults. Ohio: Ross

Laboratories, 6th -Conference, 53.;59" i 985.

is. Heyrnsfeid SB,ErolandM, Casp~rK. Grossman G, Roongpi,suthipong t. Hoff J.Head A:Enteral NlJtritional Support: Metabolic~ Cardiovacular and PulmonarInterrelations. In: Askanazi J ed. Clinics in Chest Medicine. Völ 7( I ).Philadelphia:W.B. Saunders, 4i~67, 1986.

16. Howard L, Hekd W. HeymsfieldSB, Rhoads JE. Areport_oft:heconlerence Ohclinical -nutrition training for physicians_ Am 1 Clin Nutr44:135-l53, .186.

J 7. Heymsfield SB. Human body 'composition: analysis bycomputerized'axialtomography and nuclear magnetic resonance. AIN Symposium Proceedings.Nutrtiion, 1987.'

J 8. Heymsfiéld sa, Sm-ih-Andrews J_, Hood R,'WilliamsPJ, Bagatell CJ. Nutdtionandthe heart. ln~Ùi:and R ,and Sutphin ;~,e4s. i- Thi;ory _and Practice ,ofNutriiioil ~-n

Pediatrcs. 'Boston: -ButterWofts -Pu'blishérS, 1987.

J 9, Kr-al JG-ad Heymsfield Sa. 'Morbid obeity: definitiol)s. ~p:iden1io'logy, ,admethodologiçal problems.&.itro'ClinofN Ainer 16(2): 197-205, 1987.

20. HeymsfieJd -SB. HóffRD, Gray TF, Galloway J.Caser K. Heart Diseaes. In:Ki-nney 1M. .ed. Nutritionand Metabolism in Patient Care. 'Philadelphia: W.B.-:Saunders -Co,! 98$.

62

21. H~ymsfield SB, WiUiams .pj. Nutritio.nal assessment by .cinicalandbiocbemical-methods. In: Shils ME and Young VR,eds. Mo.dem Nutrion in Health andDisease. .Philadelphia:Lea & Febiger,Seventh edition, 81 7-'860, 1(188.

22. Horowitz J. Roongpisuthipong C, floff J, Heymsfi'eld S8. Nutritional Managementoftbe SurgicalPatient~Cbapterl in Medical Management oftheSurgical 'Patient.I stand 2nd edition. Bo.ston: Butterworth Publishers, 1982 0 sted),and 1988 (2nded).

2..". ~. Horowitz J, RoongpisuthlpongC, HoffJ, Heym$IíeJd:Sa. Methods of NutritionalSupport; Chapter 2 in Medical Management of the Surgical 'Patient, -2nd edition.Boston: Butterworth Publishers. J9&8.

24. HeymstieldSB. Anthropometricmeasurem.ents in.acute andchronic illness. 1n:Lohri.an TG,Roche AF. Marorell R,eds. AnthroppmetritStandardizat.onReference ManuaL. Champaign, ILL: Human ':KineticsBooks, 198.8.

25. Heyms-field Sa,ChristyGW, UìlsE.Payne Y. Nutrition 'and CardiovascularDisease. Current Therapy inNutrition. K Jeejeehoy. B.C. Deqker, Bu.ili.nton,Ontario, 245-260,1 988.

26. Heymsfield SB. Editor of Nutrition Sect-ion and author/ço-authorofnìne,chapters inMedicine fO"rthe PractìcingPhysician.' Hurst W,ed. :8os1011: .BunenvonhPublishers,J983. 2nd edition, 1988.

27. Heymsfield SB, HoffRD~ Gray TF, Galloway J,Casper K Fleart Diseases. In:Kinney JM, Jeejeebho)' .KN, HiU GL, Owen OE, .OOs. Nwitìonand Metabolism inPatient Care. 'Philadelphia:W.B. -Saunders Co.,Ch. :26, 477.:509. 1988~

2eR. Merritt RJ, Heyinsfield'SB, Howard L,Rombe.au J. Biennial survey of physicianclinicalnutrition training .program. Am J Clio Nutr 47:911-9;21. 1981t

29. HeymsfieldSB. Postgrduate physician trainiIlg .in 'outrttìon:the :t 9:85 Americ-anSoc-ietofClínical Nutritìonsurvey. j NutrEduc 20(1):S20..:524. 19:88.. . .

JO. HeymsfiéldSB, ;Ferram R.l\lezitisNHE. Parenteral nutrition in adults. lii:RakeJRE. ea. Conn'sÜ:irrent Therapy'- Philadelphia: w.a.Sa,undets Co., 537..5-11. 1989.

31. HeynisfieldSB, Wan~ J, Auiet l\, Kehayias J,:Lichtman S, Kamen Y, Dilmanian . .'F A, Lindsay R, Pierson Ri'J Jr. Dual photoIl absorptiometry: vaJidatîon'of mineraland fattn~urern-ents.ltl: YasumuraS,.et al. eds. A~val1cesin Vivo 'Bødy

-Composition Studies. New York:Pleoum J'ress, 3i:7~337.J 990.

32. Heym:sfield sa. 'Cardiac cachexia: An ovèrview. in~ TanakaT."Okada. eds.ANutritional Support in Organ Failure. Amsterdam: Exerpta Medica, 1990.

63

33. Dilmanian FA. WeberDA, Yasumura S. Kamen Y, Lidofsky L, HeymsfieJd S8,Pierson RN JrWangJ, Kahayias JJ,hUisKJ. The peormance pfthe BNbdelayed.,and prompt-gamma .neutronadivationsystems. In: ¥asumufa S,et at. '005.Advances in Viv'oBody Composition Studies. New York: PlenumPress. 30'9-316,1990.

34. Kehayias JJ, HeymsfieJd SB, DilmarianFA Waig J, Gunther OM, Pierson .R Jr

Measurement of body fatbyneulron lneta.sticscattering:commeritS'OniilstaUation,.operation and .error-analysis. In: ¥asumura S, et ai, eds. Advances in Vivo13odyComposition Studies. New York: Plenum press, 339-346. 1990.

3S.PiersonRN Jr, WangJ,Heymsfidd 58, DiJrtanian:FA, WeberDA High precisionin vivo neutron activation analysis: ,:anew er förcomparmental analysis in body.composition..ln: Yasumura S,etaJ, .eds, Advances in Vivo Body CompositionStudies. New York: Plenum :Press, 317-325, 1990.

oj~,\

l

I,

¡

~:¡

i¡a~.j¡

.36. Heyttlsfield Sß. Anthropometric meas.urements:applicationioho-spitalized

patients. lnfusionstherapie 17 fsupp~13):48-51.,1990,

37. Heymsfield .SB. Lichtman SW. Newapproaèhes to body composition research: a

reexamination of two-tompartihenttnode-lassumpt¡ons. (nfsionstherapieI7(suppl3):4":8,1990. -.38. Matthews DE, Heymsfield sa. ASPEN 1990 researchworkshoPQn energy

metabolism. JPENI 5.:3-14,1 99l.

39. Heymsfield S8, Baumgarner RN, Dilrnanian FA. Lichtman S, Kamen Y.Assessment of body composition: In: BrodoffB, Bjorntorp P, Lippincott 18, eds.Obesity.Philadelphia,Pa, 1991.

40. Heymsfield5B. Cufrp, Kotler DP. Acquired Immunodeficiency Syndrome: Enteral..andParenteral Support. .In: Kotler UP,ed. Nutritional Managementofthe AIDS:Patient. New Yor: RavenPress,i 99:1.

41. HeymsfieJd SB. nodycompositioil methodology:advanced methods. In: FidanzaF,

.ed. Nutritional Status .Asses.sment: A manual for population ,studies. London:Chapman:& Hall, 83-.96, 1991.

42. Heyinsfie1d SB, Jain)),. Ortz 0, Waki M. OlJesity: Cardiac stilclure ¡ind function inmaikedly obese patients before and afterweighi loss. In: Wadden TAandVa.nltalleTB,eds.ireatmentof the SeriouslyOnese Patient. New York: The GuiUfordPress,

.136-162.. .19.92.

43. fIe,ymsfield$B, tight: A. WangZM. Nutritional AssessmenlbyAnthropometricand ßiochemicàl Methods. 1ft: ShiJs ,ME, Olson lA. Shike:M, .eds. Moder Nutritionin Health and Disease. 'Ph~iadelphia: Lea.and Fl::biger, Eighth Edition, :1992.

(l4

44. Sun Y, 'Cai -L, Heymsfield SB. Design ;ofa Device tor the Mechanic;,IEnergyOutplt Meaurement ofa Human During MotiOß. :In:EI-Ashram and Youssef H.t\

eds. Dev~loptnei:s inProduction Engineering Design and Control, PEDAC' 92ConferencePtoceedings, 583-592, 1992.

45. Heymsfi~ldSa. WangZM. Human body çomposition:.the five-.Ievelrildet 'anditsrelation tobioimpedance ~nalysis. RÎ\;staltaliaiJ Oi NutrizioneParemeraleEdEriteralell:71-77.. 1993.

46. T¡ghe AP. AilisonDB, Kral JG, Heymsfield sa. Nutrition support of the .obese

patient. In: Rombeau JLand CaldweJlMD,eds. 'Parenteral Nutrition., VOL. 1, Second'Editjon.Philadelphia:W.B. Saunders, 1993.

47. Wang ZM, HeshkaS, Heymsfield SB. Application of computerized axialt.omogrphyin the ,study of.bodyco,Dlposition:Eval.uatioil of lipid. water:, prôtein,,and innetal in healthy imen. In:EHis KJ and EasHnaJ JD,eds. In: Human Bad)'COl1POSJÜoti: In Vivo .Methods, 'Models. and Assessment. New ¥ork:Plenurn Pi-ss,343-344, l993. .

48. 'Baurngarter:RN, $tawberPM, McHQgh n, Wayne S,Gany PI, Heymsfield SB.Body compòsitionin -.he 'elderly using multicomparinenlal :methods. tn: Ellls KJ.Eastman JOed:HumanBo'dy'Composition: In VJvo M~thods, Models. andAssessment. New Y ork: P:lenUm Press. 251-4,1993.

49. WangJ, Oilmanian FA. Thornton J. RusseU M, ,Burase-ro S. Mazaiiegos M,Heymsfiêld SB, ,Pierson RN Jr. In yiypntutron :actvation analysis (H/NA) for bod)'fat:CoJlparison with seven 'methods. 11': Ellis KJ,Eaunan JDeds. Humal1BodyCOJlposítion:ln Vivo Methods, Models. and Assessment. New York: PletiumPress,31-34, '1993.

50. Pierson Jr. RN, Wang J, Thornton JC, ,Russen MA Heynisfitld sa, MazriegosM,:Ma:.Rl1.Weber DA. JJiolQgicat :homqgeneÎty 'and precision of measurement: 'fbebou:darycondítipns for normal ;inhody £ompøsiiioR 1n: 'Ellis KJand Eastman JDeds. Human ,Body Composition::ln Vivo Method~, Moods. and Assessment. New

. Y orkPleilumPress, :15-ZL, -l993,

51. ~Lederroan SA, ;PiersonJr. 'RN,Wang), PaxtönAThomtönJ. Wendel J.,HeýmsfietdSa. Bo:dycomposìtionrneasur:~sdurj.Qg pregnancy: hi: Ellis KJandEas.~n.JD eds. Human 'BodyCo-mpositiøn:ln ViyoMethods,Models,and'Assessment. New York: :Plenum Jl,res, 193-196. 1.993.

52. MazegQs M, HeymsfIeJd 'SBJ' W~g.ZM,Wan,), Y~umura.g. Dilmanian'fA,:Pierson Jr. RN. Aging'affeçtslJody:compQsìtion: Young ys.elderwöiTen'pairmatchednn 'boy mass index. In: Ellis KJ and Eastman IDeds. Human Body

.(15

'Composition: In VivQ Methods, Models, and Asstssment.. New York .Plenum Press.245-50,1993.

.53. Vanltallie TB, YangM-U,Hoilea,RA, Heyinsfiéld SR Applications of bodyi:mposi.tion technnlogyin dinìcalmedicine: some issues and problems. In: KraJ JGand Van Itallie TB, eds.Great Bntain: Smith Gordon, Ch.8, 87';97, 1993.

54.Van ltallieTB, YangM-'U, Hoil~u RA, Heymsfield S8. Applic.ttions of body'composìtiontechno~logy¡ndinical medicine: some issues andinsi;ghts.ln: Ktal JGand VanltaUie TB.eds. :Recent Developmelits in .Body Composition Analysis:Methods.and Applic-ations:. London: Smith-Gordon, 61-74.1993.

55. Heymsfield 58., Waki M,LichtiIan S. Baumgartner R. Multicompart:mentcheinical

madelsôf humanbodyromposition :.recentadvance andp:otentiaJapplications. l~:Kral JG and VanItalIieTB,eds. Recent Pevelopmentsin BodyCo-i'lPositio.nAnalysis: Methods and Applicati()ns. London: Smith--ordon.75-,86, 1993.'

56. Heymsfidd SB,WangZM,Withers R Multitomponent molecular"'levei models üfbody :coinpositionanalysis.ln: Røche A. 'Heymsfield sa, Lohman T.eds. HumanBödyÇoflpositioil.Champaign: Human Kinetic.s, Chap 7: '129-147.

..-.-..'~' .1-~:~:.:' .:¿:'.".: .~. .'

57. Wang ZM,Ma R,PIerson R.1\ Jr, Heymsfield SB.Five..leveJ model :recoiistruc.tioi1.ofbody weight :atatorric. 'molecular. cellular, and tissue-system levels from 'neutronaciåva.tion analysTs. Human Body Composition: in vivo methods. models, .and .assessment. New York:PlenumP-ress, 125-l2S. '199~.

58. Heymsfield sa, Mathew.sDE.Body composition: research and clinical advances-ASPEN 1993 .resear-Gh workshop. JPEN 1'8:91-103. 1994.

59. 'HeshkaS, Buhl K, H~ymsfieid SB..Obesity:Clinical evaluation of bodycomposilionandenergyexpenditure. In: Blackbutn GL and Kanders as, eds.Obesity:Pathophysiology,P.sychology.. and Treatment. New York: Chapmaß &RaU, Inc.,Cll. J, 3-9-79, 1994~

.60. Heymsfield S8, Wang ZM.. The future ofbodycomposit1onreseach. In: navies~PSWand Cole TJ,eds. .Body :Composition TeChniques in Health~nd Disease.Camb(jage UK Cambridge 'UnìversityPress, 1'995. .

.61. Heymsfield S8, Allison DB, Heshka S, P:ier.sn RN Jr. The assessmentof:bòdycomposition. In: AUisonPB,e:. Handbook of Methods for the Assessment .ofHating Behaviors and Weight RèlatedProblems. Newbury Park. CA: SagePublications,51$.,559, J995.

62. HeSllkaS..Heymsfield SB.Pbatmacolögicalìreatment of obesity. In: Brownell KD,:FairbumCG, eds. 'Eating Disorders and Obesity. New York: The -Guilford 'Pr.eS,Ch. :89, 504-509. 1995.

66

63. Heymsfleld sa and Waitzberg DL.Composicao Corpörea. In: Waitzberg nt, ed. .Nutricao EntrraJeParenteral Na Pratica Clin'Ìa, 2nd.edt¡on~. Atheile!l,SaoPaÙlø,Brazi, 'i 995.

.64. FaithMS, :PietrobeIl A, Allison DB, Heymsfiefd SB.Preventionof;pediatnc. nbesity: Exatnining the issues and forecastingreserchdii-ctions. ,In: Bimdich A:and Di;keJbaum R,eçls.Preventive Nutrition. Totowa, NJ: Human Press, Jtic., 467-86, 1996.

65. -HeymsfieJd sa, LoweJl B. Medicai nutntionecducation in the United States ofAmerica. In: Widhàlm KLeibetseder L, nauerfried M, èds. OveTandUndernutritionín Europe, 7th Europeanl\lutrtion Conference. Austrti/1 Nutrition-SØc.y :Proceings. Vienna 1996.

6:6. fleYIJsfield SB, Wang ZM. Human bodycomppsition: .conceptual adv.aiies. In:AngelA, Anderson H, Bouchard ç, .Lau 0, :Leiter L. MendelsonR., eds. .Pro:gress.jnObesrty Research, John Ubbey & Company Ltd., 245':257. 1996.

'67. Heymsfield sa, Hoy MK Obesity_ 'In: R.E. Rakel,ed. Conn's Current The¡-apy.

;Philadilphia: w~a. Saunders-Co., 510-517.1996.

68.Withers'RT. Laforgiid, Heymsfield SB, WangZM.PH!RÐS RK. Two, threçandfoor--compartment chemical modeis ofbodyoompositionanaJysis. In: Norton K .and.Olds T, eds. Anthropomettical.Sydney: University øfNe.w$outh WaJes-Press. Ch.. .-8, 199-231. 1996.

69. :Backburn GL, Mi.lneT JA. HansenBC, Heymslield SB; Mason AC,Gaul GE.Nutrition societiespresiclents' forum: futur.e,challengesand ,opportities f.or

nutritioRso:ceties in the 21.st century. Am J Clii.-Nutr .(54:8.13':822,i 996.

70. .Pietrobelli A, :Fortnica-C, Wang ZM, Heymsfield sa. Dual-energy x-tay .. $-sorptiometry body composition model:revièwof physicalconc~pts. Am J ¡Physiot

271 :-94." ~5.1 ,1996.

71.. Heymsfield sa, Wang.ZM. BaumgarnerRi"J. Ross R. Human :body composition::advancesin modelS and :methods. An.nRev Nutr 17:527-558, .1997.

72. H~ymsfield Sa. :Energy .exchange-body weigliirelations:an overView. Supp Line:14( 1):3-5, 1997.

73. HeymstieldSB. Nutrition support at the scentific frontier. JPEN 21 :252-1.58.1997.

:74.Pietmbelli A,HeymsfieldSB. Leptin.: stator c-éllaret.Genes fhesisChirur¥ic,Ill(6)::-7; 1"997.

67

75. Heymsfield SB, ;Ro~sR, Wang ZM,Fon~ger D. lmaging ieehniqlJes ofbopy

CQmposition: Advantages ofmeaslJrel1ent and -JleW :U5~S. 10: Emerging TeChnologiesfor Nutrition R.e.search.Washington, DC National AcademyPress,Ch.5, pp 127-150,1997. '

76. Heymsfíeld S8, Baumgartner RI'I, Ross R. Allison 'DB, Wang ZM. Evaluation .oftotal a,dregiona1-body composition. In: BrayGA, :Bo!Jchard C, James WPT,edscHandbookofObesJty. New York Marcel DeCker., Inc., Ch. 3,4'1-77,1998.

77. WHO Expert Sub:cornmitteeon the 'Use and Interpr~tation of Anthropometry in:theElderly'. Uses andlnterpretatjon of Anthropometry in the Elderly for theAssessment of Physical Statusltepoi;to.the Nutrition 'Unitofihe World Healt.hOtgani~tion.Jour ofNutrHeaJthand Aging2: 5-17, 1998.

78. ,P.ietrobelli A.Wal1g ZM. Heyrns:field Sl3.. T ee-miques use -jn measunnghumanbody composition. Cur Open ìn ehn Nutr and MetabCare.l:439-448, 1998.

79. Heymsfield sa. Baumgartner RN, 'Pan :SF. Nutrition Assessment ofMali1utrition :byAnthropometric Methods. In: Shils ME et :31. '.Modem Nutrition in H~ith andDisease. Baltimore: WiUiamsand Wilkins. Chap. 56,pp. 903-'92,1999.

80. WangZM, DeurenbeTg P, Wang W, P:ietrdbelli A. Baumgartner R. Heytnsfield SB"Hydration of fat.,fTee body mass: review and Gritiqueof a Classic body compositionconstant. Am J Clin Nutr69: .R3J-84 t 1999.

.81. Wan ZM, WangZM, Heymsfield$B. History of the study'ofhuman bodycomposition: a brief review. Amer J Hum 'Biol II :157-165, 1999.

82. Gallagher D, Heymsfield sa, Wa.ng Z-M. Skeletl muscle markers. 10: The role ofprotein and aminp acidsí.o 'Sustaiiiingand enhancing 'performnce. Chap l2,pp.255-27LNat AcadPress(Washingìpn DC), 1999.

83. Heymsfield BG, Heymsfield SB. T:herapelticManagementof Obesìty.PCS£ 4:55-58, 2000.

84.' HeYm'sfieid'ßG, Heymsfieid SB. Therapeutic Management ofOverwclg-htPatients.'UB/GYNSpecia) Edition 5'1..54" "2000.

85. Allson O. :FontaÎne.l Hesbka S, Mentore 1. Heymsfield sa, Alternative

Tream~nts for Weight Loss: A Critical Review..Food 'Sci~nce and Nutrtîon.FOO:and Nutrition, 41( l): :i -t8(200 I).

86. "HeymsfieId Sß, ChobaP, AUison D,F"lancbaum -t. 'Nutritional.Support of theObesePatient. Clíoicàl Nutrìiion Parenterai Nutrition, 3: 407-428(2oo-l.

87.,Geliebter A, F'urikhauser Htymsfidd SB. :MealteplacementP-ròduCts and ..Fat A,

'68

St:bstitutesin W eightcontrQland Maintenance. Primary and Secndary PreventiveNutntion .13: 223-2~B,2000.

88_ Heymsfield SR Obesity. IN.: EBMSolutions Guidelines forHeàlth Care Providersand Consumers (online database). 'Issue J. Nashvi'e, Tènn:EBM Solutions; 2000.

89. Heyinsfield SB. Arredondo ER, Alva CV, Rodriqu.ez AF. Bodycompositìonassessment: from atomic level lopatient" shed. Nutrie-ion Clinica 2(1):81-9 i. 1999.

90. Withers RT, LaFoigia J, HeymsfieId SB. Critical appraisal of the estimation of bodycompositron via two, three, :and four-compartment models. Am J Hum BioI II :175-185,1999_

91. Geliebter A, Funkhauser Heyrnsfieid Sa. Meal ReplacementP.roducts 'and Fat A.Stib~titutes in Welght contrplandMaintenance_Primaryand Secondary PreveniiveNutrition Chapter l3,pg 223-233, 2000.

92. Allson O.Fontaine K Heshk S,Mentore J, Heymsfield SB. .Alternativetreatments for weight loss: a critical review.CritIcaIReview in Food Sciences andNutritiön. 20: 1;4 I( I): 1-28.

93. Hoffman a Heymsfield SR WaitzbergDL. Composicao Corporea.ln:Waitzberg

DC, ed. NutrcaoEnterale ParenteralNaPratica Oinica,Jrdedtion; Atheneu, Sao

Paulo, BTV;il.

94. Hey,nsfield SB. The development of Ostepporosis Diagnusis, Chini;ContenipOral)'Medicine, 7(1) 18-21, +OOL

95. HeymsfieJd SB, Heshka S. Measurement of Tota Energy Stores. In: FairburnCG.Brownell KD, oos. Eating Disorders and Obesity, Seco.nd Edition. New York TheGuilford Press. Chaper 22; 121-1.25.. 2002-

.96. Heshka S, Heymsfield SB. :PharacologicaJ Treatments øoth Horizon. In:Fairburn .eG, .Browi'.¿U.KD. eds. Eating Disorders and Obesity, SecoodEdition_New York: The Guilford ,Pr~ss. Chapter JOO,S51-56.l 2002.

97. Lee R, Wang ZM, Heymsfield S. 'SkeletaJMusde Mass::Regiotia1 andWbole-bo.dyMeasurement Methods. In: .Preedy V, Peters T,eds. Skeletal MusCle:Patholoh')\Di¡innsis and Maragement ofÐisease.London: GreefiY~ch MedícalMedía_

.Chapter 39,427,.39.2002.

98.. HotTanD, Huber..MiUerRK, Allison DB, WangZ,$henW. HeymsfieldSB.Human Body Composition. In: Eckel RH.ed. .Obestý: Mtchanismsand 'ClinicalM.anagement. .Pbila.el.phia: l..ippint:ott Williams &Wilki.ns. Chapter $. 103-127_

2003_

1

"6

-99.Pi~trobeUi A Heymsfield sa. Establishing bodyeomposition i"obesity. JEndøcrinol In\Test. 2002~ '25: 8S4-89i.

100. Heymsfiel~ ;sa, Hoffan D, 'T estolín 'ç, Wang ZM. Evaluation of hÚm,anadiposiiy.In: Bjõmtor:P.ed. dlnterr~ii9nal "rextbook.ofObesity. ChicheSter. UK: Jobn Wiley& Sons. Chapter 6, 8S"'97.20() L.

:11. HeshkaS. HeymsfiéJdSÐ- 'Obesity;and Gallstones. in: Björntorp P; ,ed.International Textbook of Obesity. Chic he Stet, UK: JohnWíley & Sons. Chapter 28.399-9.2001.

J

:1

1

I,~i¡ij~

I)l

102. Heymsfie.d 5B, Hoffan :OJ. lnvest¡gación de iacomposicióncörporal. In: deGirolami DH,ed.Fündamento:s de ValoraCión Nutricional y Composición Corporal.Buenos Aires: £1 Ateileo. '.Chaplet n. 151-168. 2003.

103. Heymsfield Sa. Obesiiy. In:EBM Solutions Guidelines 'for Health Care ProvidersandConsumers'(online.datase).lssueJ. Na$hville. TN: EBM Solutions, Inc. May2003.

104. . Poehlman E, Turturro A,Bodkin eN, C~fatu W, Heyrni;fieldSa. Holloszy J, -KemnitzJ .Ca:loricR~"1riction Mimetics:P.bysicai Activity.and l:lody Co~poition Changes.) .Gerontol A Bidl Sc:Í Med.scj 200-.; 56 '~pec no :l :45-54.

) 05. Saris ~'H, Heymsfi.eld S. Meettngsummar. Obes Res 2001; 9 (Suppl. 4) :219S~225.

106.. Heymsfield SB. Rhoads Lecture.: Heat and Life: The Ongoing Scientific 'Odyssey.Jouma'lofP:arentera:l.and :Enteral Nutrition 2002~ 26(6):319-332.

107. St.,O.nge ,l\fP, Heyms.dd 'Sß.Overw~ightand,obesity stílsi,ire-linked to 'Iower lifeexpectancy . Nutrtiön Reviews 2003 ; 61(9):3 B-3 16.

108. Restrepo'PE,WanZM, ShenW, H~ymsfieid SB. Evaluación y v:i~ilancìa de lacompusi.ciónc.oi;oral.:del :paciente obeso.ln: .Barranco JG, ed. Obesidad. MexicoCity: McGraw:Hilt Chapter 1 '1,103-)21. '200.

109, Heymsfield SB. Body Coinposition: .ai øverV.iew.ln: MedciO-s-Neto G. Hipem A,Bouchard C,ed_Progress -in Obesity Research: :9. John Libbey Eurote,,,t Ltd..Chapter 20~, 997-1001. 2003.

110. .Lee :RC,ßeyin~tield sa, SheD W, Wang ZM. Total~body -cdregÌo,nal skeletalmuscle mass .meaurement 'i:~thods:an ,o:vetview. t"t J )3odComp Res 2003~ 1(-3).

R.eviews Submitted :and '¡nPress

. Schneeman aO et al R~ucing -stress fracture in .physically ..active mil-itay women.

'7()

Wâl1g ZM,G.åHagher D,P:¡etrobell A Heymsfield SB. Multicomponent models of body'compositîon:an ,overvi.ew.

~.1. Wright RA" HeymsfieJd Seeds. Nutitionalassessmentofiheadult hospitalized

;patient. .Boston: Blackwel: ScientificPubliçatiofîs.lnc. 290~ages,l 984.

2.ICral JG, Heymsfiéld Seeds. Morbid obesity rand II Gastroenterology Clinics ofNorth Ameri~, 16,:numbers2and 3, 1987.

3. Ben SJ, Mat'3Te.se LE. Heymsfieid S8 eds. Nutritit)nassessmeotanthdlogy. Silye¡-

Sprng: ASPÊN. 1'991.

4 Roche A, Heyisfielld S.a. Lohman TEeds. Body Composition. Human Kinet-cs,

Champaign, ILL, 1996.

Editøria1sfhetlersfBøok Reviews

I. (Edjiorial) Heymsficld SB,.Gteenwood T. Roongpisuthipong C.Dieteticsand

.eiiteralnutritioii: past, presen and future. J Ain Diet Assoc85(6):667.,668, i 985.

2. (Editorial) Heymsfield SB. Nutrtion and the Heart: 'an -Update. Nutr ,ClinPrac192:81-82.1986. .3. (Edìtotial) HowardL, Heitd W. Heymsfield SH. Rhoads IE. A r~poi1 of:he

conference onclinital nutrition training forphysicians. Am JClin Nut¡- 44:135-153,1986.

4. .(EditonåI)HeymsfieldSB. Thepatbogenesis of cardiac cachexia: an ovel\iew. Nûtrlnt 3 :103, 1987.

5. (Editorial) Kral JG~ HeymsfieldSB. Morbid obesity; defiitions. epidemiology, and

.inethodologi~lpfoblems.Gatro.Cljn N Atii16(2): 191-205, J987.

6. .(Letter) Seaton TB, H~ytnsfieid S8, Rosenthal W. Ursodioxychofi:cac'id and

.:gal1stonesdurjng weight loss. New Engl JMed 310:1351,1989.

1. '(Editorial) Heymsfíeld SB, Waki M, Reinus J. .Are .patients witbch¡-onlcJjyerdise bypermetabolic'? HepatoIogy 1'1 (3):502..505~ 1990.

:8. ,(Bo'k 'Rev.) Allison Dn~:Heymstield -sa. Obesity: Theory and Therapy (2nd.Edition).JPEN 17(4):396, 1993.

71

9. (Leuer) Heyilisfield SR, H~hka S~ Lichtman S. Actual vs.self~reportedintakeandexercise in obe patients. New Engl J Med 328:1495, 1993.

I O.(Editotjal) Heymsfield SB,. Wang ZM . Measurement of total body ofatby ,undehvaterweighing: new insights imd uses foran oldmetbod. Nutntion9A72-3, 1993.

JI. (Book Rev.) Allison VB, HeymsfieldSR ObesÌties. VagueJ. fPEN 18(1):87, 1994.

12. (Book Rev.) Heymsfield sa, Wa~g ZM, Lohman TG. Advances in bodycomposition assessment. .JPEN :18(3:):283., 1994.

13. (EditoriaI) Gallagher 0, H~ymsñeld sa. Obesity is had for thehtai1 .butis weightloss good'? Obes Res 2: 160-163, 1994.

14. (Book Rev.) Allisön"DB, Wolper C, Heymsfield sa. A review ofimprovin~thelong..ienn management of øbesjty.by MichaelG. :Perri, Arhur M. Nezu, andBarbara J Viegener. JPEN lS.(l):&8, 1994.

J 5. (Bøk 'Rev.) AIlison Dß,Heymsfield SB. Arevìewöf the obese child, Edited byPL~Giorgì, .RMSuskind, .and C Catassi ¡PEN 1St J ):&9, '1994_

16. (Editorial) Heymsfield :$B. 'Enteral s.olutions: is there a solution? Nutr Clio Pract10.:4-7,1995.

,.

J 7. (flook Rev.) Alli'son DB. Heyinsfield 'SB. Obesity :in Europe 93.: Proceedings of the..Fifth £uropeaCongess on Obesity, edited by H Oitschuneit,F A Gries, H Haunet,V Schusdziarra, andJ.G Wechsler. JPEN19:424, '1995. .

l&.(Editoral) :Baumgarner RNand :Heymsfield SB,Roche AF. Huma'n body

coinpositjei1 andthronic diseâe.Ohes Res3 :73-95, ,1995.

19.fEditorial) HeymsfieldSB, 'P,ietobdliA. Morhid obesity: the prK;e,ofprogress.ElldPract 3(5J:320-32~, 1997.

20. (Editor1al)P.ietrobell A. Allison UB~ HeymsfieldS:BP(actical, ''Iow-cost 'body~

cOinpositionassessments.Wcight Conti Dig 7(6):675~677, 1997.

2l. (Editoriál) Hey.msfield S.Nuñez C. .P.etrobetli A Biomp.dailceanalysis:\\;hi:arethtnext steps? Nlitr'Clin Ptact 12:20.J -203, 1991.

. 22.' tEditøoal) RoubenoffR. HeytnSfield SB,Cannon JG, KèhayiaS JJ, Rosenberg IH.. Standardìzaiionöf nomtn.clature. of body iCo'mpositlon 'in welght .loss. J C1in Nutr66:192-'l96, f997.

.23. (Lelterto the editor) Heska S, H~ymsfield sa, Pi-Sunyer FX. Reply 10 Motan et atIf'l .J Obes. 22(3): 283~'84, i 998.

72

24.. (Editorial). ;Kotler Dand Heymsficld SB. HIVinfection: a model chi-iiicillness forstuøyí"gwæ.tingdisea~es. Am Jelin Nutr, 68(3):519-520, 1998. '

25. (Lener to iheeditor) HeymsfiéldSB and Kotler DP . Reply to PP GarcìaLuna eta!.

Am J din Nutr. 10('2)~ 30,1, 1999.

26. :(Letter) WangZ. :Deurenbergl-, Wang W,Pietrobelli A, Baumgarer ItHey:~tìeid SB.Hydrationøffat-freebody masS: newphysiologiGa inod~ing

a,pproach. AIT- LPysioJ.Ëndocnno1.Metab. 278:E7S2-E753, 2000.

27.' (Book Review) Allison Dand Heymsfield SB. Nutrition. Genetics, and Obesity_New :Eng J .Med.1000~342: 747.

28. :(BoökReview) Heymsfield SB. . Fat: Fighting the Obesity Epidemic, by RobertPoóJ. 227 pp.,'iIu.strated.New Yoik, New EngJ Moo. 344 (12): 940-941_

29. (Leiertotheeditör) Heymsfield SB.Reply to 'Christopher Nunez et at Am J ClinNutr. 73 :&45 -'846.2001.

Patents

:;;....Heymsfield SB, Sindair:M. Ratiometnc digital calipel-Patent # 4251 107.

Sakata K, Ko.damaM, Sato H, He)'msfield SB. Apparatus for determining basalmetabolism. ;Patent #-6477409.

Patents .filed

Fuknda Y. Heymst"íeld SB. Impedance measurement of multi frequency with .theuse 'of 1 Ö

elecod.es-.

Heymsfe-i sa, lwabuchi T. Kodama M.Method and apparatus for estimating ':body fat

,(l/BMI7%Ûû)-

, Kodaa.'M, Saio,n. Heymsfield sa. Apparaso-f deieriníng basalmetabølism_

'13

EXHIBIT 3

The Scientist :: Fraudulent Papers Stain Co-Authors, May 18, 1987 Page 1 of 4

, ,,,' , '0 i1'.rfheS"~ntl~t. ,--,

Volume 1 I Issue 13 I Page 1 I May 18, 1987 return to web page

~ NEWS

Fraudulent Papers Stain Co-Authors

By Rex Dalton

SAN DIEGO-Young scientists unwittingly caught up in scandals over fraudulent research have found the

experience to be a drain on their emotions and a stain on their professional careers.

Interviews with nearly a dozen researchers whose, names have been linked to some of the best-known cases of

fraud revealed that the practice of "gift authorship" has sidetracked academic careers, put federal research

grants beyond reach and thrown into question other legitimate studies they have published. It has even limited

their opportunities to practice medicine privately.

The young researchers appear to have been exploited in part because of their naiveté, which was as glaring as

their eagerness to receive credit for published research. Although none has been accused of participating

knowingly in the scientific misconduct, their careers have become clouded by the specter of dishonesty.

Jeffrey J. Brown, now 31, was a radiology fellow in the early 1980s when he came into contact with Robert A.

Slutsky, a former member of the departments of medicine and radiology at the University of California at San

Diego who last year was found to have produced 13 fraudulent papers and 55 others that a special review

committee termed "questonable." Brown is listed as a co-author with Slutsky on three fraudulent papers and

four others that have been withdrawn.

"I'm planning to stay in academics," said Brown, who has remained a researcher at the medical schooL. "I am not

going to let it deter me. But I worry that it wil hurt me in looking for a job or applying for grants. There are

certain people on the faculty that think less of me for my association with Slutsky."

'Foolish' Candor

Steve B. Heymsfield's bitterest memories relate to the reactions of his superiors when they learned he had been

touched by allegations of research fraud by a co-author.

Heymsfield was a young assistant professor of medicine in the late 1970s at Emory University in Atlanta. While

there he co-authored papers with John Darsee, a resident and research fellow. In 1983 it was determined Darsee

had fabricated data in dozens of cases. Darsee lost his Harvard fellowship and was banned from receiving NIH

funds for a decade.

"like a fool, I was open, honest and straightforward," Heymsfield said. "Whatever investigating committee came

through, I told them how I felt; any suspicion I had, any observations I had made.

"The response was that Emory asked me to leave; my grants dried up. I was tenured, so they couldn't fire me.But they definitely considered me an eyesore. I was set aside-taken off the ladder to the sky. It was obvious

http://www.the-scientist.coml1987 /5/1 8/1 /2/printerfendly 9/27/2005

The Scientist :: Fraudulent Papers Stain Co-Authors, May 18, 1987 Page 2 of 4

there would be no promotions or opportunities."

Heymsfield now heads the weight control and body composition laboratory at St. Luke's Roosevelt Medical Center

in New York. He has been nominated for a faculty position at Columbia University.

"If I don't get it," Heymsfield said, "there wil be one reason: Darsee."

John Mancini also knows the anguish of being associated with a researcher whose work has been questioned. "It

has been a soul-wrenching experience for those of us who were junior researchers," said Mancini, 34, now a

cardiologist at the Veterans Administration Medical Center in Ann Arbor, Mich. "Basically, three years of effort

were wiped out. It has an effect on my brain, my psyche and my souL"

Mancini came in contact with Slutsky as a research fellow from 1980 to '83 at the University of California at San

Diego. He is listed as a co-author on one fraudulent paper and seven questionable reports in which Slutsky was

the lead author.

'Is Your Work Real?'

Mancini remembers vividly the call from a university official that was his first indication of a problem with

Slutsky's work. The inquiry came two years after he had left San Diego.

"He said, 'You wrote such and such paper. Was that study performed?' " Mancini recalled. "It was like: 'Hello,

how are you? Is this study real?' I said, of course I did it."

But the question started him thinking. "It really knocked me for a loop, psychOlogically. I didn't know what to do

but cooperate," said Mancini. "I had to reevaluate my whole experience in San Diego. But that was my research

experience."

Gideon Strich, completing a residency in radiology at the University of California at Irvine, became embroiled in

the Slutsky affair when he was given "gift authorship" for two published articles. Both articles were subsequently

determined to be fraudulent by a university committee that investigated the allegations.

"I wasn't involved in the research, n Strich said, recallng that his signature was forged on documents giving

permission for his name to be used as a co-author. Noting that "everyone shared authorship" for group projects,

Strich thought at the time that Slutsky was simply paying him back for his dedicated work in the lab. Strich left

UC San Diego before the two reports were published.

"I thought, 'Isn't this nice.' I wrote papers he had little to do with, but his name appeared on them. I thought he

was recognizing that I did a lot of work for him. I didn't realize what a favor he had done me-landing me in a

great hole of mud," said Strich.

Despite the stain, Strich has been accepted for a radiology fellowship. But he expects eventually to enter private

practice.

Revising His CV

Psychologist Salvatore Cullari is co-author of a half-dozen research papers with Stephen E. Breuning. The papers

http://www.the-scientist.com/1987/5/18/1/2/printerfendly 9/27/2005

The Scientist :: Fraudulent Papers Stain Co-Authors, May 18, 1987 Page 3 of 4

date from 1979-80, when both men were staff psychologists at the Coidwater Regional Center for Developmental

Disabilties in Michigan.

A draft report in March prepared by a panel assembled by the National Institute of Mental Health alleges

Breuning never performed some studies he wrote up and published in the early 1980s on how drug treatments

affect retarded children. Breuning, now an administrator at a facilty in western Pennsylvania, has denied anyimpropriety .

Cullari said the allegations have prompted him to remove from his vita two questioned studies he did with

Breuning. "I pulled them until this mess is cleared up. I've testified that I didn't do anything wrong: I stil don't

know if he did," said Cullari, 35, now an assistant professor of psychology at Lebanon Valley College in

Pennsylvania.

"This wil probably affect me through my practice. Sure I want federal funding: that's where the action is. But I

would say that it's unlikely that the federal government wil ever fund me because of this." Cullari said he hasn't

bothered to apply.

Psychologist Donald G. Ferguson has avoided research entirely because of fears about the effect of being a co-

author with Breuning. Ferguson, 39, is now a county psychologist in Duluth, Minn. He had been a staff

psychologist at Coidwater with Breuning in 1978-80.

"In many ways, it is very traumatic," he said. "Science operates as an honor system. You take the research of

others at face value. When someone comes along and does something like this, you feel first like you have been

betrayed, then suckered, then somewhat guilty that you didn't figure out what was going on. .

"i am now reluctant to conduct any research. In my current job, I have good access to a database; I could get a

research appointment. But I am reluctant to put a lot of effort into research. I get the feeling that even if I didhave a decent piece of research, I couldn't get it published in a journal."

Golden Protection

For most researchers, the knowledge that a senior colleague had acted Improperly came as a complete surprise.

But some admit they could have been more observant. Brown describes his reaction to his discovery, while stil

working with Slutsky, that he was being credited with authorship of articles for which he did no work.

"I resisted that, initially," he said. "I told him that if my name was on a paper, I had to do something. After that

he'd let me chase down X-rays to be photographed. But the X-rays weren't included in the paper; he was just

doing it to satisfy me.

"I realize now I should have said, 'This has got to stop.' But I didn't because he was the golden boy of the

department.

The impact of a hint of fraud is not confined to academia. One researcher damaged by the Slutsky affair was

surprised to learn the stain carried over into the private medical community.

The physician, who requested anonymity, said: "I had applied to a private group. It was a lucrative practice, but

the doctors were really caring individuals. And they were interested in me.

htt://www.the-scientist.comlI 987/5/18/1/2/printerfendly 9/27/2005

The Scientist :: Fraudulent Papers Stain Co-Authors, May 18, 1987 Page 4 of 4

"One day a partner called and said the group was concerned about Slutsky's name on my papers. I couldn't

believe it. I knew it would hurt me in the academic world, but I never thought it would make a difference for a

job.

"They didn't call me back," he went on. "When I saw this could hurt me to the tune of $250,000 per year, I

realized it was no game."

Dalton is a staff writer on The San Diego Union.

return to webpage

htt://www.the-scIentist.com/1987 /5/18/1/2/printerfendly 9/27/2005

EXHIBIT 4

630

1

2

3

HEYMSFIELD

events in my life. It was one of many.

Q. Well, the bottom line is that you

4 were asked to leave Emory University as a

5 result, fair?6

7

8

MS. KAPIN: Objection,

argumentati ve, mischaracterizing.

A. If you can find that written

9 anyplace, anywhere in any reliable document

10 I'd be happy to affirm its validity.11 (Respondents' Exhibit 20, document,

12 marked for identification, as of this13 date. )14 Q. Let me show you what' s been marked

15 as Exhibit 20, correct. Are you familiar

16 with a publication "the scientist"?

17 A. Yes.18 Q. This is Volume One, Issue 13,

1 9 Ma y 1 8 , ' 87 .

20 A. Yes.21 Q. Down at the bottom, last full22 paragraph it says, and quoting you, "The

23 response was that Emory asked me to leave; my

24 grants dried up. I was tenured, so they

25 couldn' t fire me. But they definitely

631

1 HEYMSFIELD

2 considered me an eyesore. I was set

3 aside-taken off the ladder to the sky. It4 was obvious there would be no promotions or

5 opportunities. "

6 That's what you told the reporter,

7 right?8 A. This is a newspaper article and 1'm

9 not sure what the quote context I gave this

10 quote, but if you can find anything

11 objective, and I don't mean a newspaper

12 article, from Emory University, written to me

13 in any document, and you can go to the dean,

14 you can get all the files, that asked me to

15 leave I would be very shocked.

16 Get my question back.Q. I didn i task

17 that question.18

19

20

21

22

23

This is a newspaper article.

MS. KAPIN: Doctor, you don't have

to throw out challenges to opposing

A.

question.

A.

Q.

Yes, yes.

And likely will take you up, but

24 that wasn't the question. Can you read the

25 question and we'll take a break.

202

1

2 Fifteen years.

3 Q. SO 1971, is that when you were on

4 the faculty at Emory University or --

5 A. It's when I arrved there for

6 training as an intern.

7 Q. As an intern at Emory University

8 were you on the faculty then or was it a

9 tyical medical internhip?

10 A. llypical medical internship.

11 Q. And how long was that internship?

12 A One year.

13 Q. And then after the internship did

14 you do a residency?

15 A Yes.

16 Q. That was also Emory University?

17 A Yes.

18 Q. How long was the residency?

19 A One year.

20 Q. SO it's up to 1973?

21 A. Yes.

22 Q. And then after the residency what

1

23 was the nature of your affiliation?

24 A Did a fellowship at that point.

25 Q. And is that still in a student

203

2 capacity or is that now a teaching capacity?

3 A I think that's a marginal question.

4 Of course it's a, you know, you're always

5 teaching in the university. So of course I

6 was teaching at the point I was a fellow. But

7 it's not a faculty appointment if that's the

8 question you're asking.

9 Q. You left Emory University, what?

10 '84?

11 A '86.

12 Q. '86. And anything in paricular

13 that prompted you to leave Emory University

14 and join St. Luke's?

15 A Same thing. Enormous opportnity.

16 Q. Any other reason?

17 A No.

18 Q. What is your financial arangement

19 with Merck?

2

20 A I am a full-time employee.

21 Q. Is that a salared position?

22 A. Yes.

23 Q. How much is your compensation with

24 Merck?

25 MS. RICHARDSON: I am going to go

204

2 ahead and object here. Ths is beyond

3 the scope of this expert's report.

4 MR. PRICE: I think it goes directly

5 to the issue of bias. He is employed by

6 a pharaceutical company that is studying

7 weight loss products that --

8 MS. RICHARDSON: You're

9 characterizing the witness's testimony.

10 I hear your argument.

11 MR. PRICE: Let me finish. -- that

12 wil compete hopefully with the

13 respondent's product if they get to

14 market.

15 MS. RICHARDSON: Again, I don't

16 believe the witness has testified to that

3

17 today.

i 8 BY MR. PRICE:

19 Q. You can go ahead and answer the

20 question.

21 A $300,000 a year round numbers.

22 Q. Let me have you --

4